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CHAPTER 1 
GENERAL INTRODUCTION 
This thesis describes some novel aspects of the regulation of salt and 
water secretion in the intestinal epithelium. This process is not unique for the 
intestine, but a common and necessary function of many other organs, including 
the stomach (gastric juice), kidney (urine), sweatglands (sweat), gallbladder (bile), 
testis, some endocrine glands and the lungs. Also most of the transport systems 
involved are not uniquely expressed in the intestine but shared by a variety of 
other salt transporting epithelia; this is exemplified by the generalized 
exocrinopathy seen in cystic fibrosis (CF), a genetic disease characterized by a 
mutation in a cr channel protein (designated CFTR) commonly expressed in 
epithelial tissues [Riordan et a!., 1990; Kartner et a!., 1991; Anderson et al, 1991 a; 
Bear eta!., 1992]. 
Some characteristics of ion transport regulation, however, are exclusively 
found in intestinal epithelium. These include: i) the pseudohormonal action of 
microbial enterotoxins (e.g. cholera toxin, heat labile and heat stable Escherichia 
coli toxin) on intestinal salt and water transport, resulting in secretory diarrhoea 
(SD) and dehydration: SD is still a major cause of morbidity and mortality among 
children in the developing countries [Guerrant, 1985]; ii) the role of cGMP and a 
cGMP-dependent protein kinase as intracellular mediators of intestinal ion 
secretion [DeJonge, 1981; DeJonge and Lohman, 1985; DeJonge and Rao, 
1990]; iii) the presence of G-protein-activated phospholipase C at the brush 
border membrane, despite the absence of G-protein-coupled hormone receptors 
at this subcellular region [Vaandrager et a!., 1990]; iv) the CF defect in 
cholinergic/Ca2 • -mediated activation of intestinal cr secretion [De Jonge et a!., 
1987; Berschneider et a!., 1988; De Jonge et a!., 1989], in sharp contrast to the 
normal Ca2 • -linked cr channel activation observed in most other CF-affected 
epithelia (airway [Boucher eta!., 1989; Wagner eta!., 1991], sweat gland [Sato 
and Sato, 1984]). This and some other unique aspects of intestinal signal 
transduction described in this thesis, render the study of ion transport regulation 
in the intestine especially rewarding. 
In this first chapter a brief overview is presented of current concepts 
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about the molecular basis of transmembrane and intracellular signal transduction 
mechanisms in mammalian cell types in general and in intestinal epithelium in 
particular. The last paragraph summarizes the specific aspects of intestinal ion 
transport regulation that were examined in the studies described in Chapter 2-6. 
1.0 Salt and water transport in the intestine 
The intestinal tract consists of the small intestine, divided into duodenum, 
jejunum and ileum and the large intestine or colon. Absorption of salt, water and 
nutrients is performed by the villous epithelial cells lining the lumen of the small 
intestine. In each villus a network of blood and lymph vessels serves to transport 
the nutrients taken up by the epithelial cells. Each absorptive cell bears a striated 
structure at its apical membrane, the so-called brush border equipped with 
numerous microvilli, facilitating the uptake of nutrients by enlargement of the 
membrane surface. The villous cells are surrounded by a circular depression 
known as the crypts of Ueberkuhn, responsible for salt and water secretion 
"' ~ ~
w 
0 
"' :::> 
-' ~ 
> 
~ 
-' w 
0 
,.. 
a. 
!;: 
0 
SMALL INTESTINAL EPITHELIUM INTESTINAL LUMEN 
MICRO ACTIN 
I 
J 
l 
I 
200 X 
0 TE~NAL ; 
, l~/ 
~:~@jjj)_ 
.. { 
FIGURE 1. Morphology of the small intestine. Left: light microscopic view. Right: schematic 
drawing of an epithelial celL 
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(Fig.1). Some absorption and secretion of salt and water is also performed by the 
epithelial cells lining the large intestine. All intestinal epithelial cell types, including 
the mucus-secreting Goblet cells, originate from progenitor cells (stem cells) 
located at the basis of the crypt [Ponder eta!., 1985]. Most epithelial cells, with 
the striking exception of Paneth cells, subsequently migrate along the cryptjvillus 
axis and are finally extruded into the lumen, resulting in the loss of 2.10'0 villous 
cells each day and renewal of the epithelial cell layer every 4 days [Madara, 1991]. 
The regenerative capacity of the intestinal epithelium facilitates a fast recovery 
from irreversible damage or biochemical modifications brought about by toxic 
substances in the intestinal lumen, including cholera toxin [DeJonge, 1975a]. 
A considerable amount of fluid and enzymes is secreted and added to the 
lumen of the gastro-intestinal tract to facilitate mixing and digestion of nutrients 
each day: orally 1.5 liters of fluid is consumed, opposed to 8.5 I secreted by the 
gastro-intestinal tract (salivary glands 1.5 I, stomach 2.5 I, bile and pancreas 2 I, 
small intestine 1.5 I and large intestine 1 1). To prevent dehydration, water must 
be reabsorbed, which is carried out by the villous cells of the small intestine (80-
90%) and the colonic epithelial cells. This reabsorption is very effective, causing 
loss of only 150 ml fluid in the faeces [Powell, 1987]. Since enterocytes do not 
have an active transport system for water, its transport is driven by an osmotic 
gradient across the epithelium. This gradient is built up by transcellular Na + 
absorption and cr secretion, coupled to cr absorption and paracellular Na + 
secretion, respectively [Field eta!., 1989]. 
1.1 ion transport systems involved in intestinal chloride secretion 
The vectorial transport of electrolytes across epithelial barriers depends 
on the asymmetry of permeability and pumping activities of mucosal and serosal 
portions of the epithelial cell membranes. For chloride secretion, this is provided 
by targeting of cr channels to the apical membrane and of K+ channels, Na + /K+-
ATPase and the NaKCI2-cotransporter to the basolateral membrane (Fig.2). In 
intestinal epithelial cells the inwardly directed electrochemical gradient for Na+, 
maintained by the Na + /K+ -pump, provides the energy for secondary active 
("uphill") transport of K+ and Cr through the basolateral NaKCI2-cotransporter into 
the cr secreting cell types. Na + and K+ leave the cell basolaterally by the Na + ;K+-
ATPase and K+ channels, respectively. cr. however, is secreted apically via cr 
channels. The resulting transepithelial electrical potential difference drives Na + 
from the interstitium to the luminal solution via the paracellular pathway, leading 
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to net NaCI and water secretion. 
It should be noted that all transport mechanisms indicated in Fig.2 are 
needed to provoke net chloride secretion. Therefore, inhibition of any of these 
systems will also inhibit chloride secretion. Thusfar, none of these intestinal ion 
transport systems has been characterized at the molecular level, i.e. by protein 
purification or molecular cloning. In view of this lack of information, current 
estimates of the number of different subspecies of K+ channels (at least two 
[McRoberts et al., 1985]) and cr channels (at least three [Worrell and Frizzell, 
1991]) expressed in mammalian intestine are based only on pharmacological and 
biophysical evidence rather than on differences in genes or splice variants. A clear 
exception is the molecular cloning of the cystic fibrosis-gene encoded protein 
(CFTR} which, according to very recent information [Anderson et al., 1991a; Bear 
et al., 1992]. serves as the major cr channel in the apical membrane of 
enterocytes and colonocytes. The molecular properties and function of CFTR will 
be considered later following the discussion of signal transduction pathways 
involved in CFTR regulation. 
FIGURE 2. General cell model of transport pathways in transepithelial salt secretion. The 
transporters involved are: Cr channels, K+ channels, the NaKCJ-cotransporter and the Na + /K+-
ATPase. 
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2.0 Regulation of chloride secretion 
The net flow of water and salt in the intestine is determined by a balance 
between absorption and secretion. Both processes are under strict neurohormonal 
control. In general, the transduction of extracellular signals (hormones, 
neurotransmitters) to a biological response, occurs through a cascade of 
reactions, starting with the binding of an agonist to a membrane receptor. In many 
cases, the resulting conformational change in the receptor activates a guanine 
nucleotide binding protein (G-protein), which transduces the extracellular signal 
either by activating or inhibiting membranal signalling enzymes (e.g. adenylate 
cyclase, phospholipases) or ion transporters (e.g. K+ or Ca2 + channels) [Gilman, 
1987; Brown and Birnbaumer, 1990]). The cytosolic second messengers 
generated by these enzymes (e.g. cAMP, inositol phosphates) can transfer the 
signal to multiple intracellular locations. The final messenger is often a protein 
kinase. Protein kinases constitute a class of enzymes that catalyzes the transfer 
of the terminal phosphate group of ATP to the hydroxyl group on a serine, 
threonine or tyrosine residue of a protein. This addition of negative charges to the 
protein generally results in conformational changes, responsible for altered 
function andjor interaction with other proteins, thereby initiating a variety of 
biological responses. 
Occasionally, the receptor protein is bifunctional and acts itself as a 
transmembrane signalling enzyme, e.g. a guanylate cyclase (generating cGMP) 
or a tyrosine kinase (ct. the insulin and EGF receptors [Ullrich and Schlessinger, 
1990]). Examples of each of these signal transduction pathways have been 
described in intestinal epithelium [Pillion et al., 1985; DeJonge and Rao, 1990; 
Rao and DeJonge, 1990]. In this tissue, the most prominent intracellular signalling 
molecules include cAMP, cGMP and the phosphatidyl-inositol-derived messengers, 
Ca2+ and diacylglycerol. An increase in intracellular concentrations of any of these 
mediators results in a stimulation of chloride secretion, the net effect being fluid 
accumulation in the lumen. A schematic drawing of these three signal transduction 
pathways is given in Fig.3. The properties and characteristics of the individual 
components of these pathways are summarized in the following paragraphs. 
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FIGURE 3. Signal transduction pathways leading to chloride secretion In the intestine. R, receptor; G, G-protein, AC, adenylate cyclase; GC, guanylate 
cyclase; PLC, phospholipase C, PT, pertussis toxin; DAG, diacylglycerol; lns(1 ,4,5)P3, Inositol (1 ,4,5) trisphosphate; A-kinase, cAMP dependent protein 
kinase; G-kinase, cGMP dependent protein kinase, C-klnase, calcium/phospholipid dependent protein kinase; Ca/CaM kinase, calclumjcalmodulln 
dependent protein kinase; BLM, basolateral membrane; BBM, brush border membrane. 
2.1 G-protein-coupled receptors 
The receptors that regulate G-proteins are structurally and functionally 
homologous despite the variety of stimuli, which range from light and smell to 
neurotransmitters, hormones and inflammatory agents. Each receptor is about the 
same size (40-50 kDa) and forms seven membrane spanning regions linked by 
three cytoplasmic and three extracellular loops [Taylor, 1990]. The third 
intracellular loop and the cytoplasmic C-terminal tail have several serine and 
threonine residues that are likely or demonstrated sites of phosphorylation [Taylor, 
1990]. Interaction among the second and the third intracellular loop is important 
to determine G-protein selectivity [Van Koppen and Nathanson, 1990]. The C-
terminal tail is also involved in G-protein recognition [Taylor, 1990]. In intestinal 
epithelial cells, receptors of this type have solar been localized exclusively to the 
basolateral membrane ([Vaandrager et al., 1990], see Fig.3 for typical examples). 
~ RL plasma membrane 0 GDP 
RL 
~ 0 GTP 1 Rl 
Effector 
GTP 
FIGURE 4. {ln)activation cycle of G-proteins. The interactions between agonist (A), receptor (R) 
and G-protein (a:By) are described in the text. Binding of the agonist to its receptor activates the 
G-protein by increasing the rate of guanine nucleotide exchange. Activation of the G-protein is 
coupled to the receptor cycle, in which the receptor switches between conformations with high (RH) 
and low (RL) affinity for its agonist. 
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2.2 G-proteins 
G-proteins are grouped into at least two classes: the hormone-linked 
trimeric G-proteins and the single (a) subunit G-protein typified by the ras family. 
As the (hormonal) regulation of chloride secretion is the main topic of this thesis, 
I will limit the discussion to the first of these two G-protein classes. The structural 
and functional properties of G-proteins have already been described in a variety 
of reviews [Gilman, 1987; Birnbaumer et al., 1987; Milligan, 1988; Taylor, 1990; 
Brown and Birnbaumer, 1990; Brown, 1991 and Boege et al., 1991]. Hereafter, the 
essential information from these reviews together with recent additional data will 
be discussed. Only the references not provided in the reviews above will be 
quoted separately in this section. 
GTP-binding proteins participating in hormonal signal transduction are a 
closely related family of heterotrimers, consisting of an a-subunit (39-52 kOa), a 
B-subunit (35-37 kOa) and a y-subunit (8-11 kOa). Only the a-subunit can bind 
and hydrolyse GTP to GOP and P,. The B and y subunits are always tightly 
associated. In the basal state, the G-protein exists as an a By heterotrimer with 
GOP bound to the a-subunit Upon activation of the receptor by the appropriate 
agonist, the receptor binds to the G-protein and promotes the release of GOP. 
The resulting agonist-receptor-G-protein complex binds the agonist with markedly 
higher affinity than it is to the receptor alone. At physiological concentrations, GTP 
binds instantaneously to the a-subunit This leads to dissociation of the agonist 
and the G-protein from the receptor as well as to the formation of the activated 
GTP-bound a-subunit which dissociates from the By-complex. The a-subunit is 
biologically active, although some responses are also mediated by the By-
subunits [Lotersztajn et al, 1992]. G-protein activation is terminated by an intrinsic 
GTPase activity followed by the reassociation of the GOP-bound a-subunit and 
the By subunits. A schematic drawing of this G-protein cycle is given in Fig.4. The 
a subunit of G-proteins have been implicated in a variety of biological responses 
(Table 1): regulation ofadenylate cyclase (AC), cGMP phosphodiesterase (cGMP-
POE), phospholipase C (PLC), phospholipase A2 (PLA2) and a variety of ion 
channels. The effectors that are activated by the different G-proteins have little in 
common in contrast to the G-protein-linked receptors and the G-proteins 
themselves. 
AC is dually regulated by Gs (stimulation) and Gi (inhibition). Gs is 
expressed as two long ( ± 52 kOa) and two short ( ± 45 kOa) forms, which are all 
splice variants of the same gene. Apart from the activation of AC, Gs is also 
involved in the regulation of multiple ion channels: the dihydropyridine-sensitive 
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Ca2+ channel (stimulation), cardiac 1, channels (stimulation) and neuronal Na+ 
channels (inhibition). All forms can activate AC and the Ca2+ channel and can be 
expressed together in one cell type [Mattera et al., 1989]. At present it is therefore 
not clear why different forms of Gs exist Inhibition of AC is mediated by Gi, a 
family of proteins encoded by three separate genes: Gi1, Gi2 and Gi3. Gi's are not 
only implicated in the inhibition of AC, but also in the activation of the muscarinic 
and ATP-sensitive K+ channel, activation of an epithelial cr channel and a Na• 
channel, and the activation of PLC and PLA2. Although some responses can be 
induced by all three Gi forms. e.g. activation of the [Ach]K+ channel, other 
responses are more selective, e.g Gi2 and not Gi1 or Gi3 selectively couple to the 
o subclass of the opioid receptor and some other hormone receptors [McKenzie 
and Milligan, 1990; Strussheim et al., 1990]. 
Activation of PLC is mediated both through pertussis toxin (PT) sensitive 
and PT insensitive pathways, suggesting the involvement of at least two different 
G-proteins. The identity of the G-proteins involved in the PT-sensitive pathway has 
only recently been clarified. In some systems Gi2 was implicated. In contrast, Go 
and not Gi1-3, was found to stimulate PLC in Xenopus oocytes [Moriarty et al., 
1990]. Go has not only been implicated in the activation of PLC, but also in the 
regulation of Ca2 • and K+ channels. Go is the most abundant G-protein in brain 
and constitutes a family of four proteins encoded by at least two genes [lnanobe 
1990]. Whether these different effector systems are regulated by different Go's is 
not known yet 
Candidate G-proteins for the PT-insensitive activation of PLC are Gz and 
Gq, which both lack the PT site. However, the distribution of Gz is restricted to 
neural tissues and platelets and it does not appear to be present in all tissues that 
show PT insensitive activation of PLC, arguing against a role for Gz in PLC 
coupling. In contrast, Gq was found to be ubiquitous distributed and to activate 
one of the isoforms of PLC [PLC 81, Taylor et al., 1991]. Finally, the hormonal 
activation of PLC by a number of agonists was inhibited by addition of "'• -specific 
antibodies in a variety of cell types [Gutowski et aL. 1991]. These data indicate 
that Gq couples several hormone receptors to PLC. Gq is a family oflive proteins: 
Ga:q, Ga11, Ga12, Ga13 and Ga14. Whetherthe PLC coupling is mediated by 
one of these Gq-subtypes or that each member of the Gq family can mediate this 
response is presently unknown. 
In vitro experiments suggest that a single G-protein can interact with 
multiple receptors (convergence). Interaction of a single receptor with multiple G-
proteins (divergence) is also found. The G-protein in turn can interact with multiple 
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effectors (divergence) or multiple G-proteins can interact with one effector 
(convergence). However, molecular cloning techniques have identified a still 
growing family of multiple closely related isoforms of intracellular effectors such 
as phospholipase C [Majerus et al., 1990] and K+ channels [Brown and 
Birnbaumer, 1990]. The apparent convergence of multiple G-proteins to the same 
effector may therefore be no more than a reflection of our present inability to 
detect a more specific interaction between distinct G-proteins and particular 
effector isoforms. Alternatively, the existence of multiple pathways resulting in the 
same response could be used as a fine-regulatory mechanism. 
TABLE 1. Function of G·proteins in signal transduction. 
G-protein subunit 
a:i1-3 
ao 
aq 
crt (transducin) 
By 
Effector 
Adenylate cyclase 
DHP-sensitive Ca2+ channel 
TIX-sensitive Na"'" channel 
Cardiac pacemaker It channels 
Adenylate cyclase (ai2) 
Phospholipase A2 (ai3) 
Phospholipase C (ai2) 
Muscarinic K+ channel (a:i1-3) 
ATP-sensitive K+ channel (a:i3) 
Epithelial Cr channel (a:i3) 
Phospholipase C 
Neuronal K+ channels 
Ca2 + channels 
Cardiac pacemaker 4 channels 
Phospholipase C 
cGMP phosphodiesterase 
Plasma membrane Ca2+ pump 
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Response 
stimulation, cAMP t 
opening 
closing 
opening 
inhibition, cAMP J. 
stimulation, AA 1 
stimulation, !nsPn t 
opening 
opening 
opening 
stimulation, lnsPn T 
opening 
closing 
closing 
stimulation, lnsPn t 
stimulation, cGMP .L 
inhibition of basal activity and 
stimulation of agonist..sensitivity 
closing (In absence of agonist) 
pheromone response in yeast 
2.3 Techniques used to study G-protein involvement 
To study whether a G-protein is involved in a particular biological 
response and which G-protein is involved, a variety of techniques can be used. 
First, G-proteins can be activated independently of their receptor by using i) stable 
analogues of GTP, e.g. GTPyS or Gpp(NH)p; ii) AIF;, which is thought to mimic 
the structure of the third phosphate group of GTP or iii) a wasp venom, 
mastoparan, which is thought to mimic the cytoplasmic part of the receptor. The 
elicited response should be inhibited by addition of a stable analogue of GDP, 
GDPBS, when a G-protein is involved. 
Secondly, the a: subunit of some G-proteins can be covalently modified 
by cholera toxin (CT) and/or pertussis toxin (Pn catalyzed ADP-ribosylation. 
Based on this property, the G-proteins can be divided in four groups: a substrate 
for PT (Gi, Go), a substrate for CT (Gs). a substrate for PT and CT (transducin) 
or not a substrate for these toxins (Gz, Gq). CT dependent ADP-ribosylation 
requires lipid, NAD, GTP and ARF (ADP-ribosylation factor, a member of the small 
G-protein family). The small G-proteins differ from the hormone-activated 
heterotrimeric G-proteins in that, i) they have no intrinsic GTPase activity, ii) they 
are not activated by AIF; and iii) Mg2+ is needed for nucleotide binding to the 
small G-proteins. CT -catalyzed ADP-ribosylation induces a constitutively active a:s 
subunit, leading to elevated cAMP levels (Fig.3). The PT -dependent ADP-
ribosylation also requires lipid and NAD, but ARF is not needed and GTP inhibits 
rather than stimulates the PT action as PT can only recognize the heterotrimer 
which dissociates upon addition of GTP. The PT-induced ADP-ribosylation is not 
activating the G-protein, but uncouples it from its receptor, which in the case of 
Gi, also leads to a (small) increase in cAMP levels. Thus, the sensitivity of a 
response to PT or CT provides information on which G-protein(s) could be 
involved. Furthermore, by using 32P-NAD+ in the ADP-ribosylation assay, G-
proteins are covalently labeled and their localization and behavior can be studied. 
Alternatively, the involvement of Gi can also be studied by using CT, since 
guanine nucleotide free Gi can be recognized and ADP-ribosylated by CT. In vivo, 
this can be used to identify which hormone receptor couples to Gi: hormonal 
activation of Gi induces the formation of a G-protein without bound guanine 
nucleotide (Fig.4). Labeling of Gi by CT will thus only occur when Gi has been 
activated by the agonist [Milligan and MacKenzie, 1988]. 
Third, G-protein subunit-specific antibodies have been commonly used for 
purifying G-proteins and for studying the localization and phosphorylation of 
known G-proteins and has led together with molecular cloning techniques to the 
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identification of families of G-proteins and of novel G-protein-like proteins. By 
microinjection of specific antibodies, the contribution of a specific G-protein to a 
particular biological response can be studied. The purified G-protein subunits can 
be used in reconstitution assays to obtain information on their selectivity in 
coupling to different receptors andjor effectors. 
In Chapter 2, several of the techniques mentioned above have been used 
to study G-protein expression and distribution in intestinal epithelial cells. 
3.0 The phosphoinositide cycle 
Many hormones, neurotransmitters and mediators of inflammatory 
reactions (e.g. epinephrine (a1), acetylcholine, substance P, histamine and 
bradykinin) act by activating the phosphoinositide cycle [reviewed by Berridge 
and Irvine, 1989 and Shears, 1989]. Coupling of the agonist to its receptor is 
thought to induce a conformational change such that a G-protein is activated. This 
G-protein, called Gp and in some cells identified as Gq, Gi2 or Go (see earlier), 
activates a phospholipase C (PLC). This enzyme cleaves phosphoinoshide (4,5) 
bisphosphate (PIP2) in inositol (1 ,4,5) trisphosphate (IP3) and diacylglycerol 
(DAG).IP3 induces calcium release from intracellular IP3-sensitivestores, followed 
by calcium entry via Ca2 + channels in the plasma membrane. Calcium can act 
together with DAG to activate protein kinase C (PKC), a phospholipid and calcium 
dependent serine/threonine kinase. Calcium can also activate a 
calciumjcalmodulin dependent serine/threonine kinase by binding to calmodulin 
(Fig.3). The activated kinases phosphorylate their specific substrates, thereby 
eliciting a variety of biological responses, e.g. chloride secretion in epithelial cells 
[Rao and DeJonge, 1990; Fig.3j. 
3.1 Phospholipase C 
Phospholipase C (PLC) is the enzyme that cleaves polyphosphoinositides 
to yield diacylglycerol and inositol phosphates (lnsPn). PLC consists of a family 
of cytosolic proteins of which 9 isolorms are yet identified: 1 PLC a, 3 PLC 13, 2 
PLC y and 3 PLC 3 [reviewed by Majerus et al., 1990]. All isolorms were shown 
to cleave PI, P1(4)P as well as PI(4,5)P2. However, P1(4,5)P2 is the preferred 
substrate at physiological calcium levels. The tissue distribution differs somewhat 
in that PLC "' is most abundant in liver, PLC 8 and o most abundant in brain, 
whereas PLC y is more ubiquitously distributed over many tissues. The 
differences in tissue distribution can however not explain the existence of so many 
isolorms, since more than one isoform can be expressed in one cell. 
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PLC y1 has been implicated in tyrosine kinase receptors mediated signal 
transduction pathways: PLC y1 was selectively phosphorylated by the epidermal 
growth factor (EGF) receptor and the platelet-derived growth factor (PDGF) 
receptor [Majerus et al., 1990; Rhee, 1991], leading to activation of PLC [Nishibe 
et al., 1990]. Protein kinase A-induced phosphorylation of PLC y in C6Bu1 cells 
correlated with inhibition of the norepinephrine-stimulated lnsPn formation, 
suggesting a role lor PLC y also in the action of G-protein coupled hormone 
receptors [Kim eta!., 1989]. In contrast, overexpression of PLC yin NIH 3T3 cells 
led to an increase in InsPn release by PDGF, but not by bombesin, suggesting 
that G-protein coupled hormone receptors in these cells are not coupled to PLC 
y [Cuadrado and Molloy, 1990]. This was confirmed by the finding that EGF, but 
not G-protein-coupled agonists induced the translocation of PLC y1 from the 
cytosol to the membrane [Todderud et al., 1990]. Recently, PLC 131 and not PLC 
y1 or o 1, has been shown to be activated by a; subunits of Gq, a new class of 
G-proteins [Taylor et al., 1991], suggesting a role for this isoform in signal 
transduction by G-protein-coupled hormone receptors. In condusion, dependent 
on the cell type the different PLC isoforms may be involved in different signal 
transduction pathways and therefore couple to different types of cell surface 
receptors. With regard to the intestine, no specific information is yet available 
about the PLC isoforms expressed in enterocytes and colonocytes, their 
intracellular distribution and their contribution to PI-cycling in the basolateral and 
the apical membrane. 
3.2 Inositol phosphates and calcium mobilization 
Calcium-mobilizing agonists stimulate the production of inositol (1 ,4,5) 
triphosphate (IP3), which is rapidly metabolized to a number of other inositol 
phosphates by a series of kinases and phosphatases, including inositol (1 ,3,4,5) 
tetrakisphosphate (IP4), which is postulated to act together with IP3 to regulate 
calcium entry. The metabolism of the various inositol phosphates, shown in Fig.5, 
terminates the signalling activities of IP3 and IP4. The resulting formation of 
inositol is used for lipid resynthesis. To enable the measurement of inositol 
phosphate production, u+ is used, which inhibits the degradation of lnsP to 
inositol and causes the accumulation of inositol phosphates [see also Chapter 4]. 
Recently, the receptor for IP3 has been cloned and characterized 
[Furuichi et al., 1989; Mignery and Sudhof, 1990]. The receptor has a 
transmembrane domain that forms a Ca2 ' channel and a large cytoplasmic 
domain that contains the IP3 binding site. Binding of IP3 induces a conformational 
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change leading to opening of the Ca2 + channel and a rise in cytosolic calcium. 
Often, the calcium signal initiates in one region and is than distributed over the 
cell in the form of a wave. In hepatocytes, the site of origin is shown to be 
independent of the type of PI-coupled receptor, suggesting that the IP3-sensitive 
calcium pool has a restricted localization in the cell [Berridge, 1990]. The 
propagation of the calcium signal is now thought to occur through calcium-
induced-calcium release and diffusion of IP3 deeper within the cell [Berridge, 
1990; Irvine, 1990]. The resulting IP3-induced calcium oscillations can be 
explained in two ways, which have been shown to occur both: first, the receptor 
controlled model: IP3 itself oscillates presumably caused by negative feedback of 
protein kinase Con phospholipase C; secondly, the second messenger controlled 
model: IP3 itself is at a constant level, but calcium oscillates presumably as a 
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FIGURE 5. The phosphoinositide cycle. Binding of an agonist to its receptor activates 
phospholipase C, which catalyzes the hydrolysis of phosphatidylinositol (4,5) bisphosphate 
(P1(4,5)P2). The products diacylglycerol (DAG) and inositol (1,4,5) trisphosphate (lns(1,4,5)P3) are 
further metabolized and finally combined to form phosphatidylinositol (PI). The biological active 
compounds are indicated by the fat appearance. The formation of inositol and thus the resynthesis 
of PI can be blocked by Li +. 
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result of calcium-induced-calcium release [Berridge, 1990]. The frequency of the 
spikes in the IP3-induced calcium oscillations varies with agonist concentration, 
suggesting that calcium signalling might be frequency-encoded [Berridge, 1990]. 
The mechanism by which Ca2+ and IP3 interact to control calcium release 
is still unknown. Irvine has hypothized that the IP3 receptor contains both a IP3 
binding site (cytosolic) and a calcium binding site (intraluminal) [Irvine, 1990]. 
Binding of Ca2+ to the receptor will change the affinity for IP3 and vice versa. A 
build up of cisternal calcium sensitizes the IP3 receptor to the endogenous level 
of IP3, leading to potentiation of calcium release in filled calcium pools. The 
intraluminal calcium concentration thus plays a major role in controlling the 
cytosolic calcium levels. 
The mechanism of calcium entry is still controversial, but it is partly 
regulated by the intracellular calcium pools and by IP4. The IP3 receptor is 
proposed, in analogy with the ryanodine receptor, to play a role in the 
communication between the endoplasmic reticulum and the plasma membrane 
[Irvine, 1 990]. The calcium binding site of the IP3 receptor could be important in 
transducing information about the filling of the intracellular calcium pooL 
Interaction of the IP3 receptor with the plasma membrane could occur by 
interaction with the IP4 receptor. The IP3 receptor interacts with the IP4 receptor 
when calcium andjor IP3 are bound. Binding of IP4 to its receptor causes 
dissociation from the IP3 receptor and induces calcium entry. Low intraluminal 
calcium will also result in dissociation of the IP3 from the IP4 receptor and thus 
stimulate calcium entry. This model [Irvine, 1990] is based on available knowledge 
and needs to be substantiated by further experimentation. 
It should be noted that in spite of the known occurrence of IP3-provoked 
Ca2 • release [Van Corven et aL, 1 987] and secretagogue-operated Ca2 • channels 
[MacLeod et al., 1991] in intestinal epithelial cells (cf. Chapter 4), no detailed 
studies have been undertaken to define the role of IP4 in Ca2 • entry in 
enterocytes. Another intriguiing question pertinent to the enterocyte is the 
mechanism by which the vitamin D-dependent Ca2 + -uptake pathway in the 
duodenum [Nemere and Norman, 1991] is kept separate from the Ca2• pool 
triggered by intestinal secretagogues. 
3.3 Diacylglycerol 
A well-defined pathway for generation of diacylglycerol (DAG) is initiated 
by the receptor-mediated stimulation of inositol phospholipid (PI) breakdown by 
a specific phospholipase C (PLC). In response to various calcium mobilizing 
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agonists, many cells produce DAG in a biphasic manner. The early transient 
phase peaks within 30 sec., whereas the delayed and quantitatively larger second 
phase reaches a maximum within 2-15 min. of stimulation and is long lasting 
[Billah and Anthes, 1990]. The initial rise in DAG temporally correlates with IP3 
generation and its fatty acid composition (mainly 1-stearoyl-2-arachidonoyl-sn-
glycerol) closely resembles that of Pl. These obseNations indicate that the early 
DAG is formed by PLC action on PIP2. Considerable evidence now emerges that 
the sustained DAG formation is derived from phosphatidylcholine (PC) and not 
from PI: (i) the DAG mass is kinetically distinct from and exceeds the mass of 
lnsPn; (ii) the fatty acid composition is similar to PC (rich in myristic acid) and (iii) 
certain agonist (e.g. EGF, interleukin 1 and 3 and p21 ras) induce a sustained 
increase in DAG without provoking PI hydrolysis [reviewed by Billah and Anthes, 
1990; and by Exton, 1990]. 
The second messengers derived from PIP2 hydrolysis, calcium and DAG, 
act synergistically to stimulate PC breakdown, suggesting that initial increases in 
calcium and DAG by PLC action on PIP2 may be necessary lor subsequent PC 
hydrolysis. However, sometimes PC hydrolysis preceded PI breakdown, 
suggesting that PC hydrolysis can couple to its own membrane receptor, 
independently from PIP2 hydrolysis. Several reports suggest the involvement of 
a G-protein. However, unequivocal proof lor G-protein regulation of receptor-
mediated PC hydrolysis must await appropriate reconstitution studies. 
Other pathways to raise DAG levels are also described, such as de novo 
synthesis from glucose [Farese et al., 1987; Rossi et al., 1991], PDGF-stimulated 
acylation of monoacylglycerol [Hata et al., 1989]) and IGF-1-stimulated hydrolysis 
of glycosyi-PI [Kojima et al., 1990]. Often more than one DAG generating pathway 
is activated by an agonist, e.g. IGF-1 stimulates PC hydrolysis, de novo synthesis 
of DAG and glycosyi-PI hydrolysis [Kojima et al., 1990]. 
The physiological relevance of these different DAG species is unclear. The 
distribution of PI and PC differs within the membrane, which could lead to 
compartimentalization of different DAG species within the cell and in that way elicit 
specific responses [Martinson et al., 1989]. Alternatively, the different species of 
DAG could be a mechanism to specifically activate one of the PKC isoforms. At 
present, it is not known whether these different DAG species are all capable of 
activating protein kinase C (PKC) in the intact cell. In vitro studies indicate that 
most classes of DAG are capable of activating purified forms of PKC [Go et al., 
1987]. The sustained DAG generated by PC hydrolysis could be involved in 
cellular control mechanisms that require prolonged activation of PKC. These may 
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include the regulation of transcription and other events related to cell growth and 
differentiation. In contrast, PI-derived DAG could be responsible for mediating 
short-term effects of PKC, e.g. secretory processes. 
In intestinal epithelial cells, large quantities of DAG are formed from 
monoglycerides and fatty acids during triglyceride resynthesis and chylomicron 
formation in duodenal and jejunal villous cells [Shiau, 1987]. Although it is likely 
that this pool of DAG is kept separate from the DAG involved in PKC activation, 
the mechanism underlying such a compartimentalization is still unknown. 
3.4 Protein kinase C 
Protein kinase C (PKC) is a calcium/phospholipid dependent 
serine/threonine kinase that is activated by diacylglycerol or phorbol esters. Its 
properties and characteristics are reviewed in Nishizuka, 1988; Parker eta!., 1989; 
Ohno et a!., 1990; Bell and Burns, 1991 and are discussed in the paragraph 
below. Phorbol esters can be used to activate PKC independent of receptor-
mediated processes. PKC exists as a family of at least 8 genes, encoding 9 PKC 
isoforms: a:, 61, 82, y, o, e, (, '1 and 8, which can be subdivided in calcium 
dependent (a:, 131, B2, y) and calcium independent (3, e, (, t], 8) PKC's. All PKC 
isoforms have been cloned and characterized, except PKC e which has not been 
fully sequenced yet. PKC consists of 4 conserved and 5 variable regions which 
form a regulatory (V1-C2) and a catalytic (C3-V5) domain. PKC 131 and B2 are 
splice variants of one gene and differ in their V5 region. The regulatory domain of 
PKC contains 1) the pseudosubstrate (V1/C1), an amino acid sequence that 
closely resembles PKC substrates; 2) one (PKC () or two (all other PKC's) 
cysteine rich regions (C1) probably involved in DAG and phorbol ester binding 
(PKC ( has lost its phorbol ester binding site and its response to DAG) and 3) the 
putative calcium binding domain (C2), which is only found in the calcium 
dependent PKC isozymes. The C-terminal catalytic domain of PKC contains the 
ATP binding site and the protein substrate binding sites. The catalytic domains 
can be separated from the regulatory domain by proteolysis, resulting in a 
constitutive active PKC fragment, PKM. 
Activation of PKC is believed to occur through binding of diacylglycerol 
or other lipid activators (e.g. arachidonic acid), which causes dislocation of the 
pseudosubstrate from the active site by conformational changes. The binding of 
DAG greatly increases the affinity of PKC for calcium and phosphatidylserine, 
causing enzyme activation at resting calcium levels. Upon activation PKC shows 
a redistribution from the cytosol to the membrane and sometimes to the 
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cytoskeleton [Kiley and Jaken, 1990] or nucleus [Leach et al., 1989]. Calcium is 
thought to increase the potency and rate of action of phorbol ester by eliminating 
any lag-time required lor recruitment of PKC to the membrane [May et al., 1985]. 
Sometimes, one or more PKC isotypes were already found in the particulate 
fraction of unstimulated cells, suggesting that PKC translocation is not a 
prerequisite lor activation of the enzyme [lsakov et al., 1990; Chapter 5]. 
In general, PKC ex, B1 jB2 and y have similar properties with respect to 
effector dependence and substrate specificity, although there are relative 
differences that are likely to affect cellular responses. In contrast, PKC e has a 
clearly different substrate specificity than PKC ex, B, y: Histone IllS a common in 
vitro substrate for PKC a:, B, and y was barely phosphorylated by PKC e [Schaap 
et al., 1989]. The substrate specificity seems to be defined by the regulatory 
domain, since 1) the proteolytic fragment, which has lost the regulatory domain, 
can use Histone IllS as a substrate [Schaap et al., 1990] and 2) a fusion protein 
containing the regulatory domain of PKC y and the catalytic domain of PKC e 
shows PKC y defined substrate specificity [Parker, personal communication]. The 
properties of PKC o, ( and '1 are not defined yet. 
Long-term treatment of cells with phorbol ester causes down-regulation 
of PKC. The mechanism is most likely proteolytic breakdown of PKC, since 
antibodies that recognize the cleavage site lor the protease can prevent down-
regulation [Young et al., 1988]. The sensitivity for down-regulation differs per 
isozyme and per cell type [Huang et al., 1989; Adams and Gullick, 1989]. Down-
regulation of PKC is not only triggered by phorbol esters but is also observed in 
response to physiological stimuli. In GH4C1 cells, thyrotropin releasing hormone 
(TRH) induced translocation of PKC a:, 8 and e, but only PKC e was down-
regulated [Kiley et al., 1990]. The reason for this PKC e specific down-regulation 
could be the prolonged activation of the calcium independent PKC e by the 
sustained increase in PC-derived DAG which is formed without a rise in calcium. 
The physiological importance of PKC down-regulation is unknown. 
Several inhibitors of PKC are known to exist: staurosporin, H7, 
sphingosine and pseudosubstrate peptides. However, these inhibitors cannot 
distinguish between the different PKC isotypes and the catalytic domain targeted 
inhibitors are not highly specific for PKC, but can also inhibit protein kinase A and 
G or CaCaM-kinase at somewhat higher concentration [staurosporin: Yanagihara 
et al., 1991]. Results obtained with these inhibitors in in vivo studies are therefore 
difficult to interpret. Furthermore, the effectiveness of the inhibitors in preventing 
PKC-mediated phosphorylation of intracellular substrates may depend on both the 
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nature of the substrates and, in the case of regulatory domain targeted inhibitors, 
on the relative participation of PKC versus its constitutively active proteolytic 
fragment PKM in the phosphorylation process [Junco et al., 1990]. 
3.5 Methods to study PKC isozyme specific effects 
Several approaches are being used to establish the role of the individual 
PKC isoforms in the variety of PKC-mediated responses. PKC isotype specific 
differences in sensitivity to down-regulation can be used to study PKC isozyme 
specific effects. Using this approach, PKC a has been implicated in negative 
feedback of phosphoinositide hydrolysis [Huwiler et al., 1991; Chapter 5] and in 
the initial events of differentiation of a promonocytic cell [Strulovici et al., 1989], 
whereas PKC e may play a role in the stimulation of prostaglandin synthesis 
[Huwiler et al., 1991]. However, the outcome of these studies based on 
correlations need to be confirmed by more definitive studies, such as 
reconstitution assays. 
Another approach to study isozyme-specific effects is the generation of 
cell lines that stably overproduce one of the PKC isoforms. Until now, these 
studies were not very informative with regard to the specificity of the different 
isozymes of PKC. For example, overexpression of PKC B1 was found to enhance 
tumorigenicity [Housey et al., 1988], to have no effect on the cell morphology 
[Eidar et al., 1990] or to inhibit growth [Choi et al., 1990]. Although these studies 
strongly indicate a role for PKC B1 in the control of cellular growth mechanisms, 
the effect of PKC B1 on the cell morphology seemed to be dependent on the cell 
line used, even between different fibroblast cell lines. Therefore, a comparison 
within one cell line overexpressing each ol the different PKC isotypes is necessary 
to establish whether the various isotypes have specialized functions. Such an 
approach showed a functional difference in vivo between PKC a, y and e in a rat 
fibroblast cell line: cells overexpressing PKC y failed to enhance the expression 
of c-jun in contrast to cells overproducing PKC a or e [Ohno et al., 1990]. 
Nevertheless, PKC y was able to mediate gene expression in a rat neuroblastoma 
cell line [Bernards, 1991], indicating that PKC isoforms can exhibit different 
functions probably dependent on the cell line in which they are expressed. 
Functional differences between PKC isoforms can also be studied by 
using permeabilized cells. In that way, exocytosis in pituitary cells was found to 
be induced by introduction of PKC a or PKC B, but not by PKC y [Naor et al., 
1989], again indicating that some specificity exists. An alternative approach will 
be microinjection of (not yet available) inhibitory PKC isozyme specific antibodies, 
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which will interfere with those physiological responses in which a particular PKC 
subtype is involved. Interestingly, transfection of a rat neuroblastoma cell line with 
the oncogene N-myc induced a shift in PKC isozyme expression from PKC ll to 
PKC (and resistence to phorbol ester [Bernards, 1991]. An alteration of PKC 
isoform expression was also found in H-ras transfected fibroblasts [Borner et al., 
1990]. These results suggest that alterations in PKC isoform expression may be 
a common event in cell transformation, and could provide new information on the 
role of the individual PKC isoforms. 
In summary, it should be clear that much further work is needed to define 
the exact physiological role of the individual PKC family members in cellular 
regulation. However, the differential expression of PKC isozymes in various 
tissues, the expression of more PKC isotypes in one cell and the occurrence of 
many DAG subtypes together with the results of the studies described in the 
previous paragraphs are suggestive for the existence of specific roles lor PKC 
isozymes in eliciting a biological response. 
4.0 The cAMP dependent pathway 
Many hormones and neurotransmitters, e.g. vasoactive intestinal 
polypeptide (VIP) and prostaglandin E2 (PGE2) in the intestine act by raising 
cAMP levels (Fig.3). Activation of the receptor by binding of the agonist stimulates 
a G-protein, Gs, which activatesadenylate cyclase. The resulting increase in cAMP 
activates a cAMP dependent serine/threonine protein kinase: protein kinase A 
(PKA). 
The structure and properties of both adenylate cyclase and protein kinase 
A has been extensively reviewed of which a short overview is given below 
[Edelman et al., 1987; Taylor, 1989; DeJonge and Rao, 1990]. 
Cholera toxin is (mis)using this pathway by irreversibly activating Gs. ADP-
ribosylation of its a subunit is keeping it in the active GTP bound form, resulting 
in permanently high cAMP levels and thus excessive salt and water secretion in 
the intestine. 
4.1 Adenytate cyclase 
Adenylate cyclase (AC) is a transmembrane glycoprotein, that catalyzes 
the synthesis of cAMP from adenosine triphosphate (ATP) on the cytoplasmic side 
of the plasma membrane. Genetic and biochemical evidence indicates the 
existence of multiple forms of AC. The amino-acid sequence of a hormone 
sensitive AC predicted two alternating sets of hydrophobic and hydrophylic 
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domains [Krupinski et al., 1989]. The hydrophobic domains each contain six 
transmembrane spans. The hydrophylic domains contain a sequence homologous 
to a single cytoplasmic domain of several guanylate cyclases, which are proposed 
nucleotide binding sites. AC was found to resemble a transporter or ion channel, 
related to the G-protein regulated dihydropyridine (DHP)-sensitive Ca2+ channels 
and K+ channels. This relationship, although not based on primary amino-acid 
sequence, together with the possible multiple nucleotide binding sites in AC, 
suggest an additional role for the enzyme as a transporter. The most intriguing 
hypothesis is that AC can synthesize and transport cAMP. Such a function, 
although not yet observed in mammalian cells, has been described to occur in the 
slime mold Dictyostelium discoideum [Gerisch, 1987]. AC can be activated 
independently of the receptor by forskolin. Another tool to study effects of an 
increase in cAMP levels, without activation of receptor-mediated responses, is the 
use of cell-permeable analogues of cAMP, e.g. 8-Br-cAMP or 8-pCPT-cAMP 
[Sandberg et., 1991]. A characteristic feature of AC in intestinal epithelium is its 
distinct localization in the basolateral membrane together with the AC-Iinked 
hormone receptors [De Jonge and Hulsmann, 1974; Murer et al, 1976]. In 
contrast, the receptors exposed to cholera toxin in vivo are localized at the 
luminal membrane. In addition, the in vitro AC response to Ca2 + is biphasic, being 
activated in a calmodulin dependent manner by submicromolar Ca2 + [Lazo et al., 
1984] and inhibited at higher concentrations. However, this potentially important 
link between Ca2 + -mobilizing secretagogues and those that regulate cAMP has 
been questioned more recently considering the lack of compelling evidence for 
calmodulin regulation of AC in non-neuronal tissues [Cooper and Caldwell, 1988]. 
Moreover, the inability of Ca2+ -ionophore, in contrast to forskolin or 8-Br-cAMP, 
to provoke cr secretion in some human colonic cell lines (HT29ci.19A, Chapter 
5) also argues against cross-talk between Ca2 + and cAMP in this cell model. 
4.2 Protein kinase A 
Protein kinase A (PKA) is composed of two regulatory (R) and two 
catalytic (C) subunits, R2C2. Binding of cAMP to the R subunits of PKA results in 
the dissociation of the R and C subunits to form R2cAMP4 and two active C 
subunits. The C subunit is responsible for the phosphorylation of its specific target 
proteins. Mg-ATP is the preferred substrate of PKA. The catalytic domain is 
comprised of a nucleotide and a peptide binding region. The most highly 
conserved regions in the protein kinases are the two nucleotide binding domains, 
containing the consensus sequence Gly-X-Giy-X-X-Giy. The C subunit is 
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myristylated. However, the role of this modification is not clear, as it is not likely 
to be involved in membrane association of PKA. 
There are two major forms of mammalian PKA, type I and type II, which 
differ in their R subunits. Rl and Rll are products of separate genes, which differ 
in their tissue distribution and in their specificity for various cAMP analogues. The 
role of these isoforms of PKA in the biological function is still not known. Each 
subunit of PKA is known to be phosphorylated at multiple sites. 
Autophosphorylation of the Rll subunit on Ser-95 was found to influence the 
functioning of PKA by reducing the rate of reassociation of the Rll and the C 
subunits. The importance of autophosphorylation on the other sites is not 
elucidated yet. 
A naturally occurring inhibitor of PKA has been detected, called PK-1 or 
Walsh inhibttor. Inhibition of PKA is mediated by the pseudosubstrate sequence 
present on PK-1. Other inhibitors of PKA are derivatives of isoquinoline 
sulfonamide, H7 and H8. However, H7 and H8 are not specific for PKA, but are 
also inhibiting PKG and H7 is also inhibiting PKC. PK-1 is relatively specific for 
PKA, but at concentrations higher than 1 00 11M, PKG is also inhibited. 
The expression of both the type I and type II isoform of PKA in rat 
enterocytes have been demonstrated by photoaffinity labeling and immunological 
experiments [De Jonge and Lohman, 1985]. The preferential localization of type 
II PKA in the apical membrane suggests a major role of this isozyme in cAMP 
regulation of intestinal cr secretion. 
5.0 The cGMP dependent pathway 
Agonists raising cGMP (e.g. nitroprusside and atrial natriuretic peptide, 
ANP) do not seem to activate guanylate cyclase via a G-protein, but through 
direct interaction with a receptor domain of cytosolic or membranal forms of 
guanylate cyclase, respectively [reviewed by Garbers, 1991]. The resulting rise in 
cGMP activates a cGMP dependent serine/threonine protein kinase (PKG) or 
interactswithacGMP-inhibited orcGMP-stimulated-phosphodiesterase [Nicholson 
et al., 1991]. 
5.1 Guanylate cyclase 
Guanylate cyclase (GC) catalyzes the synthesis of cGMP from GTP at the 
intracellular side of the plasma membrane. Two types of GC can be found, a 
soluble and a particulate form. The soluble enzyme is a heterodimer composed 
of an a. and B subunit. Both subunits contain a cyclase-like catalytic region, but 
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only the liB subunit complex has GC activity. The soluble GC is activated by nitric 
oxide or EDRF. This isoenzyme of GC is ubiquitously expressed in mammalian 
tissues. However, the soluble GC is absent in intestinal epithelium [De Jonge, 
1975], excluding a direct role for EDRF /NO-compounds as regulators of intestinal 
cr secretion. 
The particulate GC contains one transmembrane domain. The extracellular 
region serves as the ligand binding domain. The intracellular region contains a 
protein kinase like domain and a cyclase catalytic domain. Three isolorms of the 
particulate GC has been identified, GC-A, GC-B and GC-C, bearing receptor 
domains lor ANP, CNP (C-type natriuretic peptide) and the heat stable toxin of 
E. coli (ST J, respectively. ANP is principally synthetized in the heart, but 
distributed to many target tissues, whereas CNP is restricted to the brain and 
nervous tissue. This limited localization of CNP is in contrast with the more 
ubiquitous distributed GC-B receptor, suggesting that CNP might not be the (sole) 
agonist for GC-6. Thusfar, however, no other ligands for the GC-B receptor have 
been found. 
The identity of GC-C as the receptor for STA in intestinal epithelium has 
been recently demonstrated by molecular cloning [Schultz et al., 1990]. No 
evidence for ST.-stimulated GC activity in other tissue except opossum kidney 
[Garbers, 1991] has been reported solar. ST. is a low molecular weight {18 amino 
acids), heat stable peptide secreted by pathogenic strains of Escherichia coli upon 
colonization of the intestinal tract. Together with the heat labile, cholera toxin-like 
enterotoxin it constitutes a major cause of diarrhoeal disease among children in 
developing countries [Guerrant, 1985]. Very recently an endogenous peptide, 
designated guanylin, mimicking the action of ST. on GC has been discovered 
[Currie et al., 1992]. Interestingly, the ANP-sensitive form of GC, GC-A, is 
expressed mainly in subepithelial cell types in the intestine, but not or to a very 
low extent in the cr secreting epithelial cells, implying that ANP-provoked chloride 
secretion results from the release of an endogenous secretagogue/neuro-
transmitter in the submucosa rather than from a direct effect of ANP on mucosal 
cGMP levels [Vaandrager et al., 1992]. 
5.2 Protein kinase G 
Protein kinase G (PKG) is found in a soluble form (type I) and a 
membrane associated form (type II). The soluble form is a dimer of two identical 
subunits, of which two subspecies exist: III and IB, probably formed by alternative 
splicing of a single gene. The distribution of these two isoforms differ: I II is chiefly 
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found in the I ung, 113 in smooth muscle and cerebellum. The a and B forms also 
differ in affinities for several cGMP analogues. Binding of cGMP to PKG causes 
a conformational change, activating the enzyme by exposing the catalytic 
domains, rather than by dissociation of the subunits as found for PKA. Each 
monomer contains two cGMP binding sites (lour per holoenzyme). The membrane 
bound form of PKG (type II) is monomeric and seems to be unique to the 
intestine. The amount of PKG-11 decreases from the villus tip to the crypt. 
Autophosphorylation of PKG-1 causes a 10-fold decrease in the Ka for cAMP. 
Thus, in vivo autophosphorylation might allow PKG-1 to be activated by cAMP as 
well as by cGMP. The role of autophosphorylation in PKG-11 function has not been 
established unequivocally. However, measurements of PKA versus PKG-11 
activation in rat intestinal brush border membranes following in situ exposure to 
either CT or STA virtually rule out the possibility that STAjcGMP is acting through 
PKA or that CT jcAMP is acting through PKG-11 [Van Dommelen and De Jonge, 
1986]. 
Naturally occurring inhibitors of PKG have not been identified. However, 
H7 and H8 are known inhibitors of both PKA and PKG (H8 being more specific 
for PKG). Intracellular effects of cGMP can be mimicked by using cGMP 
analogues, such as 8-Br-cGMP, without the need for receptor activation. 
6.0 Role of PKA, PKG, PKC and calcium in intestinal chloride secretion. 
A physiological role of PKA in cr secretion was demonstrated by the 
finding that transfection of T84 cells with a mutant form of the regulatory subunit 
of PKA resulted in an inability to open cr channels, despite an increase in cAMP 
levels [Rogers et al., 1990]. 
The intestine is the sole tissue in which cGMP-mediated cr secretion 
occurs, presumably due to the unique expression of a different type of PKG (PKG-
11) in this organ. Two lines of evidence have suggested a role for ?KG-induced 
phosphorylation in cr secretion. First, Ussing chamber measurements of intestinal 
stripped mucosa obtained from cystic fibrosis patients have demonstrated a 
defect in cGMP-induced chloride secretion, distal to PKG activation [DeJonge et 
al., 1987]. Secondly, an independent role for PKG was strongly suggested by the 
finding that STA- and 8-Br-cGMP-, but not cAMP- or Ca2 + -provoked cr secretion 
could be inhibited by relatively low concentrations of the PK inhibitors H8 and 
staurosporin [De Jonge, unpublished results]. Nevertheless, PKG has been 
demonstrated to be a more potent inhibitor of sodium absorption (villus function) 
than a stimulator of chloride secretion (crypt function) in agreement with the 
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decreasing concentration gradient of PKG from villus to crypt. 
The physiological role of PKC in intestinal ion transport has been deduced 
mainly from studies using phorbol esters. In rabbit and chicken ileum and in rat 
distal colon, the stimulatory effects of phorbol esters were found to be mediated 
by release of prostaglandins from sub-epithelial cells with subsequent cAMP 
elevation [Rao and DeJonge, 1990]. However, by using epithelial cell lines, PKC 
was also found to have a direct effect on Cl" secretion: PKC stimulated and 
inhibited cr secretion in the human colon carcinoma cell line HT29 and in cultures 
of tracheal epithelial cells [Chapter 5; li et al., 1989]. Furthermore, a large 
prostaglandin-independent component of phorbol ester-provoked cr secretion has 
been shown to exist in human ileal mucosa [De Jonge, manuscript in 
preparation]. The target protein for inhibition of cr secretion is not necessarily the 
cr channel itself, but can also be one or more of the other transport systems 
needed to induce cr secretion. Indeed, PKC was found to inhibit NaKCI2 
cotransport in HT29 human colonic cells [Franklin et al., 1989]. 
An increase in calcium by Ca2+ -ionophore has been shown to stimulate 
cr secretion both in intact epithelium and in epithelial cell lines. In two human 
colon carcinoma cell lines, T84 and HT29ci.19A, the Ca2+ -activated cr 
conductance differed from that stimulated by cAMP in both anion selectivity and 
current-voltage relation [Cliff and Frizzell, 1990; Vaandrager et al., 1991]. In the 
HT29ci.19A cells, the distribution of the cAMP- and Ca2 + -activated cr channels 
also differed: Ca2+ stimulated cr efflux from both the apical and the basolateral 
membrane, whereas cAMP only stimulated apical Cr efflux. This difference in 
polarization might be the basis for the lack of Ca2+ -stimulated net cr secretion in 
this particular cell line [Vaandrager et al., 1991; Chapter 5]. As calcium is a known 
activator of a variety of enzymes, e.g. calcium/calmodulin dependent protein 
kinases (CaCaMK) and phospholipases, the effects of Ca2 • could be either direct 
or mediated through activation of these Ca2+ -activated enzymes. In the T84 cells, 
Ca2+ -stimulated cr secretion was mediated by CaCaMK-11 [Worrell and Frizzell, 
1991]. In this cell line, however, the role of CaCaMK-11-stimulated cr channels in 
allowing net cr secretion has been seriously questioned [Anderson and Welsh, 
1991]. In human small intestine, circumstantial evidence exists for the coupling of 
Ca2•, through CaCaMK-1, to a different type of Cr channel, i.e. CFTR [DeJonge, 
unpublished results]. Since CaCaMK-1 is expressed in intestine, but not in most 
other epithelia [Rao and DeJonge, 1990], this might explain why Ca2 + -mediated 
cr secretion is defective in CF ileum but not in trachea or sweat gland [Quinton, 
1990]. 
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7.0 Candidate target proteins for the induction of chloride secretion. 
Although abundant evidence has indicated a role for PKA, PKG, calcium 
and PKC in the modulation of ion transport, the protein kinase substrates involved 
in ion transport regulation are not established yet. The targets of the protein 
kinases could be the ion channel or transporter itself, or regulatory proteins of 
these transport proteins. As cystic fibrosis is associated with a defect in epithelial 
cr transport, the mutated gene product responsible for this defect could be the 
target for PKA, PKG and PKC, and in the intestine also for CaCaMK The 
identification of this gene on chromosome 7 two years ago [Rommens et al., 
1989; Riordan et al., 1989; Kerem et al., 1989] provided the tools to test this 
possibility. The gene product is called cystic fibrosis transmembrane conductance 
regulator or CFTR. Mutations in this gene were associated with cystic fibrosis. 
CFTR expression in the intestine decreases from crypt to villus, consistent with 
CFTR being responsible for cr secretion in intestinal crypts [Trezise and 
Buchwald, 1991]. 
7.1 CFTR 
Amino acid seqence analysis suggested that CFTR consists of two 
membrane spanning domains, each composed of six transmembrane regions; a 
R domain, which contains many potential consensus phosphorylation sites; and 
two nucleotide-binding folds or NSF's. Expression of CFTR induces cAMP-
activated cr channels in CF epithelial cells [Rich et al., 1990; Drumm et al., 1 990] 
and in a variety of cell types normally lacking such channels [Anderson et al., 
1991b; Kartner et al., 1991; Berger eta!., 1991], suggesting that CFTR encodes 
a cAMP-activated cr channel. However, these studies do not exclude the 
possibility that CFTR encodes a regulator of this channel, requiring that these cells 
have endogenous cryptic cr channels stimulated by cAMP only in the presence 
of CFTR. The first option, CFTR encodes a cr channel, has gained support by the 
observation that mutations in the proposed membrane spanning domains altered 
the anion selectivity of this CFTR expression-induced cr channel [Anderson et al., 
1991a]. Very recently, conclusive evidence for CFTR being a cr channel was 
reached by the succesfull reconstitution of purified recombinant CFTR protein into 
proteoliposomes and the appearance of a cAMP jPKA regulated cr channel upon 
fusion with planar lipid bilayers [Bear eta!., 1992]. 
The presence of multiple consensus sequences lor PKA, PKC and PKG 
[Kemp and Pearson, 1990] on the R domain of CFTR suggests that regulation of 
cr secretion may occur by phosphorylation of CFTR. PKA-induced 
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phosphorylation of CFTR has indeed been found to regulate this cr channel. 
Addition of the catalytic subunit of PKA to the cytosolic surface of excised patches 
activated the CFTR cr channel [Berger et al., 1991; Tabcharani et al., 1991]. 
Addition of PKC also activated the CFTR channel, but this effect was small 
compared to the effect of cAMP. Interestingly, PKC potentiated the effect of cAMP 
(rate and magnitude) [Tabcharani et al., 1991]. Seven serines in the R domain 
were substrates for PKA in vitro and phosphorylation on four of these residues 
also occurred in vivo after an increase in cAMP levels [Cheng et al., 1991]. 
Replacement of these four serines (but not three or less) by alanine prevented 
cAMP dependent activation of the CFTR channel [Cheng et al., 1991]. A CFTR 
mutant lacking most part of the R domain had lost its regulation by PKA and 
generated cr channels that were constitutively active even without an increase in 
cAMP [Rich et al., 1991]. These studies indicate an important role for the R 
domain in regulation of the CFTR channel. Nevertheless, most mutations in CFTR 
leading to cystic fibrosis are not in this R domain, but are in the nucleotide 
binding fold (NSF), particularly NBF1 [Kerem et al., 1989]. Recent studies in our 
laboratory have shown that purified PKG-11, but not PKG-1, is also able to activate 
the CFTR channel in excised patches of CFTR transfected epithelial cells [Bijman 
and De Jonge, in preparation]. Phosphorylation studies are in progress to learn 
whether CFTR itself or a regulatory protein in the same membrane is the target 
for PKG-11-catalyzed phosphorylation. 
The most common mutation in the CF gene (75%) is a deletion of 
phenylalanine at position 508 in the NBF1 (b.F508). This and other mutations in 
the NSF's prevent glycoprotein maturation, which potentially leads to defective 
membrane delivery of CFTR [Cheng et al., 1990; Gregory et al., 1990]. Those NSF 
mutants that were processed normally still failed to generate cAMP activated cr 
channels [Gregory et al., 1990]. Despite the maturation defect found in b.F508-
CFTR mutants, some of these mutated molecules, although far less efficient than 
wild-type CFTR, still reached the plasma membrane [Dalemans et al., 1991]. 
Analysis of these mutants in the plasma membrane revealed a reduced activity of 
the cAMP-dependent Cl' channel, due to an increase in closing time [Dalemans 
et al., 1991; Drumm et al., 1991]. The result of the aF508 mutation thus has two 
major consequences: 1) it prevents the maturation and normal subcellular 
localization of the protein in the plasma membrane and 2) those mutants that do 
reach the plasma membrane generate cr channels with a reduced activity. 
CFTR shows structural similarity with several members ofthe "ATP binding 
cassette" (ABC) superfamily of proteins, including the P-glycoprotein associated 
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with multidrug resistance. Several members of this family utilize the energy 
released during ATP hydrolysis to actively transport its substrate across the cell 
membrane. In analogy with these proteins, CFTR could also work as an energy 
driven pump for yet unidentified substrates. Alternatively, the NSF's could serve 
as regulators of CFTR function, rather than drive a pump. Recently, a regulatory 
role for ATP in CFTR function has been reported [Anderson et al. 1991]. 
Phosphorylation of CFTR by PKA was needed, but not sufficient to open the cr 
channel. The phosphorylated CFTR additionally required ATP or its hydrolyzable 
analogues. However, the EC50 for ATP-induced cr channel activity (± 300 11M) 
was much higher than that for most other nucleotide-binding proteins, such as 
PKA (311M), G-proteins (10 pM-100 IJ.M) and Na' jK'-ATPases (0.2-2~-LM), raising 
the possibility that CFTR might function as an energy sensor. By responding to 
cellular ATP levels, the Cr secretion rate is adjusted to the metabolic energy 
needed to perform transepithelial cr transport. Nevertheless, these studies do not 
exclude the possibility that CFTR functions both as a cr channel and as a pump 
for yet unidentified substrates. This possibility has gained interest by the recent 
finding that one of the members of the ABC family, MDR1, can also function as 
a volume-regulated cr channel [Valverde et al., 1992]. The drug pump function 
and the cr channel activity of MDR1 differed in that the drug pumping required 
hydrolyzable ATP in contrast to activation of the cr channel. For CFTR such a 
difference is not likely, as ATP hydrolysis is apparantly needed for cr channel 
opening. 
Scope of this thesis 
In this thesis the following aspects of ion transport regulation and 
transmembrane signalling in intestinal epithelial cells were studied: 
1) the polarized distribution of G-protein subunits among the basolateral and the 
apical membrane, with emphasis on the possible occurrence of novel, epithelium-
specific G-protein subspecies in the apical membrane that could play a role in the 
activation of the apical PI-cycle and/or apical cr channels. The results of this 
study are described in Chapter 2. 
2) the possible identification of apical cr channels that are directly activated by 
G-proteins, in analogy toG-protein regulated Na' and cr channels in the kidney 
[Light et al., 1989; Schwiebert et al., 1990] and cardiac ca» and K' channels 
[Yatani et al., 1987; Yatani et al, 1988]. The results of this study are described in 
Chapter 3. 
3) the possible existence of cross-talk between cyclic nucleotide-mediated 
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pathways and the PI-cycle. The apical PI-cycle could function as an amplification 
mechanism for neurohormonal signals generated at the basolateral membrane 
(e.g. cAMP, PKC, Ca2 +), or as a transmembrane signalling mechanism triggered 
by apical enterotoxin receptors (e.g. heat-stable E.coli toxin). The results of this 
study are summarized in Chapter 4. 
4) the identification of protein kinase C isozymes in intestinal epithelial cells and 
the analysis of their possible role in ion transport regulation. The results of this 
study can be found in Chapter 5. 
5) the identification of the targets for PKC-mediated effects on ion transport. These 
results are documented in Chapter 6. 
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CHAPTER 2 
ASYMMETRICAl DISTRIBUTION OF G-PROTEINS 
AMONG THE APICAL AND THE BASOLATERAl 
MEMBRANE OF RAT ENTEROCYTES. 
The distribution of the "' and B subunits of guanosine nucleotide binding 
proteins (G-proteins) among the apical (BBM) and basolateral membrane 
(BLM) of polarized rat enterocyles was investigated by in vitro ADP-
ribosylation assays and immunoblotting with G-protein subunit specific 
antisera. The enterocyles were found to express a:i2, a:i3, a:s and 13-subunits, 
whereas a:i1 and ao subunits could not be detected. The ai2 and the a:i3 
subunits were located predominantly in the basolateral membrane, in 
contrast to the as and the 13 subunits, which were distributed uniformly 
among both membranes. Furthermore, a 39 kDa and a 78 kDa protein, 
recognized by a:i1,2 in contrast to ail and «ti3 specific antisera but resistant 
to ADP-ribosylation by pertussis toxin, were localized exclusively at the apical 
border. These Gi-related proteins might represent novel members of the G-
protein family. Activation of apical G-proteins by GTP or its analogs failed to 
release the «tS, «ti and 13 subunits or the 39 kDa and 78 kDa a:i-like proteins 
from the membrane, suggesting a functional role for these proteins in the 
apical membrane itself. Our recent finding of a GTP [$]-sensitive cr 
conductance in the apical membrane of rat enterocyles suggests that one or 
more of these G-proteins may act as local regulators of specific apical 
transport functions. 
INTRODUCTION 
Guanine nucleotide binding regulatory proteins (G-proteins) are a family 
of receptor-coupled signal transducing proteins that regulate a variety of second 
messenger systems and ion channels. G-proteins are composed of three subunits 
designated a, Band y, with Mr of approximately 39-52 kDa, 35-36 kDa and 8-11 
kDa, respectively. The a subunit of each G protein is unique, the Band y subunits 
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appear to be shared. The a: subunit contains the functional domains for guanine 
nucleotide binding, GTPase activity, ADP-ribosylation by cholera andjor pertussis 
toxin, and interaction with specific receptor and effector proteins [1]. For some 
G-proteins multiple isoforms have been described, caused by alternative splicing 
of the same gene (e.g. Gs, 4 isotypes [2]) or by the existence of multiple genes, 
encoding for similar G-proteins, which form a subfamily (e.g. Gi1, Gi2 and Gi3) 
[3]. The biological importance of this diversity is as yet not fully understood, since 
all splice variants of Gs can both activate adenylate cyclase and activate Ca2+-
channels [2], and all Gi species can activate the G-protein gated atrial K+ -channel 
[4]. However, the inhibition ofadenylate cyclase in NG1 08-15 cells was specifically 
transduced by Gi2 [5]. 
It has been generally accepted that G-proteins function mainly at cell 
surface membranes where they can associate with various transmembrane 
receptors and effector proteins. Therefore it is very likely that they are distributed 
similarly to the receptor /effector systems to which they are specifically coupled. 
In enterocytes, similar to other epithelial cell types, the plasma membrane is 
composed of at least two structurally and functionally distinct regions: the apical 
or brush border membrane and the basolateral membrane. Most hormone 
receptors and adenylate cyclase are distributed asymmetrically and are found to 
be localized predominantly at the basolateral membrane [6,7]. In contrast, the 
apical membrane of rat enterocytes was found to be enriched in components of 
the cGMP-signalling system [8,9], a G-protein-activated phosphoinositide cycle [7] 
and GTP[S]-sensitive Cl"-channels [10, 11]. These findings prompted us to explore 
the possibility that at least some G-proteins might have an apical localization and 
might regulate brush border specific functions. 
Our results indicate that some G-protein subunits (as, B) are distributed 
equally among the apical and the basolateral membrane, whereas others are 
segregated predominantly to the basolateral membrane (ai2, tti3) or are localized 
exclusively in the apical membrane (a 39 kDa and a 78 kDa o:i-like protein). The 
potential biological implications of these findings are discussed. 
MATERIALS AND METHODS 
materials: Antiserum 043 (kindly provided by L. van der Voorn, Netherlands Cancer Institute, 
Amsterdam, The Netherlands) was raised in rabbits against a mixture of holomeric G-proteins 
purified from human brain and contained antibodies specifically recognizing the B-subunits and the 
a:-subunit of Go on western blots. The following antisera were kindly donated by Dr. G. Milligan, 
Glasgow [specificities and sensitivities are summarized in ref. 12 and 35]: antiserum IM1 was raised 
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in rabbits against the peptide NLKEDGISAAKOVK, corresponding to amino acids 22--35 of the a 
subunit of Go and specifically recognizes ao; antiserum SG1, produced in rabbits against a 
decapeptide (KENLKDCGLF) corresponding to the C-terminal amino-acid sequence of the a-subunit 
of transducin, specifically recognizes the ai1 and the ai2 subunits, but not the ai3 subunit; 
antiserum 138 was produced in rabbits against a peptide KNNLKECGLY corresponding to the C-
terminal decapeptide of the a-subunit of the inhibitory G-protein Gi3 and specifically recognizes a:i3, 
but not ai1 and ai2 subunits; antiserum 11C, specific for the a:i1 subunit and not recognizing the 
ai2 and the a:i3 subunits, was raised against the synthetic peptide LORIAQPNYI, corresponding to 
amino acids 159-168 of the a: subunit of the inhibitory G-protein, Gi1; antiserum C$1, produced in 
rabbits against adecapeptide (RMHLRQYELL) corresponding to the C-terminal amino-acid sequence 
of the a-subunit of the stimulatory G-protein and specifically recognizes the as subunits; 
Antiserum AS/7 (obtained from Du Pont), similar to antiserum SG1, was raised in rabbits against the 
decapeptide KENLKDCGLF and specifical!y recognizes the a subunit of transducin, Gi1 and Gi2. 
32P-NAD (specific activity 30 Cijmmol) was obtained from New England Nuclear, Frankfurt, 
Germany; pertussis toxin was from Ust Biological laboratories, Campbell, CA, USA; cholera toxin 
was obtained from Sigma; 14C-Iabeled rainbow ™ protein molecular weight markers were from 
Amersham, UK. 
Preparation of basolateral membranes: Under light diethyl ether anaesthesia the small intestine 
of a rat was removed and rinsed twice with 20 ml of icecold saline (0,9 % NaCI). All further steps 
were performed at Q-4 "C. Inside out segments of rat jejunum were mounted on metal rods attached 
to a vibration apparatus (Vibro-Mixer E1 from Chemap A. G. H3.nnedorf ZN, Switzerland). Epithelial 
cells were released by mechanical vibration (50 Hz, amplitude 1.5 mm) for 30 minutes in 0.13 M 
NaCI, 5 mM EDT A, 10 mM Tris, pH 7.4 and isolated by low speed centrifugation at 345 g. The cells 
were washed twice in 20 ml300 mM mannitol, 12 mM Tris-HCl, pH 7.4. Basolateral membranes were 
prepared essentially as described by Murer et al. [6]. Briefly, cells were homogenized in a Virtis 
blender and nuclei, cell debris and mitochondria were removed by differential centrifugation. The 
remaining membranes were pelleted and basolateral membranes were separated from apical 
membranes by sucrose gradient centrifugation. The basolateral membranes were recovered between 
30-40% sucrose, pelleted and finally resuspended in 100 mM mannitol; 10 mM Hepes~Tris, pH 7.4. 
The membranes were freshly used or were frozen in liquid nitrogen and stored at -sao c. 
Preparation of apical membranes: brush border caps and brush border membrane vesicles: 
Intact brush border (88} caps from small intestinal epithelial cells were isolated by vibration of inside 
out gut segments in hypotonic EDTA (2.5 mM) as described by De Jonge [13} and finally 
resuspended in 20 mM Tris-HCl, pH 7.3. Brush border membrane vesicles (BBMV), hereafter referred 
to as KSCN-BBMV were prepared by exposing the brush border caps to a chaotropic agent (0.52 
M KSCN) as described in detail by Hopfer eta\. [14]. Vesicles prepared by this method are virtually 
depleted of cytoskeletal proteins and calmodulin [14, 15]. Brush border membrane vesicles hereafter 
referred to as Mg-BBMV were prepared from isolated enterocytes by mechanical homogenization 
and differential Mg2+ precipitation as described [16]. The brush border membranes do not 
aggregate in the presence of divalent cations [17] in contrast to all other subceHu!ar membranes. 
ADP-ribosylation of membranes: Cholera toxin and pertussis toxin were activated by incubation 
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membrane fractions. As judged by the marker enzyme distribution, the basolateral 
membranes were relatively devoid ol brush border membrane contamination and 
vice versa. 
Identification of G.-subunits by pertussis and cholera toxin catalyzed ADP-
ribosylation. G-proteins can be distinguished by the ability to serve as a substrate 
for pertussis toxin (PT) catalyzed ADP-ribosylation (Gi, Go), cholera toxin (CT) 
catalyzed ADP-ribosylation (Gs), PT and CT catalyzed ADP-ribosylation 
(transducin) or by a lack of recognition sites for any of the toxins. These 
properties were exploited to identify G-protein species in the enterocyte. 
Incubating BB caps, KSCN-BBMV, Mg-BBMV and BLM with 32P-NAD and PT 
revealed the presence of a 41 kDa protein in all membrane fractions (Fig.1 ). This 
41 kDa protein was tentatively identified as the"' subunit of Gi, since the other PT 
substrate transducin is uniquely present in rods and cones and ctO specific 
antiserum failed to detect o:o subunits in these membrane fractions (Fig.3D). CT 
catalyzed ADP-ribosylation enabled the detection of two other proteins with Mr ol 
46 and 42 kDa, tentatively identified as splice variants of the " subunits of Gs 
(Fig.2) {3], which were likewise present in all membrane fractions. These subunits 
sometimes appeared as doublets, possibly as a result of covalent modifications. 
Identification of G-protein subunits by specific antisera. A variety of " and B 
subunit specific antisera were used to further identify the different G-proteins. 
Antiserum 136, specific forthe a:i3 subunit, identified a protein with Mr ol41 kDa 
predominantly in the basolateral membrane, although a faint staining could be 
detected in the apical membrane fractions (Fig.3A). Antiserum SG1, which 
specifically recognizes both a:i1 and cti2 subunits, also showed a substantial 
enrichment of a 41 kDa protein in the basolateral membrane compared to the 
apical membrane (Fig.3B). Since antiserum 11 C, specific for the a:i1 subunit, did 
not react with a 41 kDa protein in any of the membrane fractions (results not 
shown), the protein recognized by antiserum SG1 is tentatively identified as the 
o:i2 subunit. As indicated by combined 32P-NAD labeling and immunoblotting, the 
PT sensitive 41 kDa protein shown in Fig.1 comigrated with the proteins identified 
by antisera SG1 (Fig 4A,B) and 138 (not shown) and with purified G-proteins from 
human and bovine brain (Fig.5,6), further confirming their identity as cti subunits. 
Antiserum SG1 addhionally recognized a 39 kDa protein, which was detected only 
in the BB caps and occasionally in KSCN-BBMV, but not in the Mg-BBMV or the 
BLM (Fig.3B) and was clearly distinguishable from the 41 kDa band (Fig.4B,5). In 
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FIGURE 1. Pertussis toxin dependent 
ADP-ribosylation of intestinal epithelial 
membrane proteins. Autoradiographic 
profiles of 32P-Iabeled proteins {10 JL9/Iane) 
after incubation of BLM Oane 1), Mg-BBMV 
Qane 2), BB caps Qane 3) and KSCN-BBMV 
Qane 4) with 32P-NAD, preactivated pertussis 
toxin and 0.1 % saponin. Experimental 
details of the ADP-ribosytation assay are as 
in Methods. Migration of molecular 
standards expressed in kDa is as indicated. 
The ADP-ribosylation of the 41 kDa protein 
was observed only in the presence of PT 
(not shown). The results are representative 
for at least three other experiments. 
FIGURE 2. Cholera toxin dependent ADP-
ribosylation of intestinal epithelial 
membrane proteins. Autoradiographic 
profiles of 32P-!abeted proteins (10 J.Lgjlane) 
after incubation with 32P¥NAD, preactivated 
cholera toxin and 0.1 % saponin of BLM 
(lane 1) and Mg-BBMV (lane 2), alter 
incubation with 32P¥NAD and preactivated 
cholera toxin of BB caps (lane 3) and after 
incubation of 32P-NAD, preactivated cholera 
toxin and 25 ~ alamethlcin of KSCN-
BBMV (lane 4). Experimental detaHs of the 
ADP-ribosylation assay are as in Methods. 
Migration of molecular mass standards 
expressed in kDa is as indicated. The ADP-
ribosylation of the 46 and 42 kDa proteins 
was only obseNed in the presence of CT 
(not shown). The results are representative 
of three or more experiments. 
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FiGURE 3. Detection of G-protein subunits with subunit-specific antisera in intestinal epithelial 
membrane fractions. 5 ~g of BLM (lane 1), Mg-BBMV (lane 2), BB caps (lane 3) and KSCN-BBMV 
(lane 4) proteins were separated by SDS-PAGE. Jmmunoblotting was performed as described in the 
Methods. A) Antiserum 138, o:i3 specific, dilution 1:200. 8) Antiserum SG1, o:i1,2 specific, dilution 
1:200. C) Antiserum CS1, o:s specific, difution 1:200. D) Antiserum 043, o:o and B specific, dilution 
1:1000. Migration of the molecular mass standards expressed in kDa is as indicated. The results 
shown are representative for at least three other experiments. 
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contrast to the 41 kOa a:i subunit, this 39 kOa protein was not a substrate for 
pertussis toxin catalyzed AOP-ribosylation (Fig.1 and 4). This antiserum also 
detected a 78 kOa protein predominantly present in Mg-BBMV, although 
additionally found in BB-caps and BLM, but not in KSCN-BBMV (Fig.3B). The 
staining of the 41, 39 and 78 kOa proteins was blocked by the peptide to which 
the antiserum was raised, arguiing against non-specific binding (Fig.6). Similar 
results were obtained with a different antiserum (AS /7) raised against the same 
conjugate (not shown). 
Antiserum CS1, specific for the o:s subunits, identified two proteins with 
Mr of 46 and 42 kOa (which sometimes appeared as doublets) in both the 
basolateral and the apical membrane fractions (Fig.3C). The 46 kOa and 42 kOa 
proteins comigrated with the AOP-ribosylated cholera toxin substrates shown in 
Fig.2 and are likely to represent two species of o:s formed by alternative splicing 
[2]. The membranal rather than cytoskeletal origin of a:s was indicated by its 
relative abundance in cytoskeleton-free KSCN-BBMV in comparison with Mg-
BBMV and BB caps (Fig.3C). The distribution of the a:s subunit among the apical 
and the basolateral membrane was virtually symmetrically (Fig.3C, lane 1 and 4). 
Antiserum 043, specific for the a:o and the 6 subunits, identified only a 36 
kOa band, which comigrated with the B-subunit, in all membrane fractions 
(Fig.30), albeit slightly enriched in the apical membrane. This shows that the B-
subunit is symmetrically distributed in enterocytes. The o:o subunit could not be 
detected in any of these membrane fractions, neither by antiserum 043 (Fig.30), 
nor by a second antiserum, IM1 (not shown). In contrast, both antisera were 
found capable of detecting a:o subunits in crude membrane fractions of brain 
(043, results not shown) or of NG108-15 cells (IM1, [35]). 
G-protein subunit release experiments. To examine whether apical G-proteins 
function at the apical membrane or are released and translocated to other 
subcellular regions, in vitro release studies were performed using the non-
vesiculated BB caps as a G-protein source. First we investigated if PT and CT 
catalyzed AOP-ribosylation could trigger release of ai and a:s, respectively, from 
the open BB caps. As shown in Fig.4A, the AOP-ribosylated a:i subunit remained 
confined to the 100.000 g particulate fraction and did not translocate to the 
supernatant. This was confirmed by immunoblotting the 32P-Iabeled BB caps with 
o:i1 ,2 (Fig.4B) and a:i3 specific antisera (not shown). Also incubation of the BB 
caps with GTP[S] or p[NH]ppG uptill 60 min. at 30°C did not trigger ai release, 
either alone or in combination with ADP-ribosylation (results not shown). The AOP-
53 
1 2 1 2 1 2 
A B c 
-46_ -41 
-41 
-39 
-42 
FiGURE 4. Distribution of ADP-ribosylated substrates in particulate and soluble fractions of 
brush border caps. 150 ug brush border caps were ADP-ribosylated by pertussis toxin or cholera 
toxin as described in the methods without addition of detergent and the soluble and particulate 
fractions were prepared. Both fractions were solubilized in 70 p.l SDS sample buffer and analyzed 
on SOS-PAGE. Following electrophoresis, the AOP-ribosylated proteins were transferred to 
nitrocellulose paper and identified by autoradiography. A) Particulate (lane 1) and soluble (lane 2) 
fraction of pertussis toxin catalyzed ADP-ribosylated BB caps. B) Treatment of the same blot with 
antiserum SG1 (a:i1,2 specific; dilution 1:200) following decay of 32P radioactivity. Detection was 
done with 1251-Protein A and autoradiography. C) Particulate (lane 1) and soluble Oane 2) fraction 
of cholera toxin catalyzed AOP-ribosylated 88 caps. The results shown are representative for three 
experiments. 
FIGURE 5. Release of the 39 kDa c:i-like protein from brush border caps. Suspensions of 300 
JL9 brush border caps were incubated for 0, 5, 15 and 30 minutes at 30°C and then separated into 
particulate (lanes 2,4,6,8, 10) and soluble (lanes 3,5,7,9, 11) fractions. In Janes 10 and 11, the 
incubation was carried out for 30 minutes at 30°C in the presence of protease inhibitors (see 
METHODS). Particulate and soluble fractions were solubilized in 100 JLI SDS sample buffer and 
analyzed on SD8-gels. Proteins were detected with antiserum SG1 (a:i1,2 specific, dilution 1:200), 
followed by alkaline phosphatase--conjugated second antibody. As a marker, a purified G-protein 
mixture from bovine brain was loaded (lane 1; 0.2 JLQ). The results are representative for at least 
three other experiments. 
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ribosylated as subunits were predominantly recovered in the particulate fraction, 
although some as subunits were detected in the soluble fraction (Fig.4C}. 
lmmunoblotting with as specific antiserum confirmed these data and further 
showed that this release occurred also in the absence of CT and was therefore 
not triggered by the ADP-ribosylation assay (not shown). Incubation of the BB 
caps with GTP[S] or p[NH]ppG uptill 60 minutes at 30°C did not enhance its 
release (alone or in combination with ADP-ribosylation) nor did GDP[S] inhibit its 
basal release (not shown), suggesting that the small basal release was aspecific 
and not induced by activation of Gs. 
In contrast to the ai and ocs subunits, the 39 kDa oci-like protein 
recognized by antiserum SG1 was readily released after incubation of the 
membranes at 30°C. This release was independent of guanine nucleotides and 
could not be inhibited by GDP[S]. Its solubilization was already detectable alter 
5 min. of incubation and increased in time (Fig.5, lanes 2-9). The addition of 
protease inhibitors prevented the solubilization (Fig.5, lanes 10 and 11). This 
suggests that the release of the 39 kDa protein is triggered by endogenous 
proteases that become activated/solubilized during incubation of the BB caps at 
higher temperature. As its solubilization is not accompanied by a measurable shift 
A. 1 2 3 B 1 2 3 
FIGURE 6. Peptide displacement of immunoreactive bands in brush border caps recognized by 
a:i1 ,2 specific antiserum. 300 _ug brush border caps were incubated for 5 minutes at 30°C and then 
separated in a particulate and a soluble fraction (lanes 2 and 3, resp.). Both fractions were 
solubilized in 100 f.LI SDS sample buffer and analyzed on gel. Lane 1 contains 0.2 JL9 of a purified 
G-protein mixture from bovine brain. Proteins were detected with antiserum SG1 (a::i1,2 specific; 
dilution 1:200}, followed by alkaline phosphatase conjugated second antibody. A) SG1. B) SG1, 
presaturated with the peptide to which it was raised (0.5 mgjml, 5 min. incubated at 20°C) and 
subsequently diluted 1:200). 
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in molecular size of the 39 kDa protein (Fig.5), the release mechanism is likely to 
involve the proteolysis of another protein to which the 39 I<Da protein is coupled. 
The fraction of 39 kDa protein releasable in 15-30 minutes varied per experiment 
and is most likely dependent on the protease content of the isolated membranes, 
which can vary per BB batch and may include both intrinsic proteases and 
contaminating pancreatic enzymes. In some experiments a complete release was 
found in 15-30 minutes (Fig.4B). lmmunoblotting did not reveal solubilization of 
the B-subunit (results not shown), confirming the hydrophobic nature of this 
protein. Addition of 0.1 % BSA as a carrier protein before precipitation with 
trichloroacetic acid did not influence the results (not shown). 
DISCUSSION 
Membrane associated G-proteins generally act as signal transducers, 
coupling receptors lor hormones, neurotransmitters or light to effectors, such as 
adenylate cyclase, phospholipases, ion channels and phosphodiesterases [1]. 
Considering the asymmetrical distribution of most, if not all, G-protein coupled 
hormone receptors at the basolateral pole of the enterocyte [7], the G-proteins are 
likewise expected to reside preferentially in this subcellular region. In our 
immunochemical experiments such a distribution pattern could be substantiated 
for some of the G-proteins, notably the ai2 and ai3 subunits, but not for others: 
the as and the B subunits were present in abot..t equal concentrations in both 
membranes. Two newly detected cd-like proteins (39 and 78 kDa), identified with 
antiserum raised against a:i1 ,2, were found almost exclusively in the apical border. 
The a:i and the as subunits could also be detected in PT and CT 
catalyzed ADP-ribosylation assays, respectively. With respect to the ai subunits, 
however, the ADP-ribosylation data and the immunoblotting data were qualitatively 
but not quantitatively comparable. The ADP-ribosylation reaction is known to be 
critically dependent on assay conditions and addition of detergent. To our 
experience, the labeling of each membrane preparation changed dramatically 
when different detergents were used and their order of potency varied per 
membrane species. To ensure optimal assay conditions, different detergents were 
therefore selected for a comparison between the various membrane preparations 
examined (Fig.2). As the ADP-ribosylation under our assay conditions is 
presumably incomplete and variable between different preparations, these data are 
unsuitable for quantitative analysis. 
Besides the classical G proteins, Gi2, Gi3 and Gs, two possibly novel Gi-
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like species were detected immunochemically in the intestinal membranes. The 
39 kDa protein, detected by c:i1 I a:i2, but not by a:i1 and a:i3 specific antisera, 
differed from the 41 kDa c:i subunits in that: 1) its molecular mass was slightly 
lower; 2) it did not serve as a substrate for PT catalyzed ADP-ribosylation; 3) it 
was found only in BB caps and (at a low level) in KSCN-BBMV, but not in BLM; 
4) it was readily released alter incubation of BB caps at 30°C. As the N-terminus 
of several "' subunits is known to be important for B/y interaction and membrane 
attachment [36], one could argue that this 39 kDa protein originates from cd2 
through limited proteolysis of a N-terminal segment. Since the N-terminus of cd 
appears also essential for recognition of the "' subunit by pertussis toxin [36], its 
removal could in principle account lor the lack of PT catalyzed ADP ribosylation 
of the 39 kDa protein shown in Figs.1 and 4. Such a hypothesis would imply that 
(1) proteolysis is limited and restricted to a small N-terminal fragment, because 
the 39 kDa protein is still recognized by antiserum SG1 (raised against the C. 
terminal decapeptide); (2) the C-terminus of cd (essential for recognition of the "' 
subunit by pertussis toxin [26]) must be altered, causing the lack of pertussis-
toxin-catalysed ADP-ribosylation of the 39 kDa protein shown in Figs.1 and 4, 
however without disturbing antiserum recognition; (3) the protease responsible for 
this cleavage is located exclusively at the apical border; no evidence for a 41 to 
39 kDa protein conversion was found in purified BLM; (4} proteolysis must have 
occurred in vivo or during preparation of the BBM; in contrast, several other 
peripherous membrane proteins known to be sensitive to proteolysis (e.g. cGMP 
dependent protein kinase; villin) do not undergo proteolytic modification during 
isolation of brush border membrane caps [37]. However, if the 39 kDa protein 
arises by proteolysis of the 41 kDa c:i2 subunit, it remains unclear why prolonged 
incubation of the brush borders, leading to a time dependent increase in 
solubilization of the 39 kDa band, does not significantly diminish the intensity of 
the 41 kDa band, in clear contrast to the immunoreactive 78 kDa band (Fig.5). 
Alternatively, the 39 kDa protein may originate at least in part from proteolysis of 
the 78 kDa protein, which in some (Fig.5}, although not all experiments decreased 
when release of the 39 kDa protein increased. Although its size suggests that it 
might be a dimer of the a:i2 subunit or of the a:i-like 39 kDa protein, no 
dissociation into 39-41 kDa subunits was observed following N-ethylmaleimide 
treatment or boiling in the presence of 2-mercapto-ethanol. Similarly to the 39 kDa 
protein, the 78 kDa protein is readily released from the membrane and its release 
could be prevented by protease inhibitors (Fig.5). Its distribution is different from 
both the a:i2 and the a:i-like 39 kDa protein in that it is highly enriched in the Mg-
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BBMV (Fig.38). A similar high molecular weight protein was also detected by the 
same antiserum in rat liver membranes [32]. The rat liver 78-90 kDa protein was 
likewise enriched in fractions that contained little or no ai subunits [32]. The 
function of this protein is not yet known, but its molecular weight argues against 
a role as a classical heterotrimeric G-protein. 
Assuming that the 39 kDa protein is a novel member of the ai family, its 
ability to be readily released from the BB by proteolysis makes it difficult to draw 
conclusions about its intracellular localization. It remains possible that this protein 
is more uniformly distributed among basolateral and apical membranes in the 
intact cell, but is lost during the preparation of the basolateral membranes and the 
Mg-BBMV, but not of the BB caps. This possibility is rather remote since Mg-
BBMV's, in contrast to open BB caps, are formed immediately after shearing the 
cells and are resealed tightly in a right side out orientation preventing the release 
of intramicrovillar proteins [16]. A more likely possibility is that this protein is 
associated with the terminal web structure which is recovered only in BB caps, 
but not in Mg-BBMV or cytoskeleton depleted KSCN-BBMV. Such a localization 
might have important implications for its physiological function. It could be 
involved in endo- or exocytotic pathways or in the regulation of the organization 
of the cytoskeleton as described for G-proteins in neutrophils [29]. Assuming 
however that the 39 kDa protein is a proteolytic fragment of the 78 kDa protein, 
the unequal distribution of these proteins among Mg-BBMV (enriched in 78 kDa 
protein) and BB caps (enriched in 39 kDa protein) could reflect the protection of 
intravesicular proteins in Mg-BBMV to degradation by extravesicular proteases, 
preventing a possible conversion of the 78 kDa into the 39 kDa protein [ cf. refs. 
16 and 37]. Clearly, further studies are needed to purify and characterize both the 
78 kDa and the 39 kDa a:i-like proteins in order to identify their possible 
relationship and their physiological significance. 
The targets for the apical G-proteins do not need to be in the apical 
membrane itself. It has already been described that G-protein a: subunits can be 
released from the membrane upon activation by GTP, GTP analogs or B-
adrenergic receptor activation [25,26,27]. This is of particular interest in 
understanding the mechanism of action of cholera toxin. Enterocytes are the 
target for this toxin in vivo, causing secretory diarrhoea. It has always been 
intriguiing how cholera toxin, entering the enterocyte from the luminal site, is able 
to activate adenylate cyclase which is located at the basolateral membrane. 
Dominguez et al. [28], who were the first to demonstrate apical localization of ctS 
subunits in rabbit enterocytes by the use of non-immunological techniques, have 
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suggested that cholera toxin activates «S in the apical membrane, which then 
translocates and couples to adenylate cyclase in the basolateral membrane. 
However, in this in vitro study we could not detect release of «S, «i orB subunits 
from the apical membrane, even after prolonged exposure to GTP or its analogs 
or following cholera and pertussis toxin catalyzed ADP-ribosylation. Under similar 
conditions a slow and partial release of «S subunits has been described in rat 
glioma membranes [26]. The reason for this tissue difference is unclear. Although 
the absence of G-protein subunit translocation needs to be confirmed for intact 
epithelium, our data support the concept that the apical G-proteins fulfill a 
functional role in the same membrane to which they are targetted. In that regard, 
at least part of the cellular content of Gi and Gs is expected to be localized in the 
basolateral membrane considering their known interaction with adenylate cyclase 
in this tissue. Our study shows that this is indeed true for rat enterocytes. 
Solar no physiological activators or inhibitors of apical G-proteins in 
epithelial cells have been defined. Possible candidates include unidentified 
receptor proteins in the luminal membrane, second messengers activated by 
hormone receptors in the basolateral membrane or, in analogy with Go in the 
growth cone [30], a GAP-43 like protein, which can intracellularly activate G-
proteins, without the necessity of a G-protein coupled receptor. A polarized 
distribution of G-protein subunits was also found in the rat renal cell-line LLC-PK1 
by Ercolani [31]. In the renal epithelial cells, in contrast to the enterocyte, tti3 was 
localized exclusively in the apical membrane where it is possibly involved in the 
activation of amiloride sensitive Na+ -channels [33] and apical Cl"-channels [34]. 
A similar role for G-proteins in the apical membrane of intestinal epithelial cells has 
been suggested by our recent identification of a novel type of Cl"-channel in this 
membrane, that was activated by GTP and GTP analogs and inhibited by GDP[S] 
in the absence of cytoplasmic messengers [10,11]. The presence of a G-protein 
activated PI cycle in the apical membrane [7] also suggests a role for apically 
localized G-proteins. The as subunits and the 39 kDa/78 kDa e<i-like proteins are 
possible candidates for both cr-channel and phospholipase C activation in 
contrast to the ai subunits which were localized almost exclusively in the 
basolateral membrane. 
We thank Dr. G. Milligan for generously supplying the specific antisera to a:i1, a:i1,2, a:i3, a:o and 
as. We are a!so grateful to L van der Voorn for her gift of the specific antiserum to a.o/B and the 
G-protein mixture purified from human and bovine brains. This study was supported by the 
Netherlands Organization for the Advancement of Scientific Research (NWO). 
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CHAPTER 3 
G-PROTEINS MEDIATE INTESTINAl CHlORIDE 
CHANNEl ACTIVATION 
The localisation of several GTP-binding regulatory proteins in the apical 
membrane of intestinal epithelial cells has prompted us to investigate a 
possible role for G-proteins as modulators of apical Cl"-channe!s. In 
membrane vesicles isolated from rat small intestine or human HT29ci.19A 
colon carcinoma cells, the entrapment of GTP [S] led to a large increase in 
cr conductance, as evidenced by an increased ' 251"-uptake and faster SPQ-
quenching. The enhancement was observed in the presence, but not in the 
absence of the K• -ionophore valinomycin, indicating that the increased cr 
permeability is not secondary to the opening of K• -channels. The effect of 
GTP[S] was counteracted by GDP[S] and appeared to be independent of 
cylosolic messengers, including ATP, cAMP and Ca2+, suggesting that 
protein phosphorylation and for phospholipase C activation is not involved. 
Patch clamp analysis of apical membrane patches of HT29ci.19A colonocyles 
revealed a GTP[S] activated, inwardly rectifying anion selective channel with 
a unitary conductance of 20 ± 4 pS. No spontaneous channel openings were 
observed in the absence of GTP[S], while the open-lime probability (P.) 
increases dramatically to 0.81 ± 0.09 upon addition with GTP[S]. Since the 
electrophysiological characteristics and regulatory properties ofthis channel 
are markedly different from those ol the more widely studied cAMP fA-kinase 
operated channel, we propose the existence of a separate cr selective ion 
channel in the apical border of intestinal epithelial cells. Our results suggest 
an alternative regulatory pathway in transepithelial salt transport and a 
possible site for anomalous channel regulation as observed in cystic fibrosis 
patients. 
INTRODUCTION 
Chloride ftuxes across biological membranes are involved in a number of 
important physiological processes, including osmo-regulation, salt absorption and 
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secretion, neurotransmission and intracellular pH regulation. Among these, 
transepithelial salt secretion is of a particular interest, since anomalous regulation 
of the Cr-channel involved leads to severe pathological conditions like secretory 
diarrhoea (cholera) and cystic fibrosis [1-3]. Although little is known of the 
physical structure of epithelial cr-channels [4], their mode of activation has been 
analyzed in more detail. On the basis of electrophysiological techniques (e.g. 
patch clamp, planar lipid bilayers, Ussing chamber) several intracellular regulatory 
mechanisms are emerging. These include: 1) channel activation through cAMP-
and, in intestine, cGMP-dependent protein phosphorylation [1,2]; 2) activation 
through Ca2 + -mobilizing hormones such as acetylcholine, bradykinin or histamine 
[1 ,2] and 3) modulation of channel activity by protein kinase C [5,6]. 
According to the classical concept, regulation is initiated by hormone-
receptor activation of GTP-binding regulatory proteins (Gs, Gp) in the basolateral 
membrane, activation of adenylate cyclase or phospholipase C and subsequent 
generation of cytosolic messengers (cAMP, Ca2 +) capable of communicating with 
the apical membrane [1 ,2]. However, recent studies have demonstrated that G-
proteins are also capable of modulating ion channel activities through a direct or 
lipid metabolite-derived mechanism, independent of cytosolic messengers. This 
has been demonstrated definitely lor cardiac Ca2+ -, neuronal K+ -and epithelial 
Na+- and Cl"-channels [7-11], but G-protein involvement in intestinal Cl"-channel 
regulation has not been reported previously. We have recently found that a 
number of GTP-binding proteins, including Gs, Gp and p21 ras, are abundant in 
apical membranes of intestinal epithelial cells, despite the absence of any known 
G-protein-coupled hormone receptors ([12] and footnote 1). Since intestinal Cr-
channels are localized preferentially in the same membranes [1 ,2], a possible role 
for apical G-proteins as modulators of intestinal cr secretion was studied. In this 
report, we present data illustrating that activation of G-proteins with GTP or 
GTP[S]2 enhances the cr conductance of vesiculated intestinal membranes and 
unmasks the existence of a novel type of Cl"-channels in apical membrane 
patches from human colonocytes. 
MATERIAlS AND METHODS 
Materials: Human HT29cL19A colonocytes were generously donated by Dr. Laboisse, Unite 239 
INSERM, Paris, France. All nucteotides were purchased from Boehringer Mannheim (FRG). C251J-
iodine was obtained from Amersham Ltd. and SPQ from Calbiochem. 
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Cell culture: HT29c!. 19A colonocytes were routinely grown in Dulbecco's modified Eagle's medium 
supplemented with 10% fetal calf serum (Gibco). Cells were harvested 3--5 days after reaching 
confluency. 
Vesicle preparation: Right-side out apical membrane vesicles from human HT29ci.19A cells were 
prepared from cell homogenates by differential Mg2+ -precipitation in the presence oftrypsin-inhibitor 
(50 p;gjml), PMSF and 2 mM EGTA as described [1]. Thereafter, the vesicles were resuspended in 
a buffer containing 20 mM TrisjHEPES (pH = 7.0), 300 mM mannitol, 150 mM KCI, 6 mM MgS04 , 
3 mM CajEGTA (pCa = 6) and 1 mM NaV03 , supplemented with either 150 mM KCI (iodine uptake 
assays) or 20 mM SPQ (Cl"-influx assays). Various nuc!eotides were trapped into the vesicles through 
a single cycle of freeze-thawing in liquid nitrogen. Rat brushborder membrane vesicles ('MgjEGTA-
BBMV') were prepared as previously described [13] and guanine nucleotides were trapped as 
described above. 
Iodine uptake assay: Chloride efflux was quantitated using a 1251-uptake assay analogous to the 
23Na +-assay developed by Garty eta!. [14]. In short, extra-vesicular cr was removed by eluting the 
vesicles through a OOWEX 1X8 column (gluconateform, 700JLl bedvolume) with 150 mM potassium 
gluconate. Assays were started by mixing the vesicles suspension with tracer amounts of radioactive 
iodine (3 JLCijmg of protein) in the absence or presence of the K+ -ionophore valinomycin (10 p.M). 
Uptake was terminated by rapid elution of the vesicle suspension through a second DOWEX 1X8 
column (formate form, 400 JLI bedvolume), to remove external 125r, followed by y-scintillation 
counting of the eluate. Background radioactivity (usually less than 1000 c.p.m), as measured by the 
amount of 125r in the eluate in the absence of membrane vesicles, was subtracted. 
SPQ-quenching: Extravesicular fluorochrome was removed prior to the experiments, by washing 
three times with excess(> 10 volumes) buffer. Vesicles were added to the cuvette at a concentration 
of approx. 100 .ug proteinjml and continously stirred. Auorescence was monitored at 350 nm 
(excitation) and 450 nm (emission) as described [15], using a Perkin Elmer LS-3B fluorescence 
spectrometer. Chloride uptake was started by adding KCI (fina! concentration: 25 mM) to the cuvette. 
After 3- 5 minutes, trapped SPQ was released by addition of 10 p.l 10% (v:v) Triton X-100, in order 
to achieve maximal quenching. The rate of salt-induced SPQ quenching was determined by fitting 
the change offluorescence to F(t) = A0 +A,/ {1 + KC.(1- e"''~l + kJ [16]. In this equation, F(t) 
represents fluorescence at time t, A0 and A 1 the residua! fluorescence and the amplitude of 
quenching, respectively. k1 represents the rate constant and the term krJ was used to correct for 
linear, Cr-channe! independent quenching [16]. KC .. is the product of the Stern-Volmer constant 
(K; 92 M·') and the final [Cil (25 mM). 
Patch clamp analysis: Single channel recordings from apically localized channels were obtained 
from confluent monolayers of HT-29cl.19A cells using a Ust EPC7 amplifier. Signals were filtered at 
3kHz, digitized and stored on video tape prior to data analysis. Pipette solution contains 140 mM 
NaCI, 5 mM KCI, 5 mM HEPES (pH= 7.4), 1.2 mM MgCI2 and 1 mM Ca/EGTA (pCa = 8), whereas 
bathing solution was identical except that 10 JLM GTP[S] was added. GTP[S}-activated Cl--channels 
were identified by the expected shift in voltage-current relationship observed after increasing the 
NaCI concentration in the bath to 420 mM. The channel incidence was approx. 25% (n = 98). 
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RESULTS 
In an initial series of experiments, Cr-channel activation was studied in a 
suspension of KCI-Ioaded plasma membrane vesicles obtained from human 
HT29ci.19A cells, a cr-secreting subclone isolated from the original HT29 colon 
carcinoma cell line [17]. Conductive chloride efflux was measured by quantitating 
Cr-diffusion potential-driven uptake of tracer amounts of radio-labelled iodine. We 
found this method superior to 36CI"-influx assays because: 1) epithelial anion 
channels prefer rover cr (PtfPc, > 1) [17], 2) ' 25r is available at higher specific 
radioactivity, and 3) iodine is accumulated exclusively into intact vesicles 
containing functional Cr-channels (c.f. ref. [14]), resulting in diminished 
background labelling and increased sensitivity. Addition of trace amounts of radio-
labelled iodine to KCr-loaded vesicles results in a rapid increase in intravesicular 
'
251" (Fig.1 ). As compared to control preparations, ' 251" accumulation is much larger 
(approx. 2-3 times control values) in GTP[S] containing vesicles, suggesting that 
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FIGURE 1. ["'5 I]uptake in 
apical membrane vesicles 
from HT -29ci.19Acolonocytes. 
Time-course of radiolabelled 
iodine uptake in control (0) and 
100 JLM GTP[S]-containing (~) 
vesicles in the absence (open 
symbols) and presence (closed 
symbols) of valinomycin (10 
JLM}. Data points are all derived 
from one representative 
experiment (n = 3). 
GTP[S] induces a sustained increase in transmembrane chloride permeability. 
Disturbing the Cl"-diffusion gradient, by adding the K+ -ionophore valinomycin (1 0 
1J.M), eliminates the GTP[S]-stimulation ol 1251" uptake (Fig.1.), confirming its 
identification as conductive cr-efflux. In contrast, 1251"-uptake in control 
preparations was not affected. In the presence of valinomycin, 1251" accumulation 
is somewhat lower in GTP[S]-containing relative to control vesicles (Fig.1). This 
phenomenon is probably an artifact of the experimental procedure used, since 
increased anion permeability, as occurs in GTP[S] containing vesicles, may 
facilitate exchange of iodine from the vesicle to the Dowex column during elution. 
Although considerable variation in basal 1251" uptake between the various vesicle 
preparations was noted (approx. 2000 - 7000 c.p.m.), the GTP[S]-induced 
increase in ' 251" accumulation appeared highly reproducable (1.51 ± 0.12 times 
basal uptake at t = 30; mean ± S.E.M. for n = 3). 
The accumulation ol 1251" in GTP[S]-containing vesicles persists lor at least 
30-60 minutes. At least two phenomena may underly this sustained enhancement 
of intravesicular 1251" uptake. First, the electrogenic efflux of cr generates a 
sustained inside-positive diffusion potential, which acts as a driving-force for 
prolonged 1251" accumulation (c.f. see: ref.[14]). Secondly, the contribution of an 
additional subpopulation of vesicles which accumulate 1251" solely in the presence 
of guanine nucleotides may give rise to a further increase in the equilibrium 
concentration of intravesicular 1251". As expected for right-side out vesicles, no 
effects ol GTP[S] were observed when added after vesicle resealing (not shown), 
demonstrating that GTP[S] acts on the cytoplasmic side of the membrane. 
TABLE 1. Effects of GDP[Sl on GTP[S]-induced transmembrane Cr fluxes. 
Control 
GDP[S] 
GTP[S] 
GDP[S] + GTP[S] 
k, of SPQ quenching (% of control) 
100 
so ::t 11* 
316" 15" 
209 :t: s* 
SPO-quenching experiments were performed as described in 'Materials and Methods'. Rate 
constants (k1) were calculated and expressed as percentage relative to control preparations (mean 
::t SEM for 3 independent experiments). k1 in control preparations was 0.6 :!: 0.1 min"1• 
Concentrations used: GDP[SJ, 5 mM and GTP[S], 100 ,ILM. Asterisk indicates P < 0.05 relative to 
the control. 
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To further substantiate our finding that GTP[S] increases cr -conductance, 
we measured cr-uptake using the chloride sensitive fluorescent probe SPQ. 
Recent studies have revealed that this water-soluble dye, whose fluorescence is 
quenched in the presence of cr. is a suitable and sensitive probe for chloride 
transport assays in biological systems [15]. As shown for rat small intestinal 
brushborder membrane vesicles (Fig.2), addition of KCI (25 mM final 
concentration) to SPQ-Ioaded vesicles rapidly quenches fluorescence, indicative 
of an increasing intravesicular Cr-concentration. In the presence ofvalinomycin,i.e. 
when generation of a counteracting membrane potential is inhibited, SPQ 
quenching is much faster in GTP[S]-Ioaded relative to control vesicles (Fig.2 and 
Table 1 ). Apparently, the GTP[S]-sensitive cr conductance is not confined to 
human colon carcinoma cells, but occurs also in the apical membranes of non-
neoplastic enterocytes. Qualitatively similar results were obtained with vesicle 
preparations from cultured HT29ci.19A cells (not shown). Importantly, no 
difference between control and GTP[S]-containing vesicles was observed in the 
absence of valinomycin (Fig.2), indicating that increased cr-conductance is not 
secondary to GTP-induced opening of K+ -channels. The notion that GTP-binding 
proteins may be involved in stimulating cr-conductance is further supported by 
our observation that GTP-induced acceleration of transmembrane Cl"-influxes is 
diminished in the presence of trapped GDP[S], a well known inhibitor of GTP-
binding proteins (Table 1). 
TABLE 2. Effects of guanine nucleotides on SPQ quenching. 
Control 
ATP (1 mM) 
ATP[S] 
cAMP 
GOP 
GDP[S] 
k1 of SPQ quenching (min.1) 
0.64 = 0.08 (10) 
0.70 = 0.09 (5) 
0.69 = 0.17 (3) 
1.63 = 0.10 (3). 
0.65 = 0.02 (3) 
0.90 = 0.05 (3). 
GTP 
GTP - Vanadate 
GTP[S] 
GTP[S] + cAMP 
GMP-PNP 
1.08 = 0.18 (3)" 
0.69 = 0.17 (3) 
1.52 = 0.20 (10( 
2.17 = 0.12 (2). 
2.03 (1) 
Various guaninine nucleotides (100 JLM), ATP[S] (200 JLM) and cAMP (1 mM) were trapped into rat 
brush border membrane vesicles as described in Figure 2. Effects of cAMP :!::: GTP[S] were tested 
in the presence of 1 mM ATP. Rate of SPO quenching was determined as described under 'Materials 
and Methods' and expressed as mean ~ SEM. Number of independent experiments is given 
between parentheses. Asterisk indicates P < 0.05 relative to the control. 
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FIGURE 2. Rate of SPQ quenching. Cr-influx in control (C) and GTP[S]..containing rat brush border 
membrane vesicles was determined in the absence H or presence ( +) of valinomycin (10 p.M) using 
the Cr-sensitive probe SPQ. 
We have studied the effects of various nucleotides by trapping equimolar 
(100 ~M) concentrations into rat intestinal brushborder membranes vesicles. As 
clearly shown in Table 2, non-hydrolysable GTP-analogues such as GTP[S] and 
GMP-PNP are potent activators of conductive cr-influx. GTP activates chloride 
transport also, but only when GTPase inhibitor vanadate [19] is present (Table 2). 
Other guanine nucleotides, including GMP and GOP, were always ineffective. A 
small increase in SPQ-quenching, however, was observed in GDP[S]-containing 
vesicles (Table 2), suggesting the possible existence of a channel inhibitory G-
protein in brushborder membranes. ATP (1 mM) or ATP[S] (200 ~M) alone did not 
induce Cl--influx (Table 2), nor did it potentiate the response to GTP[S] 
(notshown). This suggests that protein phosphorylation andjor ATP-binding is not 
essential for a GTP-mediated increase in Cr- conductance. In the presence of 1 
mM ATP, cAMP was found to stimulate transmembrane ion fluxes additional to the 
response to GTP[S] (Table 2), most likely through protein kinase A mediated 
protein phosphorylation [1 ]. 
Chloride selective anion channels have been previously studied in detail 
in various human tissues, including nasal polyps [20], tracheal cells [21, 22]. 
sweat gland duct cells [3] and renal epithelium [11], as well as in a number of 
tumour cell lines such as T84 [23] and HT29 intestinal cells [24]. We have studied 
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FIGURE 3. Patch clamp analysis ol GTP[S]-activated Cl'-channels. A) Activation of Cl'-channels by GTP[S] (10 #M) In apical membrane patches 
obtained from HT-29ci.19A cells. Closed (c) and open (o) states of the channel are indicated. GDP[S] represents a recording of a GTP[S] activated 
channel 2 minutes after addition of 2 mM GDP[S]. B) Patch clamp recordings of a GTP[S)-stlmulated Cl'-channel at various holding potentials. C) 
Voltagejcurrent relationship of GTP[S] activated Cl'-channels. D) Open state probability of GTP[S] activated Cl'-channels. Data are expressed either 
as mean ± S.D. for 4 determinations or as the mean of a duplicate observation. 
the biophysical characteristics of GTP[S]-activated Cl"-channels in HT29ci.19A 
colonocytes using patch clamp analysis, enabling a comparison with the well 
documented cAMP-activated Cl"-channel. 
Upon exposure of inside-out apical membrane patches to 10 llM GTP[S]. 
highly frequent channel openings were observed within 2 - 20 minutes (Fig.3A). 
The channels were anion-selective (P0JP"• > 8), as determined by changing the 
ionic composition of bathing solutions, and showed the permeability sequence 
N03- > Br' .=. r > cr > F. Since addition of GDP[S] (2 mM, Fig. 3A) blocks the 
channel rapidly, we suggest that they are identical to those involved in the 
GTP[S]-induced increase in transmembrane Cl"-flux (c.f. Fig.1 and 2). GTP-
activated cr-channels display an average single channel conductance of 20 ± 4 
pS and exert a prominent, inward rectification (Fig.3B,C). At physiological 
membrane potential, the open-state probability (P0 ) is 0.81 ± 0.09 (n ; 10), which 
tends to decrease by depolarization (Fig.3D). Interestingly, this particular channel 
was only found after stimulation with GTP[S] and, in contrast to the cAMP /protein 
kinase A activated channel, never occurred spontaneously or following membrane 
depolarization. 
Electrical properties of the GTP[S]-activated channels differ markedly from 
the cAMP /protein kinase A activated Cl"-channels, which have a somewhat larger 
unitary conductance and, most importantly, were found to be outward rectifying 
[21-24]. This suggests that, in addition to cAMP-activated channels, a different 
class of cr-selective channels exists, which are coupled toG-proteins. This notion 
is supported by our observation that, in vesicle preparations, co-stimulation with 
GTP[S] (100 I'M) and cAMP (1 mM), in the presence of ATP, results in an 
additional rather than synergistic, increase in the rate of SPQ quenching (Table 
2). 
DISCUSSION 
The co-existence of an activating G-protein and ion channel in the apical 
membrane of a polarized epithelium is not unprecedented: the activity of 
amiloride-sensitive Na+ -channels and of Cl"-channels in renal apical membranes 
has likewise shown to be regulated by GTP and GTP[S]. presumably acting 
through «i3 [9-11]. Although the renal cr-channel has characteristics very different 
from the GTP[S]-activated channel in intestinal epithelia (e.g. single channel 
conductance of 305 pS, activation by protein kinase C and Ca2+, frequent 
spontaneous openings [11 ]), these findings suggest a more wide spread role for 
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G-protein operated anion channels in transepithelial ion fluxes. Presently, little is 
known about the identity of the channel-associated G-protein or about its cellular 
activators. According to the classical concept of cholera toxin-provoked intestinal 
salt and water secretion, the A 1 subunit of the toxin is released at the apical 
membrane and, upon translocation to the basolateral membrane, activates 
adenylate cyclase through ADP-ribosylation of a basolateral pool of the stimulatory 
G-protein Gs [25]. Subsequently, cAMP triggers the opening of apical Cl"-channels 
through protein kinase A-mediated phosphorylation [1]. The recent demonstration 
of a distinct pool of Gs (Gs .. ) in the apical membranes [26] has led to the 
speculation that as••, rather than A1, translocates to the basolateral membrane 
following its ADP-ribosylation at the apical border [25, 26]. Alternatively, it remains 
possible that the inward-rectifyer functions as a stress- or swelling-activated cr-
channel recently identified in epithelial tissues, including intestine [27, 28]. 
Coupling of the G-protein to the Cl"-channel may either be direct, as 
shown previously for the action of several hormones and neurotransmitters on 
cation channels [7-11], or indirect, possibly through locally produced autacoids, 
as demonstrated earlier lor cardiac muscarinic K+ -channels [29, 30]. Our 
experimental conditions however, exclude the possibility that GTP[S] acts 
indirectly through the generation of cytosolic messengers such as cAMP and 
Ca2•. Furthermore, the co-localization of the GTP-receptor and the Cr-channel in 
the apical membrane patches and vesicles virtually rules out a channel recruitment 
model in which the G-protein, analogous to the GE postulated for exocytosis [31], 
would trigger the fusion of channel-containing vesicles with the apical membrane 
(c.f. ref. [32]). As yet, no information is available about the molecular structure of 
GTP-activated Cl"-channels. A putative structure of the cAMP /protein kinase A-
activated Cl"-channel has recently been proposed from the nucleotide sequence 
of CFTR, the cystic fibrosis transmembrane conductance regulator [33]. Because 
CFTR contains two nucleotide binding folds [33], capable of binding both ATP and 
GTP [34], we cannot exclude that GTP[S] increases Cr-conductance through 
CFTR. However, in view of the prominent differences between cAMP- and GTP[S]-
sensitive cr-channels (1/V characteristic, voltage activation; c.f. ref [1]), the 
existence of a different class of anion-selective channels seems more likely. 
Interestingly, an apically localized, inwardly rectifying Cr-channel has recently 
been reported lor gastric oxyntic cells in amphibians [35]. Although this particular 
channel has electrical characteristics very similar to the GTP[S]-activated 
channels, they are certainly not identical, since marked differences exist in 
sensitivity for cAMP-dependent protein phosphorylation and membrane 
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depolarization. Therefore, it is important to establish whether or not G-protein 
coupled cr-channels are functional in cystic fibrosis patients, because the 
presence of functional GTP-activated channels may imply a possible route for 
bypassing the defect in cAMP-, cGMP and Ca2 + activation of cr secretion [2, 36-
38], most plausibly the primary lesion in this disease. 
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1. N.v.d.Berghe et al., in preparation. 
2. Abbreviations used: ATP[S], adenosine 5'-0-{3-thiophosphate); CFTR, Cystic Fibrosis 
transmembrane conductance regulator; EGTA, [ethylenebis(oxyethylenenitrilo)]tetraacetic acid; 
GDP[S), guanos;ne 5'-0.(2-th;ophosphate); GMP-PNP, guanylyl-;m;dod;phosphate; GTP[S], 
guanosineS'-0-(3-thiophosphate); HEPE$,4-(2-hydroxyethyl)-1-piperazineethanesulfonicacid;PMSF, 
phenyl-methyl-sulfonyl-fluoride; P 0 , open time probability; Pc11 channel permeability to Cl--ions; P1, 
channel permeability to !"-ions; PNa• channel permeability to Na+-ions; SPQ, 6-methoxy-N-(3-
sulfopropyl)..quinolinium. 
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PHORBOL ESTER AND cAMP 
CARBACHOL-INDUCED CALCIUM 
CHAPTER 4 
INHIBIT THE 
RESPONSE AT 
DIFFERENT TARGETS IN HT29cl.i9A CELLS. 
Our recent identification of a GTP-activated phospholipase C in the apical 
membrane of rat enterocytes, despite the lack of ca•• -linked hormone 
receptors in this subcellular region [Vaandrager et al. Am.J.Physiol. 259: 
G410-G419, 1990] and the apparent role of ca•• as a third messenger in 
cyclic nucleotide-induced inhibition of Na• absorption [Semrad et al., 
J.Ciin.lnvest. 86: 585-591, 1990], prompted us to examine possible cross-talk 
between second messengers generated at the basolateral membrane (cAMP, 
Ca2 \ protein kinase C) and the PI-cycle in HT29ci.19A and T84 colonocytes. 
In HT29ci.19A cells, ca•• -ionophore caused a slight stimulation of lnsPn 
production. However, HPLC analysis revealed a rise in lnsP1, rather than 
lns(1,4,5)P3, arguing against a role lor ca•• as a trigger of apical or 
basolateral PIP2 hydrolysis. Short-term treatment with phorbol ester (PMA) 
did not affect basal lnsPn levels but inhibited the carbachol-induced rise in 
lnsPn and calcium, indicating negative feedback by PKC. Downregulation of 
PKC a resulted in recovery of both responses. In contrast, cAMP had no 
effect on the production of lnsPn, either alone or in the presence of 
carbachol. However, cAMP strongly inhibited the carbachol-induced calcium 
response, without affecting basal calcium levels. Furthermore, heat-stable 
Escherichia coli toxin (ST J, a cGMP-Iinked agonist, was likewise unable to 
affect lnsPn levels in T84 colonocytes. In conclusion, we found no evidence 
for a role of calcium as third messenger in the action of cyclic nucleotides 
in the colonic cell lines. In addition, no evidence was obtained lor a 
physiological role of cAMP, cGMP, protein kinase C or calcium as triggers 
of (apical) PI-derived signals. Instead, PMA and cAMP were found to inhibit 
the carbachol-activated calcium response, by acting on differenttargets: PMA 
at a step upstream, cAMP downstream of lnsPn formation. 
75 
INTRODUCTION 
In the intestine, at least three signal transduction pathways are involved 
in the regulation of transepithelial salt and water transport (1 0). These pathways 
include protein phosphorylation through cAMP- and cGMP-dependent kinases and 
activation of phospholipase C (9,10). Since intestinal epithelial cells are exposed 
to multiple stimuli in vivo (4), several different pathways may become activated 
simultaneously. Cross-talk between second messenger-generating pathways has 
been described in several other tissues and appears to affect multiple cellular 
functions (see below). 
The mechanism of cross-talk between cyclic nucleotides and the PI-cycle 
varies between the cell types studied. Inhibition of the PI-cycle by cyclic 
nucleotides has been described to occur upstream of phospholipase C (PLC), 
through phosphorylation of a 24 kDa G-protein (23) or the 50 kDa VASP protein 
(32,36) as well as downstream of PIP2 hydrolysis through phosphorylation of a 
brain lnsP3 receptor (31) or inhibition of calcium entry and/or activation of the 
Ca2 + -ATPase (11, 13). In addition, stimulation of the PI-cycle by cyclic nucleotides 
has also been demonstrated both upstream (15) and downstream (5, 7,22,24,27) 
of PLC activation. 
Apart from this modulatory role of cyclic nucleotides, the PI-cycle is also 
known to be under inhibitory control of protein kinase C (PKC). The targets for 
PKC-induced inhibition can be the enzyme itself (PLC B, 28) or the coupling 
between the G-protein and PLC (18). Furthermore, PKC was found to inhibit 
lns(1 ,4,5)P3-induced calcium mobilization by enhancing the metabolism of 
lns(1 ,4,5)P3 (16) and by inhibiting the lns(1 ,4,5)P3 operated calcium channel (37). 
In intestinal epithelial cells, a potential interaction between cyclic 
nucleotide-mediated pathways and the PI-cycle is of a particular interest. First, in 
chicken enterocytes, cAMP- and cGMP-induced sodium absorption was mediated 
through a rise in cytosolic calcium (6,29,30). In the human colon carcinoma cell 
line HT29ci.19A, however, cAMP could, but a rise in calcium by itself could not, 
provoke chloride secretion (35), indicating that cAMP can not solely act through 
calcium. However, a role for calcium as a permissive factor in cAMP-induced 
chloride secretion can not be excluded. Whether or not cAMP can mobilize 
calcium in the colonic cell lines is therefore important to examine. 
In addition, while all known Ca2+ -mobilizing hormone receptors are 
localized basolaterally, enterocytes contain a GTP-activated form of PLC in both 
the basolateral and the apical membrane (34). Cross-talk between second 
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messengers elicited at the basolateral (cAMP, PKC, Ca2 +) or the apical (cGMP) 
membrane and the apical PI-pool may constitute a hypothetical mechanism lor 
regulation of lnsPn release and Ca2+ -signalling at the apical membrane. 
In the present study, the effects of hormone- or enterotoxin-generated 
second messengers on PLC activation were studied by measuring the formation 
of inositol phosphates and calcium mobilization in the absence and presence of 
carbachol. This report shows that: i) cAMP does not stimulate lnsPn production 
nor the mobilization of calcium in HT29cl.19A cells, suggesting that cAMP-induced 
calcium mobilization in the intestine is a unique feature of the absorptive villous 
cells; ii) PMA and cAMP inhibited the carbachol-activated calcium response, by 
acting on different targets, upstream and downstream of lnsPn formation, 
respectively. 
MATERIAL AND METHODS 
Materials: Cell culture media and fetal calf serum were from Gibco. Forskolin, carbachol and PMA 
were from Sigma and A23187 and 8-Br~cAMP from Boehrir"~ger, Germany. Myo-[2-3H}lnositol was 
obtained from NEN-Dupont, Germany. lndo-1 acetoxymethylester was from Molecular Probes. AG1 
X8 Dowex 100-200 mesh was obtained from Bio-Rad, Eugene, OR. 
Cell culture: HT29ci.19Acells (kindly donated by Dr. C.L Laboisse, JNSERM, Paris, France) and T84 
cells were routinely grown in cell culture flasks (Falcon) under a humidified 95% air, 5% C02 atmos-
phere at 3~C. HT29cl.19A medium contained: Ou!becco's modified Eagles medium {OMEM), 10% 
fetal calf serum (FCS), 40 mgjl penicillin and 90 mgjl streptomycin. T84 medium contained: OMEM/ 
Ham's (1/1), 5% FCS, 5% HEPES and penicillin and streptomycin. Cells were subcultured at a 
surface ratio of 1:7 (HT29cl.19A) or 1:5 (T84) after trypsinization every 7 days, when they had 
reached 70.SO %confluence. The passage number of the cells used in this study varied between 1 1 
and 30 (HT29ci.19A) and between 20 and 40 (T84). 
Determination of total inositol phosphates. Cells grown to 7Q-80% confluency on 6 well cell culture 
plates were labeled for 48 hours with [3H]Inositol (Z.U.Ci/ml) in inositol free medium, supplemented 
with 5% fetal calf serum under an atmosphere of 95% air, 5% C02 at 37°C. At 1 h before stimulation, 
the ce!ls were shifted to serum-free OMEM containing 10 mM HEPES (pH 7.4). The cells were 
stimulated with carbachol for various periods in the presence of 10 mM UCl and incubations were 
terminated by replacing the medium by 1 ml of 10% ice--cold trichloroacetic acid. After 10 minutes, 
extracts were collected and trichloroacetic acid was removed by washing with diethylether. The 
samples were neutralized with 1 M Tris, pH 8.5 and processed for analysis of the total [3H]inositol 
phosphate containing fraction (lnsPn) by anion exchange chromatography on AG1 X8 Dowex 
columns {formate form) as previously described {33). In some experiments, long-term pretreatment 
with PMA {27 h) decreased the total water-soluble [3H]Inositol uptake (as determined by radioactivity 
present before separation of the inositol phosphates). This has also been described for vascular 
smooth muscle cells {26). The reason for this PMA related decrease in inositol uptake is unclear. In 
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our calculations corrections were applied for these differences in total amount of radioactivity per 
sample. 
Separation of inositol phosphates by HPLC. HT29c1.19A cells were labeled with 20 p.Ci 
{3H]inositoljml for 48 h. At 1 h before stimulation, the cells were shifted to serum free DMEM 
containing 10 mM HEPES and then stimulated with carbachol for 10 sec. The incubation was 
stopped by adding trichloroacetic acid. After diethy!ether extraction, the samples were neutralized 
with Tris-base and inositol phosphates were separated on a Partisil Sax column (250.4.6 mm; 
Whatman) at a flow rate of 1.25 mljmin. The gradient used was as previously described (33). 
Nucleotide standards (2.5 mM AMP, ADP and ATP) were added. For quantification of the various 
inositol phosphates, 0.5 min (625 JLI) fractions were collected and 3H radioactivity was determined. 
Calcium measurements. HT29cl19A cells were grown to 70-80% confluency on cover slips (9.21 
mm). The cover slips were loaded with Indo 1-AM (5 JLM, 45 min.) in culture medium at 3r>C, 5% 
C02. Extracellular Indo 1-AM was removed by three washes with calcium buffer (120 mM NaCI, 5 
mM KCl, 1 mM MgCl2 , 1 mM CaCI2 , 20 mM HEPES, 10 mM glucose, pH 7.4 adjusted with Tris) and 
incubations were carried out at 3r>C in the same buffer. Calibration of the responses was performed 
by adding 10 mM CaCI2 and 0.1 mgjml digitonin (Fmax). followed by addition of 2.5 mM MnCI2 
(Fmin). The intracellular calcium concentration was calculated using the following equation: [Ca2 +}1 
= Kd (F-Fmin/Fmax-F). The Kd value used was 250 nM (14). 
RESULTS 
Carbachol-induced production of inositol phosphates. Carbachol induced a 
dose-dependent rise in inositol phosphate (lnsPn) formation in both the 
HT29ci.19A cells (Fig.1) and the T84 cells (not shown). Half-maximal release 
occurred at 10 11M. whereas maximal release was found at 100 11M carbachol. 
The formation of lnsPn was linear for up to 30 minutes in both cell lines (Fig.2, 
HT29CI.19A cells). A HPLC profile of the carbachol-induced release ollnsPn in 
HT29ci.19A cells showed a rise ollns(1 ,4,5)P3 and of its breakdown products 
lnsP1, lnsP2, lns(1 ,3,4)P3 and lns(1 ,3,4,5)P4 (Fig.3). 
Effects of cAMP, cGMP and calcium on the !ormation ol inositol phosphates. 
A possible modulation of lnsPn production by cAMP or calcium was tested in 
HT29ci.19A colonocytes. Since the intestinal isoforms of guanylate cyclase and 
cGMP dependent protein kinase are no longer expressed in this subclone (De 
Jonge, unpublished observations), effects of cGMP were studied in the T84 cells. 
As indicated in Table 1, the cell-permeable analogue ol cAMP, 8-Br-cAMP and the 
specific activator of intestinal guanylate cyclase, heat stable E.coli enterotoxin 
(ST J, added alone or in combination with carbachol had no effect on the 
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FIGURE 1. Dose dependency of 
carbachol-induced inositol phosphate 
accumulation. [3H]lnositol labeled 
HT29cl.19A cells were incubated with 
the indicated concentrations of 
carbachol for 30 min in the presence of 
10 mM UCJ. The incubations were 
terminated with trichloroacetic acid and 
inositol phosphates were analyzed on 
Dowex columns as described in Material 
1 o-? 10" I 0-4 and Methods. Data are expressed as 
mean = S.D. for three determinations. 
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FIGURE 2. Time-course of the 
carbachol-induced inositol phosphate 
formation. [3 H]Inositol labeled 
HT29ci.19A cells were incubated with 
1 00 JLM carbachol for the indicated 
time periods. All incubations were 
performed in the presence of 10 mM 
UCI during 40 min. After termination 
with trichloroacetic acid, inositol 
phosphates were analyzed on Oowex 
columns as described in Materia! and 
Methods. Data are representative for 
three determinations. 
production of lnsPn. Calcium ionophore A23187 alone slightly activated the 
release of lnsPn, but did not significantly affect the carbachol-induced release of 
lnsPn (Table 1). Since HPLC analysis revealed an increase in lnsP1 (1.6 ± 0.2; 
n=3) but not in lns(1 ,4,5)P3 (0.9 ± 0.1; n =3), the effect of Ca2 + -ionophore is most 
likely the result of calcium activated hydrolysis of PI, ratherthan activation of PIP2 
breakdown by phospholipase C (20). 
Inhibition of carbachol-induced lnsPn formation by protein kinase C. Effects 
of protein kinase C were studied by using the tumor promotor phorbol 12-
myristate 13-acetate (PMA). Pretreatment of HT29ci.19A cells for 10 min. with 5.1 o· 
7 M PMA resulted in a strong inhibition of the carbachol induced release ollnsPn 
(Fig.4). Pretreatment of the cells for 27 h with 5.1 o·7 M PMA, which is known to 
result in a complete downregulation of PKC a:, but not of the other PKC isozymes 
(B1, y, 11 and () expressed in this cell type (35) was associated with a full 
recovery of the carbachol-induced PIP2 hydrolysis (Fig.4). PMA alone did not 
affect basal lnsPn levels (Table 1). 
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FIGURE 3. HPLC profile of eH]Inositol phosphates obtained from control and carbachol-
stimulated HT29ci.19A cells. Carbachol was added (100 JLM, 10 sec) to eH]lnositollabeled cells 
and after termination of the incubation by trichloroacetic acid, inositol phosphates were separated 
on a Partisil Sax column as described in Material and Methods. Closed symbols, control; open 
symbols, carbachol stimulated cells. 
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FIGURE 4. Effects of PMA pretreatment on the carbachol-induced inositol phosphate 
accumulation. eHJlnositollabeled HT29cl.19A cells were pretreated for 10 min or 27 h with 5.10"7 
M PMA, before addition of 250 p.M carbachol. After 30 min incubation in the presence of 10 mM 
UCI, reaction was stopped by adding trichloroacetic acid. Inositol phosphates were analyzed on 
Dowex columns as described in Material and Methods. Data· are expressed as mean =: S.D. for three 
experiments in triplo. 
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TABLE 1. Effects of carbachol, cAMP, STA (cGMP) and Ca2+ on [3H]!nsPn formation in 
HT29ci.19A and TS4 cells. 
a) Control 
b) Carbachol 
c) 8-Br-cAMP 
d) A23187 
e) STA 
f) Carbachol + 8-Br-cAMP 
g) Carbachol + A23187 
h) Carbachol + ST A 
i) PMA 
HT29ci.19A 
1.0 
4.7 ~ 0.9 (10) 
1.1 ~ 0.1 (4) 
1.5 ~ 0.3 (5) 
ND 
4.6 ~ 1.0 (3) 
4.2 ~ 1.1 (3) 
ND 
1.1 ~ 0.1 (5) 
T84 
1.0 
6.3 ~ 1.1 (3) 
ND 
ND 
0.9 ~ 0.1 (3) 
ND 
ND 
6.0 ~ 0.9 (3) 
ND 
Cells were preincubated for 10 minutes with 10 mM UCI (a,b,c,d,e,i) or LiCI with 8-Br-cAMP (f) or 
A23187 (g) or STA (h) and carbachol (b,f,g,h), 8-Br-cAMP (c) or A23187 (d) were added tor another 
10 min. The incubations were terminated with trichloroacetic acid and [3H]inositol phosphates were 
analyzed on Dowex columns as described in Materials and Methods. Data are expressed as factor 
stimulation of inositol phosphates production compared to control cells '(mean :::!:: SO). Number of 
experiments are indicated between parentheses. The concentrations used are: carbachol 100 JLM, 
8-Br-<::AMP 1 mM, A23187 10 JLM, STA 300 Unitsjml, PMA 5.10-7 M. NO, not determined. 
Measurements of [Ca2•];- Cross-talk between the PI-cycle and cyclic nucleotides 
has been described to occur not only at the level of phospholipase C activation, 
but also at the level of calcium release. Therefore, we subsequently examined the 
effects of PMA and cAMP on intracellular calcium levels, by using indo 1-AM as 
a fluorescent calcium probe. The adenylate cyclase activator forskolin was used 
as a cAMP raising agent, since 8-Br-cAMP was autofluorescent at the wavelengths 
used for Indo 1-AM calcium measurements. Basal calcium levels were 159 ± 24 
nM (mean ± SD, n=23). Carbachol induced a transient rise in calcium with a peak 
value of 832 ± 343 nM (n=8; Fig.5A). Both PMA and forskolin failed to induce 
calcium release (Fig.5B,C). However, 10 minutes pretreatment of the cells with 
PMA or forskolin resulted in a strong inhibition of the carbachol-induced calcium 
response down to a level of 275 ± 42 nM (n=6) and 302 ± 82 nM (n=6), 
respectively (Fig. 5B,C). In PKC a: depleted cells, the carbachol-triggered calcium 
release showed a partial recovery (546 ± 155 nM; n=5; Fig.5D). In two 
experiments, a similar decrease in calcium mobilization was found when cells 
were pretreated with 8-Br-cAMP (the data were corrected for autofluorescence 
caused by 8-Br-cAMP addition), indicating that the inhibition is most likely 
mediated by cAMP and not due to non-specific effects of forskolin. 
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FIGURE 5. Effects of PMA pretreatment and cAMP on the carbachol-Induced Ca2+ ·rise, HT29ci.19Acells were loaded with indo 1-AM and changes 
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Is Indicated with an arrow. 
DISCUSSION 
In this study cultures of intact colonic epithelial cells were exploited to 
investigate the possibility of cross-talk between cyclic nucleotides or other second 
messengers and the phosphoinositide (PI)-cycle. As enterocytes contain a PI-
cycle at both the basolateral and the apical membrane, despite the lack of G-
protein-coupled hormone receptors at the luminal membrane, cross-talk could be 
a physiologically important mechanism in the activation of the apical PI-pool. 
Hypothetically, PI-derived messengers at the apical membrane may serve as local 
regulators ol cellular functions, e.g. cr transport across apical cr channels. 
However, our measurements of inositol phosphate (lnsPn) accumulation and 
calcium signalling in human colonocytes did not provide evidence in favour of this 
model. In contrast, our data revealed the existence of a negative feedback 
mechanism by protein kinase C (PKC) on the carbachol-stimulated lnsPn 
production and calcium release in HT29ci.19A cells. Cyclic AMP also partially 
inhibited the carbachol-induced calcium response, however without inhibition of 
the lnsPn formation, indicating cross-talk between PI- and cAMP-mediated 
pathways. In chicken enterocytes, cAMP and calcium routes did also interact, but 
in an opposite manner: cAMP alone stimulated the mobilization of calcium (29). 
These differences between chicken enterocytes and human colonocytes might be 
species-specific. More plausibly, however, they may reflect regional differences in 
regulatory mechanisms along the lenght of the intestine: calcium was found to 
serve as an independent activator of cr secretion in human ileum, but not in 
human and rabbit colon (2,8, 12). A similar difference between chicken enterocytes 
and human colonocytes was found with respect to cGMP effects on Ca2+ 
mobilization: whereas the cGMP-Iinked agonists atrial natriuretic factor (AN F) and 
heat stable E.coli toxin (STJ, have been shown to exploit Ca2+ as a third 
messenger in chicken and rat enterocytes, respectively (17,30), no evidence was 
found for a role ollnsPn (present study) or Ca2+ (19) in the action of ST. in T84 
colonocytes. 
The mechanism underlying PMA-inhibition olthe carbachol-induced lnsPn 
production is unknown, but inhibition of PLC activity or the coupling of this 
enzyme to a G-protein, as has been described to occur in other cells (18,28), is 
most likely. Surprisingly, a similar decrease in lnsPn formation could not be 
demonstrated following activation of PKC by carbachol itself, since (I) the 
production of lnsPn by carbachol was linear for up to 30 minutes (Fig.2), and (ii) 
downregulation of PKC did not result in potentiation of the lnsPn release by 
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carbachol (Fig.4). The different efficacy of PMA- and carbachol-activated PKC is 
unlikely to result from the involvement of different PKC isozymes: carbachol-
induced chloride secretion and PMA-induced inhibition of carbachol-activated 
lnsPn release are both mediated by PKC o: (35). As PMA is an irreversible 
activator of PKC, whereas carbachol transiently activates PKC (measured by PKC 
translocation, Ref.35), this might explain the observed differences. Such a 
discrepancy between PMA and endogenously activated PKC was not found 
universally in all cell types: both carbachol and PMA could inhibit lns(1,4,5)P3-
induced calcium release in pancreatic acinar cells (37). 
Possible mechanisms for the cAMP-induced inhibition of the calcium 
mobilization may include: (i) a decrease in the activity of lns(1 ,4,5)P3 to release 
calcium; (ii) inhibition of cellular calcium entry mechanisms; or (iii) activation of 
the Ca2 + ATPase. Examples of each of these mechanisms can be found in the 
literature (11, 13,31). Which one of these molecular targets is predominant in the 
HT29ci.19A cells needs further study. 
In renal epithelial cells, cGMP-provoked inhibition of the Na+ -channel is 
suggested to be mediated through protein kinase C (25). A similar intermediary 
role of PKC in the mechanism of action of cGMP-Iinked secretagogues (e.g. ST J 
could be postulated in intestinal epithelial cells. However, since STA was 
apparently unable to trigger lnsPn release, either in intact colonocytes (this study) 
or in isolated apical membranes (34), the possibility that PKC is activated by 
diacylglycerol derived from PIP2 breakdown can be ruled out. Nevertheless, it 
remains possible that STA is capable of activating PKC independently of lnsPn and 
calcium release, e.g. by activating a phosphatidylcholine specific phospholipase 
C (3) or by releasing diacylglycerol from yet unknown sources as has been 
reported for tracheal epithelial cells in response to B-agonists (1 ). 
In conclusion, we found no evidence for our hypothesis, that the intestinal 
apical PI-pool may serve as an amplification step in the regulation of chloride 
secretion by cAMP, cGMP, calcium or PKC. Although a predominant contribution 
of the basolateral PI-pool to lnsPn generation and calcium mobilization may have 
masked minor effects of second messengers on the apical PI-pool, this possibility 
seems rather remote: at least in mature enterocytes, the capacity of the apical 
membrane to release lnsPn exceeded the capacity of the basolateral membrane 
(34). The mode of regulation of the apical PI-cycle therefore still remains to be 
elucidated. The outcome of this study warrants a further search for agonists and 
receptors in the apical membrane, capable of activating apical G-proteins and 
phospholipase C and modulating apical transport systems through the local 
B4 
generation of PKC activating and calcium mobilizing second messengers. In 
tracheal epithelial cells, calcium-linked P2-purinergic receptors have been 
identified in both the apical and the basolateral membrane (21 ). However, the 
relative contribution of the apical versus the basolateral membrane receptors to 
lnsPn formation and Ca2• -signaling was not assessed separately in this study. 
This study was supported by the Dutch Organization for the Advancement of Scientific Research 
(NWO). 
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CHAPTER 5 
DUAL ROLE FOR PROTEIN KINASE C a AS A 
REGULATOR OF ION SECRETION IN THE HT29ci.19A 
HUMAN COLONIC CELL LINE. 
The involvement of protein kinase C (PKC) in the regulation of intestinal ion 
secretion was studied in polarized monolayers of the HT29ci.19A human 
colon carcinoma cell line. Carbachol, phorbol ester (PMA/PDB) and 8-Br-
cAMP induced chloride secretion as measured by a rise in the short circuit 
current (lscl· The electrical response to carbachol coincided with a transient 
translocation of PKC o: from the soluble to the particulate fraction. The 
carbachol-, PDB- and 8-Br-cAMP-induced lsc responses were inhibited by 
pretreatment of the cells with PMA (5.10"7 M) lor 2h, a time period in which 
PKC a:, 81 andy levels were not changed. As shown by "Rb+ and 1251" efflux 
studies, the main targets for this inhibition were basolateral K+ transporters 
rather than apical cr-channels. Prolonged exposure to PMA (24 h) led to a 
60% recovery of the 8-Br-cAMP response, but not of the carbachol- or PDB-
provoked secretion. As shown by immunoblotting with PKC isozyme specific 
antisera, the recovery of the 8-Br-cAMP response coincided with the 
downregulation of PKC o:, whereas the levels of PKC B1 and y were 
unmodified. These results suggest that PKC o:, but not PKC B1 or y, is 
involved in both acute stimulation and chronic inhibition of ion secretion in 
the HT29ci.19A colonic cell line. 
INTRODUCTION 
The protein kinase C (PKC) family is known to consist of multiple 
isozymes encoded by a family of genes (Nishizuka, 1989; Rao and DeJonge, 
1990). PKC o:, B1, B2 andy are calcium and phospholipid dependent kinases, 
with only minor differences in their dependence on diacylglycerol and their 
substrate specificity (Huang et al., 1988; Marais and Parker, 1989). PKC Eisa 
calcium independent, but phospholipid dependent kinase with a different substrate 
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specificity (Schaap and Parker, 1990). The more recently cloned PKC o and ( are 
not fully characterized yet (Ono et al., 1988). The physiological role of PKC 
isozymes in general and in epithelial ion transport in particular is still unknown. 
Since PKC a, Bandy are described to be differentially downregulated by phorbol 
ester, this phenomenon could possibly be used as a tool to study isozyme 
specific effects (lsakov et al., 1990). 
Solar studies to determine the role of PKC in epithelial ion transport have 
been carried out with purified PKC, consisting of a mixture of isotypes (Hwang, 
1989; Li et al., 1989), or with PKC inhibitors (staurosporine, H7, peptide 
pseudosubstrates) and PKC activators (phorbol esters, diacylglycerol analogues), 
which are unable to discriminate between distinct PKC isozymes (Rao and De 
Jonge, 1990). In membrane patches of tracheal cells, PKC provoked chloride 
channel activation at low calcium levels and chloride channel inactivation at high 
calcium levels, suggesting a model in which ion secretion in epithelial cells is 
controlled in an opposite direction by calcium dependent and calcium 
independent PKC isoforms (Li et al., 1989). 
Current information on the role of PKC in intestinal ion secretion is based 
mainly on studies in rabbit and chicken ileum and in rat distal colon, in which 
PMA-induced cr secretion is mediated predominantly by prostaglandin synthesis 
in sub-epithelial cell types (Smith et al., 1982; Chang et al., 1985; Donowitz et al., 
1986; Musch et al., 1990). Recent studies in a cr secreting subclone of the 
human colonic cell line, HT29ci.19A, however show that phorbol esters and cAMP 
trigger ion secretion also in the presence of prostaglandin inhibitors and suggest 
that both secretory pathways share the same transport systems required to allow 
net chloride secretion, i.e. apical chloride channels and basolaterallocalized K+-
channels, NaKCI2-cotransporters and Na+ JK+ -ATPase (Vaandrager et al., 1992; 
Bajnath et al., 1991). Hence, the major difference between the stimulus-secretion 
pathways activated by phorbolesters and by cAMP appears to reside in the 
exploitation of different protein kinases, rather than different transport systems. 
In the present study PKC isozyme specific antisera were used to examine 
the effects of phorbol ester treatment on the levels and possible translocation of 
each isozyme in HT29ci.19A cells. The effects of PKC activation and 
downregulation on intestinal ion transport pathways were monitored in parallel by 
a combination of short circuit current (lscl and isotope efflux measurements ('251" 
and 86Rb•). The results suggest a key role for PKC a, but not PKC B1 or y, in 
both acute stimulation and chronic inhibition of ion secretion in this cell line. 
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MATERIALS AND METHODS 
Materials: Cell culture media and fetal calf serum were from Gibco. Forskolin, carbachot, PMA and 
PDB were from Sigma (St Louis, U.S.A) and A23187 and e~Br-cAMP from Boehringer, Mannheim, 
Germany. Na1251 (14 Cifmg), 80RbCI (5 mCijmg) and 14C-Iabeled Rainbow ™ protein molecular 
weight markers were from Amersham (England). Myo-[2-3H]Inositol was obtained from NEN-Dupont, 
Germany. The rabbit polyclonal anti-peptide antibodies used in this study were raised and 
characterized earlier in the laboratory of Or.P.J.Parker (Marais and Parker, 1989). These antibodies 
were found capable of specifically recognizing PKC isozymes and did not show cross-reactivity on 
immunoblots with other isoforms of PKC (see Marais and Parker, 1989, Figure 5). 
Cell culture: HT29cl.19A cells (kindly donated by Dr. C.L Laboisse, INSEAM, Paris, France) were 
grown in cell culture flasks {Falcon) under a humidified 95% air, 5% C02 atmosphere at 37 oc in 
Dulbecco's modified Eagles medium, 10% fetal calf serum, 40 mgjl penicillin and 90 mg/1 strepto~ 
mycin. Cells were subcultured at a surface ratio of 1 : 5 after trypsinization every 5 days, when they 
had reached 7Q-80% confluence. The passage number of the cells used in this study varied between 
11 and 30. 
Measurements of short circuit current and transepithelia1 resistance: HT29ci.19A cells were 
grown to confluency (12~14 days after plating at a 1 : 2.5 surface ratio) on tissue culture treated 
polycarbonate filters firmly attached to a polystyrene ring (6.4 mm diameter, Transwell, Costar). The 
filter was placed in a tightly fitting insert separating the serosal and mucosal compartment of an 
Ussing chamber. The bathing solution was a modified Meyler buffer (108 mM NaCI, 4.7 mM KCI, 1.3 
mM CaCI2 , 1.0 mM MgCI2, 20 mM NaHC03 , 0.8 mM Na,HP04 , 0.4 mM NaH2P04 , 20 mM Na-
HEPES, 10 mM glucose, pH 7.4), which was aerated by a gas lift system using 95% 0 2 and 5% C02• 
Short circuit current (lsc) was measured with two platinum current electrodes in direct contact with 
the bath, and two calomel electrodes connected to the bath by salt bridges. The transepithelial 
electrical resistance ofthe filter-grown HT29cl.19A mono layers, as calculated from voltage deflections 
induced by positive and negative current pulses with a duration of 1 sec., was 108 = 27 n.cm2 
(mean =S.D.; n=24) in the absence of secretagogues. 
SDS..PAGEand immunoblotting: SDS.polyacrylamide gel electrophoresis was performed according 
to laemmli, 1970. Samples were dissolved in SDS sample buffer (0.1 M Tris, 1.7 % SDS, 6.7% 
glycerol, 0.7 M 8-mercapto~ethanol, o. i %bromophenol blue, pH 7), boiled for three minutes and 
separated on 7.5% polyacrylamide slab gels. HT29cl.19A cells used for both the Ussing chamber 
measurements and immunoblotting were solubi!ized in boiling SOS sample buffer to prevent 
proteolytic degradation of PKC. After SDS..PAGE, proteins were electroblotted onto nitrocellulose 
paper (0.1 _u.M, Schleicher and Schuell) in 25 mM Tris, 192 mM glycine and 20% methanol. The blots 
were then incubated with 3% gelatin in Tris buffered saline (TBS: 20 mM Tris-HCI, pH 7.5, 0.5 M 
NaCI) to block non~specific binding. After 2 washes with TTBS (0.05% Tween in TBS; 5 min.jwash), 
the blots were incubated with antisera (1 :500 in TTBS) tor 60 minutes at room temperature. The blots 
were washed again in TTBS (3 times, 10 min.jwash) and incubated with goat~anti-rabbit antiserum 
conjugated to alkaline phosphatase tor 60 minutes at room temperature (1:1000 in TTBS). After five 
washes with TTBS and two with TBS (10 minutesjwash), 0.8 mg 5-Bromo-4-Chloro~3-
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lndolylphosphate and 1.65 mg Nitro Blue Tetrazolium in 5 ml 0.2 M Tris, 10 mM MgCI2, pH 9.1 was 
added for colour development. The reaction was stopped in H20. 
PKC translocation assay: HT29cl.19A cells were grown to 90-100% conf!uency in 6 well cell culture 
plates. One hour before the experiment started, the medium was replaced by a modified Meyler 
buffer. Incubation of the cells was done at room temperature for the indicated time period in fresh 
Meyler. The reaction was stopped in ice and the cells were immediately washed twice with icecold 
buffer A (25 mM Tris-HCl, pH 7.4, 0.25 M sucrose, 2,5 mM Mg-acetate, 2 mM OTT), followed by a 
wash with lysis buffer at 4°C (buffer A + 2.5 mM EGTA). The cells were then scraped in lysis buffer 
containing protease inhibitors (leupeptin 10 JLg/ml, PMSF 100 JLM), sonicated (3 bursts of 5 sec.) 
and the particulate and the soluble fractions were separated in an airfuge (3 min., 100.000 g, 4°C). 
The particulate fraction was resuspended in lysis buffer containing protease inhibitors and sonicated 
(3 burst of 5 sec.). After protein determination, the fractions were solubilized in SOS sample buffer 
to a final concentration of 1 mgjml or if necessary, concentrated by TCA precipitation {10% TCA, 
10 min. on ice) and then solubilized in SOS-sample buffer. The pH of the samples was adjusted with 
1 M Tris, pH 8.5. The recovery of the proteins was 80-100 %. The samples were separated by 80S-
PAGE and, after transfer to nitroce!lulose paper, incubated with PKC a, 131 and y specific antisera. 
Isotope efflux experiments: HT29cl.19A cells were grown to 70-80% confluence in 6 well cell culture 
plates. Cells were loaded fof 1.5 hour under a humidified 95% air, 5% C02 atmosphere at 37 "C in 
0.5 ml of a modified Meyler solution containing the isotopes ( 3 JLCijml 125r or 1 JLCijmJ 86Rb +). 
Extracellular isotope was removed within 1 minute by washing three times with 3 ml modified Meyler 
solution at room temperature. The cells retained 0.31::0.4 % of the added 125r and 23::4 % of the 
added 86Rb+ (n=20). The isotope efflux was determined at 37 °C by addition and consecutive 
replacements of 1 ml of a modified Meyler solution at 1 to 2 minute intervals. The cells were kept 
under a 95% 0 2 and 5o/o C02 atmosphere, except during the replacements. The residual isotope at 
the end of the experiment was determined by addition of 1 ml 1 M NaOH. Due to its relatively high 
uptake, 86Rb + could be determined together with 125r in a gamma counter. To compare the isotope 
efflux at the various time points we expressed the data as the fractional efflux per minute i.e. the 
amount of released isotope in an interval as percentage of the amount of cell-associated isotope 
present at the beginning of that interval and divided by the length of that interval (c.f. Clancy et al., 
1990). 
Determination of total inositol phosphates: Cells grown to 70-80% confluency on 6 well cell culture 
plates were labeled for 48 hours with ('H]Inositol (2JLCijml) in inositol free medium, supplemented 
with 5% fetal calf serum under an atmosphere of 95% air, 5% C02 at 37°C. At 1 h before stimulation, 
the cells were shifted to serum-free OMEM containing 10 mM HEPES (pH 7.4). Control and PMA 
(27h, 5.10-7 M) pretreated cells were stimulated with 250 JLM carbachol for 30 minutes in the 
presence of 10 mM LiCl. Incubations were terminated by replacing the medium by 1 ml of 10o/o ice~ 
cold trichloroacetic acid. After 10 minutes, extracts were collected and trichloroacetic acid was 
removed by washing with diethylether. The samples were neutralized with 1 M Tris, pH 8.5 and 
processed for analysis of the total [3H]inositol phosphate containing fraction {lnsPn) by anion 
exchange chromatography on AG1 X8 Oowex columns (formate form) as previously described (Tilly 
et al., 1990}. ln some experiments, long-term pretreatment with PMA (27 h) decreased the total 
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water~soluble [3H]Inositot uptake (as determined by radioactivity present before separation of the 
inositol phosphates). This has also been described for vascular smooth muscle cells (Pfeilschifter 
et al., 1989). The reason for this PMA related decrease in inositol uptake is unclear. !n our 
calculations corrections were applied for these differences in total amount of radioactivity per 
sample. 
Protein determination: Protein was determined by the protein assay kit from Pierce, Rockford 
lllinois. 
RESULTS 
!on transport measurements. The effects of carbachol, Ca2 + -ionophore, phorbol 
esters and 8-Br-cAMP on the short circuit current (lscl in filter grown monolayers 
of HT29ci.19A colonocytes were measured in a modified Ussing chamber. In the 
HT29ci.19A subclone the lsc mainly reflects electrogenic cr secretion to the 
mucosal side, as demonstrated eartier by transepithelial and intracellular potential 
measurements (Bajnath et al., 1991) and isotope flux studies (Augeron et al., 
1986). Muscarinic stimulation by carbachol induced a transient rise in lsc, followed 
by a sustained second phase (Fig.1A; Table 1). The phorbol esters PDB (Fig.1B; 
Table I) and PMA (data not shown) induced a sustained response (EC50: 5.10"" M), 
either in the presence or absence of Ca2+ -ionophore (Fig. 1 B. Table 1). Ca2+-
ionophore A23187 did not induce an electrical response itself (Fig.1 B,C; Table 1), 
nor did it enhance the PDB-induced secretion (Table 1 ). The most potent 
secretagogue. 8-Br-cAMP, considered as a non-PKC linked agonist (Rao and De 
Jonge, 1990), induced a large and sustained rise in the lsc that was considerably 
enhanced in the presence ol Ca2•-ionophore (Fig.1C; Table 1). 
Addition ol PDB to 8-Br-cAMP pretreated colonocytes had an additive but 
transient effect on the lsc• followed by an inhibition down to basal levels within a 
time frame of 2 hours (Table 1; IC50: 4.10"" M). In the presence of Ca2 + -ionophore, 
the PDB inhibition of cAMP-provoked secretion was potentiated and basal lsc 
values were reached as early as 60-80 minutes (Fig.1 C). Prolonged exposure of 
the colonocytes to PMA (2-Sh) resulted also in a strong inhibition of the response 
to carbachol and PDB (Fig.1A,B; Table 1). Chronic treatment of the cells with PMA 
(24 h) resulted in a 60% recovery of the 8-Br-cAMP response, whereas the 
carbachol response and the responses to PDB remained inhibited (Fig.1A,B,C; 
Table 1). 
Both the stimulatory and inhibitory effects of PMA on the lsc were not 
seen in response to the inactive phorbol ester analogue 4a:-phorbol 12,13 
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FIGURE 1. Stimulatory and inhibitory effects of phorbolesters on net ion secretion In 
HT29ci.19Acolonocytes. Cells were grown as monolayers on filters and short circuit measurements 
were performed in a modified Ussing chamber. Panel A Changes in the short circuit current (lsc) 
provoked by carbachol (250 JLM,--) and its inhibition after 2-5 h (----)and 24 h (----) 
pretreatment with 5.10"7 M PMA. Panel 8: Changes in lsc provoked by addition of calcium ionophore 
(10 ~M) and PDB (5.10"7 M; --)and its inhibition after 2-5 h (----)and 24 h PMA (--·-) 
pretreatment of the cells with 5.10·7 M PMA Panel C: Changes in lsc provoked by sequential 
addition of calcium ionophore (10 JLM), 8-Br-cAMP (0.7 mM) and PDB (5.10"7 M) in control (--) 
and PMA pretreated (-- --.-- • -) HT29cl.19A monolayers. The tracings shown are representative 
for at least three experiments (see table 1) and are expressed as lsc per filter (0.33 cm2). 2-Sh PMA: 
full inhibition was already manifest at 2h PMA and persisted for the following 3h. 
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TABLE 1. Short circuit current measurements. 
lsc (JLA j em") 
Control 2-5 h PMA 24 h PMA 
Basal 0.2 " 0.2 (1 0) 0.3 " 0.3 (4) 0.3 " 0.3 (4) 
Carbachol 21.0 " 8.4 (9) 0.6 " 0.3 (3) 2.4 " 1.8 (4) 
ea2+ -ionophore 0.3 " 0.3 (7) 0.6 " 0.6 (3) 3.6 " 0.6 (3) 
PDS 21.3 " 4.2 (6) ND ND 
Ca2+ ~ionophore 21.6 " 4.5 (6) 0.6 " 0.6 (3) 0.6 " 0.6 (3) 
+ PDS 
8-Br-cAMP 94.2 " 31.8 (5) 6.6 " 4.2 (3) 50.0 " 12.3 (3) 
8-Br-cAMP 
+ Ca2+ -ionophore 
178.2 " 42.9 (3) 8.4 " 5.3 (3) 104.7 " 29.9 (6) 
8-Br-cAMP + PDB 115.2 " 35.3 (3) 6.6 " 4.2 (3) 50.0 " 12.3 (3) 
8-Br-cAMP + Ca2+ ~ 181.8 " 43.2 (5) 8.4 " 5.3 (3) 104.7 " 29.9 (6) 
ionophore + PDB 
HT29ci.19A cells were grown to confluency on filters and the short circuit current (lsc) was measured 
in a modified Ussing chamber with and without PMA pretreatment for 2·5 h and 24 h. The data are 
expressed in p.Ajcm2 (mean = SO) and represent maximal values. The concentrations used are: 
carbachol, 100 ttM, Ca2+-ionophore, 10 JLM, PDBJPMA 5.10"7 M and 8-Br-cAMP, 0.7 mM. The 
number of experiments are indicated between parentheses. Values of transepithelial electrical 
resistance {mean :t: SO; ncm2) in control, 2-5 h PMA pretreated and 24 h PMA pretreated 
monolayers were 108 = 27 (n=24), 119.5 = 26.6 (n=8) and 142.1 :t: 24.7 (n=9), respectively. NO, 
not determined. ~ Full inhibition was already manifest at 2h and persisted for the following 3h. 
didecanoate (5.10"7 M). The transport inhibition was not accompanied by 
significant changes in electrical resistance (Table 1, legend), arguing against a 
possible impairment of cell viability or monolayer architecture. These data suggest 
a dual role for protein kinase C (PKC) in acute stimulation (Fig.1A,B; Table 1) and 
chronic inhibition (2-Sh PMA; Fig.1A,B,C; Table 1) of ion secretion in HT29ci.19A 
cells. 
Iodide and rubidium efflux measurements. Earlier studies have shown that the 
transport system responsible for PMA-induced activation of the lsc is a chloride 
channel in the apical membrane of the HT29ci.19A colonocytes (Vaandrager et al., 
1992). In the present study, the transport systems serving as possible targets for 
PMA-induced inhibition were studied in more detail by measuring the effects of 
PMA on iodide and rubidium efflux rates, mainly reflecting the activity of apical 
chloride channels and basolateral potassium transporting systems, respectively 
(Clancy et al., 1990; Venglarik et al., 1990; Vaandrager et al., 1991). Forskolin, a 
specific activator of adenylate cyclase, was used instead of 8-Br-cAMP as a cAMP 
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FIGURE 2. Effects of PMA on forskolin induced scRb and 1251 efflux. The iodide (panel A) and 
rubidium (panel B) efflux in response to forskolin (5 J.LM) was studied in HT29ci.19A cells with and 
without PMA pretreatment for 3 and 24 hours. Data are expressed as maximal values (mean :!: SD) 
and were obtained after 5 minutes forskolin stimulation. The data are representative for at least two 
other experiments. The rubidium efflux following 24 h PMA pretreatment was significantly different 
from the values obtained after 3 h PMA exposure ln both control (p < 0.05, Student's t-test) and 
forskolin treated cells (p < 0.05, Student's t-test). 
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raising agent, since the response to 8-Br-AMP was relatively slow and therefore 
difficult to measure accurately in the efflux assay. 
As shown in Fig.2A, PMA treatment of the cells for three hours did not 
inhibit the forskolin-induced iodide efflux, whereas only a slight inhibition was 
found after 24 hours of PMA exposure. In contrast, the forskolin-induced rubidium 
efflux was strongly inhibited after 3 hours of PMA exposure and showed a partial 
recovery (30%) after 24 hours of PMA pretreatment (Rg.2B). Since the potassium 
transport systems seem to be shared by the different secretion pathways, we 
conclude that the inhibition of the 8-Br-cAMP-, carbachol- and PDB-induced lsc 
responses after 2-5 hours PMA pretreatment apparently results from the inhibition 
of a potassium transport mechanism rather than a chloride channel. 
Effects of PMA on PKC isozyme levels. In order to identify the type ol 
isozyme(s) of PKC involved, possible effects of PMA pretreatment on the cellular 
content of PKC isozymes were tested by immunoblotting with PKC isozyme 
specific antisera. Filter grown monolayers of HT29ci.19A cells were pretreated for 
various time periods with PMA, monitored in the Ussing chamber and immediately 
boiled in SDS-sample buffer to prevent proteolytic degradation of PKC. 
lmmunoblotting with PKC isozyme specific antisera showed a complete 
downregulation of PKC a: following 24 hours exposure to 5.1 0"7 M PMA (Fig.3A). 
No downregulation was detectable at early time points up to 5 hours (Fig.3A). In 
contrast, the levels of PKC 131 and PKC y remained unaffected following PMA 
treatment for up to 24 hours (Fig.3B,C). No significant levels of PKC 132 or PKC 
E could be detected by the immunoblotting technique (results not shown). 
Reactivity with PKC a:, 131 and y (both bands) could be blocked by presaturating 
the antisera with the antigenic peptide (results not shown). As in leukemic T cells 
(lsakov et al., 1990), PKC y was manifest as a doublet in both HT29ci.19A 
homogenates and in two batches of freshly purified PKC mix (Fig.3). However, a 
single band is found in most other studies (see Marais and Parker, 1989). Whether 
the doublet reflects a covalent modification or different subtypes of PKC y is 
presently unknown. The selective downregulation of PKC a: after 24h PMA 
pretreatment coincided wtth the partial (60%) recovery of the 8-Br-cAMP response 
in the Ussing chamber, suggesting a role for PKC a: in the inhibition of the lsc 
responses following 2h PMA pretreatment. 
Carbachol-induced PKC a: translocation. The sustained loss of PDB- and 
carbachol-induced ion secretion in PKC a: depleted cells suggest that PKC a. 
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FIGURE 3. Effects of PMA pretreatment on levels of PKC a, 61 and y. HT29ci.19A cells were 
pretreated for several hours with 5.10·7 M PMA. Samples of cell homogenates (15 JL9 protein) were 
separated by SDS.PAGE, transferred to nitrocellulose paper and incubated with PKC isozyme 
specific antisera. A} Antiserum specific for PKC a: (1 :500}. B) Antiserum specific for PKC 81 (1 :500). 
C) Antiserum specific for PKC y (1 :500). The first lane contains a purified PKC mix (0.5 JL9) from 
human brain together with rainbow marker proteins. Similar results were obtained in two other 
experiments. 
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might act as a mediator of carbachol- and PDB-induced ion secretion. To test this 
possibility, PKC translocation assays were performed using PKC isozyme specific 
antisera. Plastic-grown monolayers of HT29ci.19A colonocy1es were exposed for 
0-10 min. to carbachol or 10 min. to PMA or Ca2+ -ionophore and the particulate 
and the soluble fractions were separated. lmmunoblotting with PKC isozyme 
specific antisera identified a transient PKC 11. redistribution in response to 
carbachol: PKC a. appeared in the particulate fraction at 2-5 minutes following 
carbachol addition and disappeared again after 10 minutes of carbachol exposure 
(Fig.4). The fraction of PKC a. translocated in response to carbachol was 
apparently too small to reveal a significant fall of PKC 11. levels in the soluble 
fraction. Despite the presence of PKC a. in the particulate fraction at 5 min., a fall 
in the carbachol-dependent lsc was manifest. This observation suggests that 1) 
incomplete translocation of PKC is apparantly sufficient to reach the lsc peak value 
and 2) a separate negative feedback signal (e.g. protein dephosphorylation} is 
generated which is clearly different from reversed translocation of PKC 11. from the 
particulate to the soluble fraction. PMA induced a similar but persistent 
translocation of PKC 11., whereas Ca2+ -ionophore had no effect on PKC 11. 
2345678 "12345678Mw 
FIGURE 4. Carbachol induced PKC a:: translocation. HT29cl.19A cells were exposed for several 
time periods to carbachol (100 ~M), Ca2 +-ionophore (10 ~M) or PMA (5.10"7 M). Soluble (S) and 
particulate fractions (P) were separated by centrifugation and samples of each fraction (20 #-9 
protein) were subjected to SOS-PAGE, transferred to nitrocellulose and incubated with PKC a 
specific antiserum (1:500). Lane 1: control, Jane 2-6: carbachol 1, 1.5, 2, 5 and 10 minutes, resp., 
lane 7: PMA 10 minutes, lane 8: Ca2+ -ionophore 10 minutes. Similar results were obtained in two 
other experiments. 
99 
redistribution (Fig.4), supporting the concept that PKC a: is a mediator of the 
PMA- and carbachol-induced ion secretion. 
In most experiments, the PMA- and carbachol-induced PKC redistribution 
differed in that carbachol caused the appearance of a doublet of PKC a: in the 
particulate fraction, which migrated faster than the single band of PKC a: observed 
in PMA treated cells (Fig.4). However, in some experiments (2 out of 6) a doublet 
was also found in response to PMA, whereas occasionally (1 out of 3 
experiments) a single band was detected in response to carbachol (results not 
shown). The doublet presumably reflects phospho- and dephosphoforms of the 
enzyme (Parker et al., 1987). 
Since PKC B1 and PKC y were located predominantly in the particulate 
fraction, translocation of these isozymes could not be studied (results not shown). 
Carbachol-induced inositol phosphate formation. The loss of carbachol-
induced ion secretion in PKC a: depleted cells could in principle also result from 
the inhibition of phospholipase C (PLC) by a downregulation resistant form of 
PKC. To test this possibility, we measured the formation of inositol phosphates 
(lnsPn) in the absence and presence of carbachol in control and PMA pretreated 
cells (27h). As shown in Table 2, chronic PMA pretreatment did not lead to a 
significant reduction of the carbachol-induced lnsPn formation and thus does not 
interfere with carbachol-provoked PLC activation. This result strongly suggests 
that (i) the diacylglycerol produced, in spite of its possible action as activator of 
PKC B1 or y, is apparantly unable to provoke active ion secretion; (ii) the loss of 
carbachol-induced ion secretion in PKC a: depleted cells most likely results from 
PKC a: downregulation rather than from a lack of activating signal, i.e. 
diacylglycerol. 
TABlE 2. Formation of inositol phosphates in HT29cl.19A cells. 
Addition 
a) None 
b) Carbachol 
c) Carbachol after 27 h PMA 
lnsPn (dpm) 
24,872 = 923 
325,989 = 23,090 
324,955 = 8,928 
[3H]Inositol labeled HT29ci.19A cells were incubated for 30 min in the presence of 10 mM UCI alone 
(a), UCI and 250 _u.M carbachol (b) or were pretreated for 27 h with 5.10"7 M PMA, before addition 
of carbachol and UCJ (c). The reaction was stopped by adding trichloroacetic acid. Inositol 
phosphates (lnsPn) were analyzed on Dowex columns as described in Material and Methods. Data 
are expressed as mean :!: SO and are representative for three experiments done in triplicate. 
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DISCUSSION 
Expression pattern of PKC isozymes in HT29ci.19A colonocytes. In the 
present work, using PKC isozyme specific antisera, the HT29ci.19A cells were 
shown to express three PKC isozymes, a:, B1 and y. Two other PKC isotypes, B2 
and E could not be detected immunologically. To our knowledge, the expression 
of PKC y in non-neuronal tissue has not been described before. However, since 
intestinal and neuronal tissues are embryologically related, this could account for 
the unexpected detection of PKC y in HT29ci.19A · colonocytes. This study 
presents evidence lor a complex role of PKC a:, but not PKC 81 or y, as a 
regulator of intestinal ion transport. Although PKC B1 and y are also expressed 
in significant quanttties, no clue was provided concerning their function. 
Role of PKC "' as an ion secretion inhibitor. The possible target(s) for PMA 
induced inhibition of the lsc responses was investigated by a separate assessment 
of cr and K+ channel activtty, based on measurement of iodide and rubidium 
efflux rates, respectively. Surprisingly, no evidence was found for an inhibitory 
action of PKC activators on forskolin-(i.e. cAMP-) provoked cr-channel activation 
under condttions in which the cAMP-provoked lsc was completely abolished (Fig. 
2A). In this respect the HT29ci.19A colonocytes clearly differ from tracheal 
epithelium, in which PMA was shown to inhibit cAMP-provoked iodide efflux in 
intact cells and to block protein kinase A-activated Cl'-channels in excised 
membrane patches in the presence of purified PKC (Li et al., 1989). The molecular 
basis for this tissue difference in Cl'-channel regulation is presently unknown, but 
may reside in possible differences in PKC isozyme pattern/localization, in Cr-
channel subtypes or in other regulatory factors. 
Instead, 3h exposure of the HT29ci.19A colonocytes to PMA led to an 
almost complete inhibition of the forskolin-induced rubidium efflux, indicating the 
inhibition of a Rb/K transport system by PKC. In the parental HT29 cell line, PMA 
has been reported to inhibit the bumetanide sensitive NaKCI2-cotransport activity 
with a similar time course (Franklin et al., 1989). Since the PMA-induced inhibition 
is relatively slow, the mechanism most likely involves a reduction in the number 
of K+ transporters, e.g. by endocytosis or proteolytic breakdown, as has been 
described for the NaKCI2-cotransporter (Franklin et al., 1 989). This process may 
be triggered by PKC-catalyzed phosphorylation of the K+ transporters theirselves 
or may possibly involve different (regulatory) phosphoproteins. 
Our conclusion that PKC cr. rather than any of the other isozymes 
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expressed in this cell line (i.e. PKC B1 andy) is responsible for transport inhibition 
is based on our finding that part of the cAMP-induced lsc (60%, Rg.1 C) and "'Rb 
efflux rate (30%, Fig.2B) is restored following 24 hours PMA treatment. At this time 
point, the cellular level of PKC a was completely downregulated, whereas PKC B1 
and y remained resistant to downregulation (Fig.3). The finding that the recovery 
of the lsc response is less than 100% can be explained in several ways. For 
example, the cAMP-induced 86Rb efflux apparently recovers very slowly and might 
remain rate limiting for net ion secretion. Alternatively, a fraction of the 8-Br-cAMP 
induced ion secretion may be mediated via PKC a. This possibility has gained 
interest in view of the recent finding that forskolin is able to elevate diacylglycerol 
levels in tracheal cells (Anderson and Welsh, 1990). It is also possible that 
expression ol the cAMP-activated apical Cr-channel is impaired following chronic 
PMA treatment. The recent findings that (i) the cystic fibrosis gene encoded 
protein, CFTR, is most likely identical to the cAMP-activated Cl"-channel itself 
(Anderson et al., 1991; Kartner et al., 1991) and 0i) expression ol the CF gene is 
indeed strongly inhibited by phorbol ester treatment (Trapnell et al., 1990) lends 
some support to the latter explanation. 
Role of PKC a as a mediator of ion secretion. The carbachol- and ?DB-
provoked rise in short circuit current (lsc) shown in Fig.1 and the rapid increase 
in fractional efflux of 36CI and 1251 occurring across the apical membrane as 
observed in a previous study (Vaandrager et al., 1992) suggest that their common 
mediator, PKC, exerts an acute stimulatory effect on apical cr channels in the 
HT29cl.1 9A colonocytes. The PKC a subtype is likely to play a crucial role in the 
activation process for the following reasons. First, both carbachol and PMA were 
found to induce a rapid translocation of a small fraction ol the cellular PKC a pool 
!rom the cytosolic to the particulate fraction. The carbachol-provoked translocation 
is apparently triggered by diacylglycerol formation rather than calcium signalling: 
Ca2+ -ionophore alone does not provoke net ion secretion (Fig.1) and does not 
translocate PKC a (Fig.4), although in other cell types Ca2+ -ionophore induced 
PKC translocation has been described (Ho et al., 1 988). Secondly, the initial phase 
ol the carbachol induced lsc response (Fig.1) and the PKC a translocation (Fig.4) 
were both transient Qasting 2-5 minutes), whereas phorbol ester-provoked 
changes in lsc (Fig.1) and PKC a. translocation (Fig.4) were sustained for at least 
1 0 minutes. Thirdly, our finding ol a selective recovery of cAMP-, but not ol 
carbacholjPDB-provoked ion secretion in PKC " downregulated cells, under 
conditions in which all other PKC isozymes were normally expressed, also 
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strongly supports an obligatory role for PKC a: in carbachol- and PDB-triggered 
ion secretion. Other possible explanations for a selective inhibition of 
carbacholjPDB-induced secretion, i.e. PMA-induced uncoupling olthe muscarinic 
receptor from phospholipase C or a complete PMA-induced downregulation of 
any of the participating transport systems itself, are rather remote, considering our 
observations that: (i) the production of inositol phosphates by carbachol is not 
inhibited after 27h PMA treatment (Table 2), and (I~ the same transporters which 
fail to respond to carbachoi/PMA-induced signals are still able to respond to 
cAMP-induced signals. 
In summary, this study presents evidence for a complex role of PKC a. as 
a regulator of intestinal ion transport. Among the various PKC isozymes detected 
immunologically in the HT29ci.19A colonocytes (a:, B1, y) only the a. form showed 
rapid translocation in response to PKC activators (PMA, carbachol) and became 
down regulated by chronic exposure to PMA (24h; 5.1 o·7 M) 1• Measurements of 
ion transport activities carried out in parallel suggest a dual role for PKC a. as a 
stimulator and inhibitor of intestinal ion secretion. 86Rb • and 125r efflux studies 
showed that inhibition was relatively slow and targetted on basolateral potassium 
transport systems, while the stimulation was acute and exerted at the level of an 
apical chloride channel. Extrapolation of these results to the intestinal epithelium 
in vivo would imply that the action of intestinal secretagogues capable of 
provoking prolonged PKC activation (similar to PMA) would be self-limiting (i.e. 
lasting < Sh) and would bring about a state of resistance to other secretagogues, 
including microbial toxins (cholera toxin, heat-stable E.coli toxin) acting through 
different intracellular signals (cAMP, cGMP). Attempts to substantiate this 
prediction in an animal model are in progress in our laboratory. 
FOOTNOTE 
1 Preliminary results, using PKC S, ( and "'J specific antisera, indicate that PKC { and 1J (but not 
PKC 8) are also expressed in the HT29ci.19A cells, but do not downregutate in response to PMA 
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CHAPTER 6 
PHORBOL ESTERS STIMULATE AND INHIBIT Cr 
SECRETION BY DIFFERENT MECHANISMS IN A 
COLONIC CEll LINE. 
Phorbol12-myristate 13-acetate (PMA) was found to increase both the short-
circuit current (15 c) and the efflux of 1251" or "cr in the colonic epithelial cell 
line HT29ci.19A. Neither the PMA-provoked rise in lsc nor the stimulation of 
1251" efflux was affected by the cyclooxygenase inhibitor indomethacin. The 
PMA-induced increase in cr efflux was not accompanied by a rise in cAMP 
levels. A prolonged incubation with PMA (3 h), however, inhibited the PMA-
and the cAMP-stimulated lsc by > 90%, whereas the cAMP-provoked 1251" and 
"'cr efflux was not inhibited. The long-term PMA treatment was found to 
inhibit the basal and cAMP-provoked .. Rb+ efflux by 65 ± 9% and 86 ± 7% 
respectively. A 3 h incubation with PMA also strongly inhibited the Ca2 + 
ionophore A23187-induced increase in ''Rb+ efflux, whereas the A23187-
stimulated ' 251" efflux was only marginally inhibited. These data suggest that 
phorbol esters, presumably by activation of protein kinase C, can provoke cr 
secretion in HT29ci.19A colonocytes independently of a prostaglandin- or 
cAMP-mediated pathway. Prolonged exposure to PMA, however, causes an 
inhibition ol net electrogenic cr secretion by downregulation of the activity 
of K+ transporters. 
INTRODUCTION 
Activation of protein kinase C is thought to be a key step in the 
mechanism of action of various intestinal secretagogues (6, 7,11-13,21 ). In excised 
patches of cr-secreting tracheal epithelial cells, protein kinase C and cAMP-
dependent protein kinase were shown to directly activate apical cr channels 
(15,17). From these studies it was suggested that protein kinase C stimulates cr 
secretion independently of cAMP-dependent protein kinase by activating apical 
cr channels. 
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The phorbol esters, phorbol 12-myristate 13-acetate (PMA) and phorbol 
12,13-dibutyrate (PDB), are known to activate protein kinase C and to reproduce 
the effects of diacylglycerol (DAG), the main second messenger involved in the 
protein kinase C signal-transduction pathway (20,21). In rabbit and chicken ileum 
(7,19), and in rat distal colon (12) the phorbol ester-provoked electrogenic cr 
secretion was found to be mediated largely by prostaglandins, known activators 
of adenylate cyclase. However, the presence of sub-epithelial cells in the intestinal 
preparations, which were found to be the main sources of the phorbol ester-
generated prostaglandins {19,23) may mask direct effects of the activation of 
protein kinase C on epithelial cells. 
The present study was aimed to investigate the effects of the phorbol 
esters on cr secretion in a homogenous population of colonic eptthelial cells. The 
subclone 19A of the human colon carcinoma cell line HT29 was selected as a 
model system because tt responds to both cAMP-linked (e.g. forskolin) and Ca2 +-
linked secretagogues (e.g. carbachol). It also forms tight monolayers when grown 
on filters, enabling electrical measurements in an Ussing chamber (2-5). 
Both the acute and the long-term effects of PMA on cr secretion were 
monitored, considering the opposite effects of both treatments reported for other 
epithelial cells. After a stimulatory phase, PMA was found to inhibit cAMP-activated 
cr efflux in tracheal cells (17) and to diminish Na-K-CI2 cotransport activity in 
HT29 colonocytes (14). 
We report here that phorbol esters stimulate cr secretion in HT29ci.19A 
colonocytes, independently of prostaglandin synthesis and without a detectable 
increase in the cAMP levels. Prolonged incubation with PMA did not inhibit the 
cAMP- or Ca2+ -activated cr conductance but suppressed net electrogenic cr 
secretion by inhibiting K• transport pathways. 
MATERIALS AND METHODS 
Materials: HT29c!. 19A cells were kindly donated by Dr. C.l. Laboisse (Jnstitut National de Ia Sante 
et de Ia Recherche Mediacale, Paris). Cell culture media and fetal calf serum were derived from 
GIBCO. Forskolin, carbachol, PMA, POB and 1-oleyl~2...acetylglycerol (OAG) were obtained from 
Sigma Chemical (StLouis, MO) and A23187 and 8-Br--e:AMP from Boehringer (Mannheim, Germany). 
H"'Cl (19 JLCifmg), Na125i (14 Cijmg), and 86RbCI (5 mCijmg) were purchased from Amersham 
(UK). 
Cell culture: HT29ci.19A cells were grown in cell culture flasks (Falcon) under a humidified 95% air-
S% C02 atmosphere at 37"C in Dulbecco's modified Eagle's medium, supplemented with 10% fetal 
calf serum. The medium additionally contained 40 mg/1 penicillin and 90 mgjl streptomycin. Cells 
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were subcultured at a surface ratio of 1 : 5 after trypsinization every 5 days, when they had reached 
70-80 %confluence. The passage number of the cells used in this study varied between 11 and 30. 
Measurements of short-circuit current: HT29cl.19A cells were grown to confluence (7-9 days after 
plating at a 1:2.5 surface ratio) on tissue culture-treated polycarbonate filters firmly attached to a 
polystyrene ring (6.4 mm diameter, Transwell, Costar). The ring containing the filter was placed in 
a tightly fitting insert separating the serosal and mucosal compartment of an Ussing chamber. The 
bathing solutions consisted of a modified Meyler buffer [0n mM) 108 NaCI, 4.7 KCl, 1.3 CaCI2, 1.0 
MgCI2 , 20 NaHC03, 0.8 Na,HP04 , 0.4 NaH2P04 , 20 Na·N·2·hydroxyethylpiperazine-N'·2· 
ethanesulfonic acid (HEPES) and 10 glucose, pH 7.4], which were perfused and aerated by a gas-lift 
system using 95% 0 2-5% C02" The cr-free medium consisted of Qn mM) 128 Na-gluconate, 4.7 K-
gtuconate, 1.3 Ga..:yctamate, 1.0 Mg$04 , 0.8 Na,HP04 , 0.4 NaH2P04 , 20 Na-HEPESand 10 glucose, 
pH 7.4, aerated with 100% 0 2 . lsc was measured with two platinum current electrodes in direct 
contact with the bath, and two calomel electrodes connected to the bathing media by salt bridges. 
The electrical resistance of the filter-grown HT29cl.19A monolayers, as determined at the beginning 
of the lsc measurements, was 115 :!: 27 (SO) n.cm2 (n = 18}. 
Isotope efflux experiments: HT29cl.19Acells were either grown to 70-80% confluence (4-5 days after 
plating) in six-well cell culture plates (diam wells 34 mm; Nunc) or to full confluence on a filter (diam 
24 mm, Transwell, Costar) similarly as described for the determination of lsc· Cells were loaded for 
1.5 h under a humidified 95% air-5% C02 atmosphere at 37"C in 0.5 ml (wells) or 2.5 ml {filters) of 
a modified Meyler solution containing the isotopes (5 .uCi/ml 36Cr, 3 .uCijml 125r or 1 .uCijml 
86Rb +). The extracellular isotope was removed within 1 min with three washes of 3 ml modified 
Meyler solution at room temperature. The cells in the wel!s were found to retain 0.31 :!: 0.4% of the 
added 125r, 0.23 :!: 0.04% of the added 36Cr and 23 = 4% of the added 86Rb + (n =20). For the filter-
grown cells these figures were 0.14 = 0.02% for 125r, 0.09 ::: 0.02% for 36Cr and 8.9 = 1.0% for 
86Rb+ (n= 12). The isotope efflux from the cells grown in wells was determined at 37 °C by addition 
and consecutive replacements of 1 ml of a modified Meyler solution at 1 to 2 min intervals. The cells 
were kept, except during the replacements, under a 95% 0 2-5% C02 atmosphere. The residual 
isotope at the end of the experiment was determined by addition of 1 ml 1 M NaOH. The efflux into 
the upper compartment (mucosal side) of the cells grown on filters was determined in a similar way, 
whereas the efflux into the serosal bath was monitored simultaneously by transferring the filters at 
the same time points into consecutive wells containing 2 ml of modified Meyler. 125r was measured 
simultaneously with 36Cr by P-scintillation counting, whereas 86Rb +, due to its relatively high 
uptake, could be determined together with 125r in a gamma counter. 
To render the isotope efflux at the various time points more comparable we expressed the 
data as the fractional efflux per min, i.e. the amount of isotope lost from the cells in the interval 
preceding a time point expressed as a percentage of the amount of isotope associated with the cell 
layer at the beginning of that interval and divided by the length of that interval (24). 
cAMP determination: HT29c!. 19A cells were cultured in six-well plates as described for the isotope 
efflux experiments. The cells were pre incubated in 1 ml of a modified Meyler solution for 30 min at 
3~C under a 95% 0 2-5% C02 atmosphere, and consecutively incubated in a fresh Meyler solution 
(1 ml) for 10 min (control, PMA) or 3 min (forskolin). The incubation was terminated by removal of 
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the Meyler solution and addition of 0.25 ml of ice-cold 0.1 M HCI to the wells. The cAMP levels were 
determined with a commercial test kit from Amersham. 
RESULTS 
Short term effects of PMA on cr secretion. In HT29ci.19A cells, the 
secretagogue-induced increase in transepithelial electric current was found to be 
caused predominantly by the opening of apical cr conductances, and is thus 
indicative for electrogenic cr secretion (3-5). After a lag phase of 5-1 o min, PMA 
(0.5 11M) was found to provoke a clear increase in lsc across a monolayer of filter-
grown HT29ci.19A cells (Fig.1, Table 1). We also observed a slight increase in the 
transepithelial resistance after addition of PMA. The delay in the response might 
be caused by a slow penetration of PMA into the colonocytes, as the more 
permeant phorbol ester PDB (0.1 11M) induced a similar rise in lsc without a 
significant lag time (results not shown). As shown in Table 1, OAG (0.1 mM), a 
membrane permeant analog of the physiological activator of protein kinase C 
DAG, was able to mimic the effect of PMA on lsc. The PMA·induced rise in lsc 
was not observed in cr.free medium and was inhibited by subsequent serosal 
addition of bumetanide (0.1 mM), an inhibitor of Na-K-CI2 cotransport, or barium 
(5 mM), an inhibitor of K+ channels by 86 :>: 5% and 92 :>: 4% (n =3) respectively. 
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FIGURE 1. Phorbol 12-myristate 13-
acetate (PMA) provoked rise in short-
circuit current (lsc) in HT29cl.19A cells. 
Confluent monolayers of HT29ci.19A cells 
grown on filters were placed in Ussing 
chamber. lsc was monitored as described in 
MATERIALS AND METHODS. PMA (0.5 JLM) 
was added to both mucosal and serosal 
bath at timepoint indicated with arrow. 
Shown is representative tracing from 6 
experiments. 
Because the activity of both cotransporters and basolateral K+ channels is 
required during sustained cr secretion (6), these data also indicate that the 
stimulation of lsc by PMA represents an increase in electrogenic cr secretion. 
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TABLE 1. Effects of PMA on isc In HT29.ci19A colonocytes. 
Addition 
Basal 
PMA (0.5 JLM) 
OAG (100 JLM) 
PMA (0.5 JLM) + indomethacin (20 JLM) 
8-Br-cAMP (1 mM) 
control 
0.3 ~ 0.3· 
19.8 ~ 8.7 
16.3 ~ 4.9 
24.8 ::!:: 7.2 
94.0::!: 32 
lsc max (J!.Ajcm"') 
3h PMA 
1.5 ±: 0.8 
ND 
ND 
6.6 ~ 3.2 
Values are means =: SD; n=6 experiments. Confluent monolayers of HT29cL19A cells grown on 
filters were placed in Ussing chamber. Short-circiut current (lsc) was monitored as described in 
MATERIALS AND METHODS. Phorbol 12-myristate 13 acetate (PMA) and 1-oleyl-2-acetylglycerol 
(OAG) were added to both mucosal and serosal bath, wheras 8-bromoadenosine 3',5'-cyclic 
manophosphate (8-Br...cAMP) was added to serosal bath only, because no further changes were 
detected after subsequent addition to the mucosal bath in initial experiments. Indomethacin (20 JLM) 
was added to both bathing solutions 20 min before the addition of PMA Prolonged PMA treatment 
was perfomed by exposing the filters to 0.5 p.M PMA for 3 h in the cell culture medium in incubator 
and subsequent addition of PMA to bath solutions after filters were placed in Ussing chamber. 
Maximal value of lsc was reached 25-30 min after addition of PMA and OAG or 10-15 min after 
addition of 8-Br-cAMP. NO, not determined. '"Data from Ref 24. 
To test whether the PMA-provoked rise in lsc in HT29ci.19A cells was 
mediated by prostaglandins, we repeated these experiments in the presence of 
the cyclooxygenase inhibitor indomethacin. As shown in Table 1, the PMA-induced 
rise in lsc appeared unaffected by indomethacin at a concentration up to 20 I'M. 
To ascertain that the PMA-provoked increase in lsc resulted from the 
activation of a cr conductance pathway, we measured the effect of PMA on the 
efflux of radiolabeled r and cr. Efflux measurements of 1251" and 36CI" have been 
advocated recently as a convenient method for studying cr conductances in 
epithelial cells (8,24,26). PMA present in the efflux medium caused a small but 
significant increase in 1251" and 36CI" efflux from HT29ci.19A cells grown on plastic 
(Fig.2). Because the unstimulated fractional efflux rate decreased with time, 
precise quantitation of the PMA effect was difficult (cf.Ref 24). The initial increase 
(determined at 3 min after the addition of PMA) in fractional 36CI" efflux was found 
to be 2.2 ± 0.6-fold larger than the increase in fractional 1251" efflux. The observed 
36CI" to 1251" ratio of the PMA stimulated efflux resembled that of the cAMP-
activated anion efflux (1.91 ± 0.45), but was dissimilar to the Ca2 + ionophore-
induced efflux ratio (0.36 ± 0.14) determined under similar conditions (24). The 
difference in cr to r efflux ratio between the cAMP- and Ca2 + -stimulated anion 
efflux suggests that these second messenger activate different types of cr 
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FIGURE 2. PMA stimulates 3Gcr and 125 r efflux in HT29ci.19A colonocytes. HT29cl.19A cells were 
grown in 6-we!J cell culture plates to 70-80% confluence. Ce:!s were loaded with both 36Cr and 125r 
and fractional 36Cr Oeft) and 125r (right) efflux was determined simultaneously as described in 
MATERIALS AND METHODS. PMA (0.5 _uM; a) was included in efflux medium at t=O and kept 
present throughout experiment. Control cells (o) received only vehicle [0.1% dimethyl sulfoxide 
(OMSO)]. Data are means~ SO (n=S experiments). '"mfferent from paired controls, P<0.01. 
conductances in HT29ci.19A cells (cf.Ref.9). The PMA-induced rise in 1251" efflux 
from plastic-grown HT29ci.19A cells could be mimicked by PDB (0.5 I"M), and 
was not inhibited by indomethacin {20 I"M. 20 min preincubation; results not 
shown). 
We also determined the effect of PMA on the 1251" efflux from filter-grown 
monolayers of HT29ci.19A cells. As shown in Fig.3. PMA merely increased the 1251" 
efflux across the apical border, but had no effect on basolateral anion efflux. The 
cAMP-linked secretagogue forskolin showed a similar although larger increase of 
1251" efflux solely into the mucosal bath (Fig.3). In contrast, Ca2 • ionophore A23187 
was found to provoke a rise in ' 251" efflux across both the apical and the 
basolateral membrane (24). As shown in Fig.3, PMA, like forskolin, also caused 
a significant increase in 86Rb• efflux rate into the serosal bath. The increase in 
serosal K+ efflux follows the increase in apical efflux of cr and may assist in 
maintaining a sustained cr secretion (cf.Ref.6). The stimulation of the 1251- and 
86Rb+ efflux by PMA seemed slightly faster than the stimulation of lsc determined 
in the Ussing chamber. Presumably PMA action may have been more efficient in 
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FIGURE 3. PMA stimulates apical 125r and basolateral ssRb+ efflux from HT29e!.19A 
colonocytes. HT29ci.19A cells were grown on tissue culture-treated polycarbonate filters to full 
confluence. Cells were loaded with both 125r and 86Rb +. Fractional 125r (!eft) and 136Rb + (right) efflux 
was determined simultaneously as described in MATERIALS AND METHODS. Forskolin (5 JLM) was 
added to both PMA-treated and control cells 4.5 min after start of efflux experiment as indicated by 
arrow. PMA (0.5 JLM; e) was added at t=O and kept present throughout experiment. Control cells 
(o) received only vehicle (0.1% OMSO). Sign of positive fractional efflux into serosal bath was 
arbitrarily reversed into negative sign, to discriminate serosal efflux graphically from mucosal efflux. 
M, mucosal side; S, serosal side. Data are means ::: SO (n=3 experiments) *Different from paired 
controls, P < 0.01. 
the efflux experiments because in this assay cells were exposed to a premixed 
PMA solution, whereas PMA in the Ussing chamber was added as a bolus 
injection from a concentrated stock solution. 
Because the PMA-induced anion efflux resembled the forskolin-stimulated 
efflux, a possible role of cAMP as a modulator of the PMA-induced Cl" secretion 
was investigated further by direct measurements of cAMP levels. However, a 10 
min exposure of plastic-grown HT29ci.19A colonocytes to PMA (0.5 11M), under 
similar condition as used for the '251" efflux determinations, did not lead to a 
significant difference in cAMP levels as compared to control cells (stimulation 
factor 0.92 :t 0.12, n=4). For comparison, forskolin (5 11M, 3 min incubation) was 
found to raise the cAMP levels in the same series of experiments 5.9 :t 1.6 fold 
(n=4). 
As shown in Fig.3, a short (4.5 min) preincubation with PMA had no 
significant effect on the forskolin induced increase in ' 251" and ""Rb+ efflux from 
filter-grown HT29ci.19A cells. 
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Long-term effects of PMA on cr secretion. Prolonged incubation up to 3 hour 
in the presence of 0.5 J.1M PMA resulted in a return of the lsc to a value which was 
only slightly above the value of unstimulated HT29ci.19A cells. Furthermore a 3 
h preincubation with PMA caused a 93 ± 4% inhibition of the lsc response to 8-Br-
cAMP (fable 1). The electrical resistance of the PMA-treated monolayers (119 ± 
25 O.cm2 ; n=12) was notsignificantlydiflerentfrom control cells (115 ± 28 O.cm2 ; 
n=18), excluding the possibility that PMA inhibited the lsc by affecting the 
resistance of the monolayers. The PMA-provoked inhibition of the lsc might result 
from inactivation of apical cr channels, or from inhibition of transport pathways 
necessary for the maintenance of electrogenic cr secretion, e.g. basolateral K+ 
channels, or Na-K-CI2 cotransporters (6,18). To discriminate between these 
possibilities a more direct method of determining the activity of cr or K+ 
transporters was used, based on the efflux rates of radiolabeled ions (8,24,26). 
The loading of ' 2'1' in the long-term PMA-treated cells as determined after 
the washing procedure (0.42 ± 0.04% of the added isotope; n=5) was 30% higher 
than into untreated cells (see MATERIALS AND METHODS). This difference in 
loading is not expected to have large effects on the fractional anion efflux, as this 
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FIGURE 4. Prolonged PMA treatment inhibits basal and forskolin~stimulated 86Rb + efflux but 
not 125r efflux; comparison with K+ transport inhibitors. HT29c1.19Acells were grown in &well cell 
culture plates to 70..80% confluence. Cells were loaded with both 125r and 86Rb +,and fractional 125r 
Oeft) and 86Rb + {right) efflux was determined simultaneously as described in MATERIALS AND 
METHODS. Forskolin (5 JLM) was added to different incubations 4.5 min after start of efflux 
experiment as indicated by arrow. PMA (0.5 JLM; o) was added to cells 3 h before start of efflux 
determination and was also included in efflux medium. Control cells {o) received only vehicle (0.1% 
DMSO). Barium (2 mM; a) or bumetanide (100 JLM; V) was included in efflux medium at t=O min. 
Data are means ::!::: SO (n =3 experiments). 
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FIGURE 5. Prolonged PMA treatment does not inhibit forsko!in-stimu!ated 36Cr or 125r efflux 
from HT29ci.19A colonocytes. HT29ci.19A cells were grown on tissue culture-treated polycarbonate 
filters to fuH confluence. Cells were loaded with both 36Cr and 125r, and fractionai 36Cr Oeft) and 125r 
(right) efflux was determined simultaneously as described in MATERIALS AND METHODS. Forskolin 
(5 JLM) was added to both PMA-treated and control cells 4.5 min after start of efflux experiment as 
indicated by arrow. PMA (0.5 J.LM; o) was added to cells 3 h before start of efflux determination and 
was also included in efflux medium. Control cells (o) received on!y vehicle (0.1% DM$0). Sign of 
positive fractional efflux into serosal bath was arbitrarily reversed into negative sign, to discriminate 
serosal efflux graphically from mucosa! efflux. Data are means ~ SO (n =3 experiments). 
value is corrected for the amount of radioactivity present in the cells. As shown 
in Fig.4, plastic-grown HT29ci.19A cells showed a 20-25% lower fractional efflux 
rate of 1251" after the 3 h incubation with PMA compared to control cells. In 
contrast, the forskolin-stimulated 1251" efflux showed a slight increase in response 
to the prolonged PMA treatment. A similar response of both basal and forskolin-
stimulated 1251" and 36CI" efflux to a prolonged PMA incubation was observed in 
filter-grown HT29ci.19A colonocytes (Fig.S). As also shown in Fig.S, PMA inhibited 
the basal efflux of radiolabeled anions into the serosal as well as the apical bath. 
The increase in 1251" efflux induced by 8-Br-cAMP (1 mM), which was 2-3 fold 
smaller than the increase in 1251" efflux after addition of forskolin, appeared likewise 
insensitive to a 3 h PMA preincubation (results not shown). These data indicate 
that the PMA-provoked inhibition of the cAMP-induced rise in lsc is not caused by 
inhibition of the cAMP-activated apical Cl" channel. 
However, a 3 h exposure of plastic-grown HT29ci.19A cells to PMA was 
found to inhibit the basal 86Rb+ efflux by 65 ± 9% (n=S) and the forskolin 
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FIGURE S. Prolonged PMA treatment 
Inhibits 86Rb + efflux from HT29ei.19A 
colonocytes grown on permeable supporL 
HT29ci.19A cells were grown on tissue 
culture·treated polycarbonate filters to full 
confluence. Cells were loaded with 86Rb +. 
Fractional 86Rb + efflux was determined as 
described in MATERIALS AND METHODS. 
Forskolin (5 JLM) was added to both PMA-
treated and control cells 4.5 min after start 
of efflux experiment as indicated by arrow. 
PMA (0.5 JLM; o) was added to cells 3 h 
before start of efflux experiment and kept 
present in efflux medium throughout 
experiment. Control cells (o) received only 
vehicle (0.1% DMSO). Sign of positive 
fractional efflux into serosal bath was 
arbitrarily reversed into negative sign, to 
discriminate serosal efflux graphically from 
mucosal efflux. Data are means ~ SO (n =4 
experiments). 
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FIGURE 7. Time course of PMA inhibition of basal and forskolin~stimulated 86Rb + efflux. 
HT29ci.19A cells were grown in 6-weH cell culture plates to 7Q-80% confluence. Fractional 86Rb + 
efflux was determined as described in MATERIALS AND METHODS. Forskolin (5 JLM) was included 
in efflux medium 5 min after start of efflux experiment. PMA (0.5 JLM) was added to cells at various 
time points before start of efflux determination and was also included in efflux medium. PMA effects 
on basal 86Rb + efflux (o) were determined by comparing fractionai 86Rb + efflux of PMA-treated and 
control cells (Incubated in presence of vehicle, 0.1% DMSO) at 5 min after start of efflux experiment. 
Effects on forskolin-stimulated efflux (o) were determined by comparing fractional 86Rb + efflux of 
PMA-treated and control cells at 5 min after addition of forskolin (when 86Rb + efflux was maximal) 
after subtraction of 86Rb+ efflux in absence of forskolin. Data are means = SO (n =3 experiments). 
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FIGURE 8. Prolonged PMA treatment inhibits Ca2 + ionophore-stimulated 86Rb + efflux but not 
125r efflux; comparison with K+ transport inhibitors. HT29ci.19A cells were grown in 6-we!! cell 
culture plates to 70-80% confluence. Cells were loaded with both 125r and 86Rb +.and fractional 125r 
(left) and 86Rb+ (right) efflux was determined simultaneously as described in MATERIALS AND 
METHODS. Ca2+ ionophore A23187 (10 ~M) was included in efflux medium 4.5 min after start of 
efflux experiment as indicated by arrow. PMA (0.5 p.M; o) was added to cel!s 3 h before start of 
efflux determination and was also included in efflux medium. Control cells (o) received only vehicle 
(0.1% OMSO). Barium (2 mM; A) or bumetanide (100 Jt.M; V') was included in efflux medium att=O 
min. Data are means = SO (n =3 experiments). 
stimulated 86Rb + efflux by 87 ± 6% (determined at 5.5 min after addition of 
forskolin, n=5) (Fig.4). A similar inhibition of basal and lorskolin stimulated 86Rb+ 
efflux across both the apical and basolateral membrane was observed in 
colonocytes grown on filters (Fig.6). The loading of 86Rb+ into the PMA-treated 
cells (23.4 ± 3.3% of the isotope added; n=5) was almost identical to the loading 
of untreated cells (see MATERIALS AND METHODS). As shown in Fig.7, after a 
relatively fast initial stimulation, PMA starts to inhibit the 86Rb+ efflux after 20 min, 
and reaches a maximal inhibition after 3 h. A 3 h incubation in the presence of 
PMA also strongly inhibited the increase in 86Rb+ efflux induced by the Ca2 + 
ionophore A23187, whereas the A23187 stimulated 1251" efflux was only marginally 
inhibited (Fig.8). 
In Figs.4 and 8 the effect of prolonged PMA treatment on 86Rb+ efflux is 
compared with inhibitors of K+ transport mechanisms. Bumetanide at a 
concentration that is reported to completely inhibit the Na-K-CI2 cotransporter in 
HT29 cells (1 00 I'M; Ref.16) inhibited the basal 86Rb + efflux 47 ± 8 %, but started 
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to inhibit the forskolin- and Ca2 + ionophore-provoked 86Rb+ efflux only after a lag 
time of 1.5-3 min after addition of the agonist. Barium (2 mM), a well-known 
inhibitor of epithelial K+ channels (6,18) induced in comparison with bumetanide, 
a smaller reduction of basal 86Rb- efflux (27 ± 9%), but a faster and larger 
inhibition of the forskolin-stimulated 86Rb + efflux, and a somewhat larger inhibition 
of the A23187-provoked efflux. In conclusion. barium and bumetanide were found 
to be less inhibitory towards basal, cAMP- and Ca2+ -provoked "'Rb+ efflux 
incomparison with prolonged PMA treatment (Figs.4 and 8). Neither barium nor 
bumetanide inhibited forskolin- or A23187 -stimulated 125r or 36Cr efflux to a 
significant extent (results not shown; cf.Ref.8,24). 
To further characterize the mechanisms of 86Rb + efflux from HT29ci.19A 
cells we also performed ion replacement studies. As shown in Fig.9, replacement 
of cr and HC03- by gluconate inhibited forskolin-stimulated 86Rb- efflux to a 
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FIGURE 9. Cr-free medium inhibits basal and forskolin-stimulated 36 Rb+ efflux but not 125r 
efflux. HT29ci.19A cells were grown in 6-well eel! culture plates to 70-80% confluence. Cells were 
loaded with both 125r and 88Rb+ in buffer without HC03" [(in mM) 130 NaCI, 4.7 KCJ, 1.3CaCI2, 1.0 
MgCI2 , 20 HEPESjTris, pH 7.4, 10 glucose). Fractional 125r (left) and 86Rb+ (right) efflux was 
determined simultaneously as described in MATERIALS AND METHODS in efflux buffers similar to 
loading buffer (o,e) or in similar buffer in which Cl" was replaced by gluconate (a,A}. Forskolin (5 
tLM) was included in some experiments (e,A)in efflux medium 4.5 min after start of efflux 
experiment as indicated by arrow. Data are means = SD (n =3 experiments}. 
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similar extent as found after prolonged PMA exposure, whereas the forskolin-
induced 1251" efflux was not inhibited. Omittance of K+ or Na + was less inhibitory 
towards the forskolin-activated 86Rb + efflux, and mimicked the effect of 
bumetanide including a delayed onset of the inhibition (results not shown). 
DISCUSSION 
From both the lsc and the isotope efflux measurements it is evident that 
phorbol esters are able to stimulate electrogenic cr secretion in the HT29ci.19A 
human colon carcinoma cell line. In rabbit colon and chicken ileum the phorbol 
ester-induced cr secretion was found to be mediated predominantly by prosta-
glandins presumably synthesized in sub-epithelial cells (7,12,19,23). However, 
PMA-stimulation of cr transport in the HT29ci.19A cells must occur more directly, 
since (1) this cell line consists of a homogenous population of Cr-secreting 
epithelial cells and is completely devoid of subepithelial cell types, and (2) the 
PMA-induced cr secretion was not inhibited by the cyclooxygenase inhibitor 
indomethacin. 
Phorbol esters added at submicromolar concentrations are thought to act 
as specific activators of protein kinase C (20,21). Activation of protein kinase C by 
PMA in HT29.ci19A cells was supported by immunolocalization studies with 
protein kinase C specific antibodies. These studies provided preliminary evidence 
for a rapid translocation of protein kinase C-a from the cytosol to the particulate 
fraction after addition of PMA (Van Den Berghe, unpublished data). Furthermore, 
OAG a membrane permeant analog of diacylglycerol (DAG), the physiological 
activator of protein kinase C could mimic the effect of PMA on lsc in HT29ci.19A 
cells. Activation of protein kinase C might represent an independent route for 
activation of apical cr channels in the HT29ci.19A cell line, distinct from the cAMP 
or Ca2+ mediated signal-transduction pathways, because 1) PMA did not change 
cAMP levels in HT29.ci19A cells under conditions in which it generated a clear 
increase in ""Cr and 1251' efflux, and 2) several characteristics of the PMA-induced 
""Cr and 1251" efflux were different from those of the Ca2 + ionophore-provoked 
anion efflux (24). 
As judged by the similarity between the PMA- and the forskolin-stimulated 
1251" and ""Cr efflux, protein kinase C and cAMP-dependent protein kinase might 
activate a similar or identical Cl" channel. Such a model was suggested from 
patch-clamp studies with tracheal epithelial cells (15,17). In these studies both 
cAMP-dependent protein kinase and protein kinase C were found capable of 
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activating a similar outwardly rectifying cr channel. However, the actual 
contribution of this channel to cAMP- or PMA-provoked cr currents in intact 
epithelial cells remains to be established (9). 
The main physiological activator of the protein kinase C pathway is 
thought to be DAG (20,21 ). DAG is generated by a specific phospholipase C after 
stimulation by a various secretagogues e.g. carbachol or bradykinin (1 ,20,21 ). This 
phospholipase C was found to be abundant in both the apical and the basolateral 
membrane of rat enterocytes (25). In T84 colonocytes carbachol and phorbol 
esters have been reported to provoke a similar protein phosphorylation pattern 
(1 0). 
In contrast to the stimulation of cr secretion observed upon short-term 
exposure to PMA, a prolonged activation of protein kinase C was found to result 
in a profound inhibition of the PMA- and cAMP-provoked lsc. Most likely this 
inhibition was not caused by downregulation of protein kinase C, since the levels 
of all major protein kinase C isoenzymes remained stable after a 3 hour incubation 
with 0.5 11M PMA (Van den Berghe, unpublished data). The prolonged PMA 
treatment also induced a decrease in the basal fractional 1251" and 36Cr efflux. 
However, both the basolateral anion efflux as well as the apical anion efflux 
became inhibited, whereas only the latter was specifically stimulated by short-term 
PMA exposure. This suggests that the PMA-induced decrease in 125 1" and "'cr 
efflux represents an inhibition of the basal cr permeability of both membranes 
rather than a specific inhibition of the PMA-stimulated cr efflux pathway. 
The cAMP-induced 1251" and 36CI" efflux was not inhibited by a short- or 
long-term (3 h) exposure to PMA, arguing against a direct inhibitory effect of 
protein kinase C activation on the cAMP-stimulated Cl" channels. In this respect 
the colonic HT29ci.19A cells clearly differ from tracheal cells, in which PMA 
decreased the cAMP-provoked 1251" efflux (17). This difference might reflect a 
dissimilarity in the type of cr channels activated by cAMP between both cell 
types, as evidenced by a pronounced difference in the sensitivity of the cAMP 
stimulated Cr efflux lor the Cr channel blocker NPPB between tracheal and 
HT29ci.19A cells (4, 17,24). The forskolin-induced stimulation of 1251" and 36CI" efflux 
was actually enhanced by the 3 h PMA treatment. This enhancement may be 
caused by a stimulatory effect of PMA on adenylate cyclase, since protein kinase 
C activation is known to increase the forskolin-provoked rise in cAMP levels in 
other cell types (22). We also have preliminary evidence that PMA enhances the 
forskolin-induced, but not the basal, cAMP formation in plastic-grown HT29.ci19A 
cells (unpublished observations). The Ca2 + -stimulated 1251" efflux in HT29.ci19A 
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cells, which presumably represents a cr conductance distinct from the cAMP-
activated cr channel (9,24) appeared equally insensitive to a prolonged exposure 
to the protein kinase C activator PMA. 
In contrast to the absence of clear inhibitory effects of PMA on cAMP- and 
Ca2+ -provoked anion efflux, the cAMP-stimulated 86Rb+ efflux was dramatically 
inhibited by prolonged exposure to PMA. This finding indicates that the inhibition 
of the cAMP-induced electrogenic cr secretion is caused by an inhibition of a K+ 
transport system, rather than ol the cAMP-stimulated apical cr channel. The time 
course of the PMA-induced inhibition of the K+ efflux pathway was much slower 
than the stimulatory effect of PMA on the cr and K+ efflux, resulting in a biphasic 
effect of PMA on cr secretion. The difference in time course suggests that the 
mechanism by which PMA activates cr secretion (presumably phosphorylation of 
a cr channel or its regulatory protein) is dissimilar from that by which K• efflux 
is inhibited. 
Among the different K• transporters known to be present in Cr secreting 
epithelial cells, the Na+ /K+ -ATPase is unlikely to serve as a major target for PMA; 
long-term exposure to PMA did not significantly affect the 86Rb + loading of the 
HT29ci.19A cells which apparently accumulates above its extracellular 
concentration due to the activity of the Na+ /K+ -ATPase. 
In the parental HT29 cell line prolonged exposure to PMA has been 
reported to inhibit the bumetanide-sensitive Na-K-CI2 cotransport activity, 
presumably through a down regulation of the carrier itself (14). The time course of 
the PMA-provoked inhibition of the cotransporter in HT29 cells was comparable 
to the time course for the inhibition of the 86Rb+ efflux in the subclone 19A. In our 
study bumetanide was also found to inhibit the 86Rb + efflux, although to a 
considerably lower extent than PMA. Only part of the PMA-induced inhibition of 
86Rb• efflux may therefore be explained by an inhibition of the bumetanide-
sensitive Na-K-CI2 cotransporter. 
It is however unlikely that 86Rb • is released from the HT29ci.19A cells by 
direct cotransport with cr. because neither basal nor cAMP-stimulated 36CI' efflux 
was apparently inhibited by bumetanide or long-term PMA treatment. In contrast 
to 86Rb • efflux, no stimulation of 36CI' efflux was observed across the basolateral 
membrane in response to forskolin, also arguing for different transport systems 
for 86Rb+ and 36Cr efflux in HT29ci.19A cells. This suggests that either 86Rb+ efflux 
is (in part) mediated by a bumetanide-sensitive transport system without an 
obligatory coupling to cr cotransport, or that 86Rb + efflux is indirectly affected by 
an inhibition of the Na-K-CI2 cotransporter (e.g. as a consequence of a lower Cr, 
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K• or Na• influx into the cells). Such a coupling between 86Rb+ efflux and cr influx 
might also explain the striking observation that replacement of extracellular cr and 
HCO; almost completely blocked the cAMP-induced 86Rb + efflux without affecting 
the anion efflux pathway. 
However, because 3 h PMA pretreatment decreased the basal and 
forskolin-induced 86Rb + efflux considerably more than a maximal concentration of 
bumetanide (16), PMA must at least also affect additional K• efflux pathways 
besides the bumetanide sensitive transporter. As judged by the large barium-
induced inhibition of the cAMP-stimulated 86Rb+ efflux, this other PMA-inhibitable 
transport system might include barium-sensitive K+ channels. These channels are 
known to play an important role in maintaining net electrogenic cr secretion in 
epithelial cells (6, 18). 
Another intriguing possibility, raised by the similar inhibitory effects 
induced by extracellular cr and HCO; replacement and prolonged PMA exposure, 
is that the PMA inhibitable 86Rb + efflux in HT29ci.19A cells is mediated by a novel 
transporter which is dependent on cr influx. This system would be stimulated 
during a state of active cr secretion in order to facilitate the efflux of K+ which 
accumulates by the increased activity of the Na+ ;K•-ATPase and the Na-K..CI2 
cotransporter. 
The Ca2 • -provoked 86Rb+ efflux was also inhibited by PMA, barium and 
bumetanide, suggesting that similar K+ transport systems are active during cAMP-
and Ca2•-mediated cr efflux. The HT29ci.19A cell line seems to differ in this 
respect from the colonic cell line T84, where forskolin in contrast to Ca2 • 
ionophore induced only a very small increase in 86Rb+ efflux (26, unpublished 
observations). 
Clearly further research is needed to identify the PMA-sensitive 86Rb + 
efflux pathways at the molecular level and to determine the mechanism by which 
a tonic stimulation of protein kinase C leads to a virtually complete downregulation 
of these pathways in the HT29ci.19A colonocytes. 
We are grateful to Or. C.L Laboisse (Unite 239, lnstitut National de la Sante et de Ia Recherche 
Medicinale, Paris) for the donation of the HT29ci.19A colonocytes. 
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CHAPTER 7 
GENERAL DISCUSSION 
This thesis describes several aspects of the regulation of intestinal 
chloride secretion. As a model system, freshly isolated rat enterocytes and human 
colon carcinoma cell lines, HT29ci.19A and T84, were used. These cell lines were 
not only selected for their capacity to secrete chloride, but also for their polarized 
morphology and their formation of tight junctions, allowing electrical 
measurements of ion transport in the Ussing chamber. 
A major goal of our studies was to determine the relative contribution of 
regulatory components and ion channels localized in the apical and the 
basolateral membrane to transepithelial chloride secretion. In a previous study, the 
enterocytes were found to contain a GTP-activated phospholipase C (PLC) at the 
apical membrane. As all G-protein-coupled hormone receptors are localized at the 
basolateral membrane, GTP-activated PIP2 hydrolysis in the brush border region 
was unexpected. To further investigate subcellular differences in signalling 
pathways, we studied the distribution of several G-proteins among the apical and 
basolateral membrane. This study revealed an asymmetrical distribution of G-
proteins: Gs and Gp were present at both the apical and the basolateral 
membrane, whereas Gi2 and Gi3 were predominantly localized at the basolateral 
membrane. Furthermore, two novel G-proteins, immunologically related to Gi, 
have been identified: a 39 kDa (apical) and a 78 kDa (apical and basolateral) ad-
like protein [Chapter 2]. Thusfar three G-proteins have been implicated in the 
activation of phospholipase C: Gq, Gi2 and Go (see Chapter 1: General 
Introduction). In enterocytes, Gp is likely to be identical to Gq (Fig.1), as Go is not 
detectable by immunoblotting and Gi2 is predominantly localized at the 
basolateral membrane [Chapter 2]. The G-protein that couples to phospholipase 
C at the basolateral membrane could be identical to Gq or Gi2. However, since 
pertussis toxin pretreatment did not abolish carbachol-induced cr secretion, the 
involvement of Gi2 is unlikely [DeJonge, unpublished results]. As specific antisera 
against the Gq family have been generated recently, a tool to study the 
expression of Gq in enterocytes is now available [Gutowski et al., 1991]. The 
specific targeting of some, but not all G-proteins to the apical membrane supports 
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the idea that G-proteins might have a specific function at this subcellular region. 
Much attention was paid to the possibility that some of the apical G-
proteins might act as regulators of apical Cl"channels. In this study, cr 
conductance measurements in apical membrane vesicles of rat enterocytes and 
HT29cl.19A colonocytes were combined with single channel analysis of cr 
conductance in inside-out patches of HT29c1.1 9A membranes. In both model 
systems, GTPyS activated a novel type ol cr channel, different from CFTR, 
apparantly through interaction with an apical G-protein [Chapter 3]. The identity 
ol this G-protein is presently unknown, but apical Gs and Gp (probably Gq) 
proteins are potential candidates. The observation, however, that choleratoxin 
(CT)-induced cr secretion is abolished in CF patients, as concluded from short-
circutt current (lscl measurements in the Ussing chamber [Bijman et al., 1990], 
suggests that Gs does not activate the (CF-insensitive) G-protein-gated cr 
channel, unless: 1) the apical Gs is not activated by CT or 2) the G-channel does 
not contribute to the CT -provoked lsc. The biophysical and regulatory properties 
of the G-channel are different from the cAMP-, the volume- and the Ca2• -regulated 
cr channels in T84 colonocytes as determined by the whole cell patch clamp 
technique [Chapter 3; Worrell and Frizzell, 1991]. Further studies defining the 
intracellular and tissue distribution ol this G-channel and the identity of the G-
protein involved might help to elucidate the function of this novel Cr channel. The 
identtty of the G-protein(s) involved may be confirmed by demonstrating G-
channel activation in excised membrane patches by purified G-protein a subunits. 
Alternative candidates for activation of the G-channel, might be the novel 
39 kDa Gi-like proteins or other yet unidentified G-proteins present at the apical 
membrane (Gx in Fig.1 ). It is tempting to speculate that the 78 kDa Gi-l ike protein 
might be a proteolytic degradation product of P1 00, a GTP-binding protein 
immunologically related to Gi [Traub et al., 1990; Traub et al., 1991]. P100 shares 
a putative receptor binding sequence with Gt and Gi, and is proposed to be 
involved in receptor trafficking. As the 78 kDa protein is localized at the 
basolateral membrane, the possible relationship between the 78 kDa protein and 
P1 00 deserves further study. 
Furthermore, the possibility that the a subunit of Gs can be released from 
the apical membrane and couple to adenylate cyclase at the basolateral 
membrane was studied. This process might be facilitated by the lack of myristic 
acid on the a subunit ol Gs, in contrast to most other G-protein a subunits [Buss 
et al., 1987]. Although several investigators have found evidence for a GTPyS-
induced release ol as from plasmamembranes [Milligan and Unson, 1989], 
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GTPyS- or cholera toxin did not induce the release of as from non-vesiculated 
intestinal brush border membranes [Chapter 2]. This finding has two important 
implications. First, the presence of Gs at the apical membrane and the lack of its 
release from this membrane, suggest that Gs in the enterocyt does not function 
as a "programmable messenger" [Rodbell, 1985]. but may have different targets 
at the apical membrane (e.g. ion transport systems) and the basolateral 
membrane (adenylate cyclase)(Fig.1). Secondly, cholera toxin itself, rather than 
ADP-ribosylated Gs, musttranslocate from the apical membrane to the basolateral 
membrane in order to activate adenylate cyclase at this subcellular region (Fig.1, 
the A1 subunit of CT). 
The identification of two G-protein-activated effectors at the apical 
membrane: phospholipase C and a distinct class of cr channels, suggests the 
presence of physiological activators. The possibility that other signal transduction 
routes could function as activators of apical PIP2 hydrolysis was investigated, by 
studying the possible potentiating effects of cAMP, cGMP, Ca2 • and PKC on 
inositol phosphate production and calcium mobilization. However, PKC and cAMP 
inhibited rather than stimulated these processes: PKC upstream and cAMP 
downstream of phospholipase C activation [Chapter 4]. Negative feedback on the 
PI-cycle by PKC is commonly found in many cell types. In contrast, cAMP-induced 
inhibition of carbachol-induced calcium mobilization was rather unexpected, as 
in chicken enterocytes cAMP itself mobilized calcium [Semrad and Chang, 1 987; 
Chang and Musch, 1990; Semrad et al., 1990]. The mechanism of the cAMP-
induced inhibition is presently unknown, but cAMP-induced inhibition of 
lns(1,4,5) P3-triggered calcium mobilization [Supattapone et al., 1988] and calcium 
entry [Felbel et al., 1988] have been reported for other cell types. Very recently, 
carbachol-stimulated calcium entry in HT29 cells was found to be inhibited by 
membrane depolarization [Fischer et al., 1992], which could be an alternative 
mechanism as cAMP has been shown to induce membrane depolarization in 
HT29ci.19A cells [Bajnath et al., 1991]. A possible interaction of cGMP with 
inositol phosphate production and diacylglycerol (DAG) formation seemed worth 
considering a recent report showing that ANF- and 8-Br-cGMP-induced Na+ 
channel closing in renal epithelial cells was mediated by PKC [Mohrmann et al., 
1987]. In enterocytes, the apical membrane contains both the cGMP pathway and 
a GTP-activated PI-turnover. Thus, cGMP could theoretically act through activation 
of this PI-cycle, leading to formation of DAG and subsequent activation of PKC in 
these cells as well. However, STA, the heat-stable E.coli toxin that raises cGMP 
levels did not activate phospholipase C [Chapter 4]. Since sources other than 
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PIP2 for DAG formation exist, this finding does not entirely rule out the possibility 
that cGMP acts through PKC. For instance, in tracheal epithelial cells, cAMP was 
found to raise DAG levels independently of PIP2 hydrolysis [Anderson and Welsh, 
1990]. 
Other potential activators of the apical signalling routes may include as 
yet unidentified receptors at the apical membrane (Fig.1, extracellular regulator?). 
In addition, it is also possible that non-receptor mediated signals can activate 
these pathways, such as cell volume changes. Alternatively, intracellular 
messengers other than cAMP, cGMP, calcium and DAG could be involved (Fig.1, 
intracellular regulator?). Examples of such intracellular activators of G-proteins are 
growth cone associated protein, GAP43, which has been found to stimulate Go 
[Strittmatter et al., 1990], and NDP-kinase (nucleotidediphosphate kinase), which 
could stimulate Go, Gi and Gs by direct transfer of they phosphate of ATP to the 
GOP bound to these G-proteins [Kikkawa et al., 1990]. 
Stimulation of chloride efflux does not necessarily lead to net chloride 
secretion. This is illustrated in HT29ci.19A cells, where Ca2 + -ionophore induces cr 
channel opening as measured by ' 251" or 36CI" efflux [Vaandrager et al., 1991], but 
does not induce an lsc in the Ussing chamber, indicative for net chloride secretion 
[Chapter 5]. This apparant paradox is explained by the co-localization of Ca2+-
sensitive cr and K+ channels in both the apical and basolateral membrane (Fig.2) 
[Vaandrager et al., 1991]. These channels are different from CFTR by their 
distribution, anion selectivity and biophysical parameters [Vaandrager et al., 1991; 
Cliff and Frizzell, 1990]. 
In contrast, calcium is capable of regulating CFTR in human ileal mucosa: 
Ca2 + -ionophore-induced cr secretion was absent in CF ileum [Berschneider et al., 
1988; DeJonge et al., 1989]. As calcium regulation of CFTR is not observed in 
most other cell types [Boucher et al., 1989], a unique signalling pathway for 
calcium-induced CFTR activation may exist in the small intestine. The mechanism 
through which calcium regulates CFTR in human ileum is unknown, but direct 
binding of calcium to CFTR is very unlikely as EF hand structures in CFTR have 
not been described. Furthermore, such a regulation can not explain the difference 
between intestinal and other epithelial cells. Activation of CFTR by a 
Ca2+ /calmodulin kinase (CaCaMK) is more likely, since CFTR is found to be 
regulated by a variety of kinases, e.g. PKA, PKC [Tabcharani et al., 1991] and 
PKG-11 [DeJonge and Bijman, in preparation]. CaCaMK-11 is ubiquitously present 
in most epithelial and non-epithelial cell types and is linked to a class of Cl" 
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channels different from CFTR [Worrell and Frizzell, 1991], making this pathway 
unlikely to be involved in calcium-triggered activation of CFTR. The other forms 
of CaCaMK, type I and Ill, could potentially regulate CFTR. However, CaCaMK-111 
is highly substrate-specific, using only elongation factor 2 as a substrate [Rao and 
DeJonge, 1990], suggesting that CaCaMK-1 is the most plausible candidate lor 
CFTR activation. This hypothesis is supported by the recent finding that CaCaMK-
1, but not CaCaMK-11, can phosphorylate CFTR in vitro in the R-domain [A.C.Nairn, 
personal communication] and by the immunological demonstration of CaCaMK-1 
in intestinal epithelial cells [Rao and DeJonge, 1990]. The lack of calcium'induced 
CFTR activation in non-intestinal epithelial cells and in the colon carcinoma cell 
lines suggest that CaCaMK-1 (apart from its known presence in neuronal cells) is 
uniquely expressed in epithelial cells of the small intestine. It is worthwile to test 
this hypothesis by using isolorm-specific CaCaMK-directed antisera. 
To establish the role of PKC in cr secretion, HT29ci.19A human colon 
carcinoma cells were chosen as model system. In these cells, activation of PKC 
by phorbol esters was found to stimulate basal chloride secretion and to inhibit 
cAMP-induced chloride secretion [Chapter 5]. As PKC is a family of enzymes, 
these bimodal effects could be mediated by different forms of PKC.However, 
despite the variety of PKC isoforms expressed in the HT29ci.19A cells (a:, B1, y, 
11 and (), only PKC a: was found to play an important role in both stimulation and 
inhibition of cr secretion (Fig.2)[Chapter 5]. 
As the cr secretory response (lscl in the Ussing chamber depends on the 
proper functioning of at least four different ion transporters [Chapter 1: Fig.2], 
inhibition of the lsc in response to chronic stimulation by PKC does not reveal 
which transport system is the main target for PKC-inhibition. However, by using 
isotope efflux studies, PKC-induced inhibition was found to be directed at the K+ 
transporters (Fig.2), rather than the cr channel itself [Chapter 6]. These data are 
different from those described in tracheal epithelial cells, in which PKC has been 
reported to inhibit cAMP-activated chloride efflux [Li et al., 1989]. The reason for 
this discrepancy is presently unknown, but could reside in differences in PKC 
isozyme pattern between these cell types. Even between two colon carcinoma cell 
lines, the T84 and HT29ci.19A cells, differences in isozyme content exist. For 
example, the most important PKC isoform in the regulation of chloride secretion 
in HT29cl.19A cells, PKC a:, is not detectable in T84 cells [Van den Berghe, 
unpublished results]. Consequently, PMA did not induce cr secretion in the T84 
cells [Kachintorn et al., 1992], strengthening the idea that PKC a: fulfills a key role 
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in the activation of intestinal cr secretion. Furthermore, in human intestinal 
mucosa, the expression of PKC a correlates with the ability of PMA to induce cr 
secretion [Van den Berghe, unpublished], suggesting that the HT29ci.19A cells is 
a better representative for studying PKC regulation than the T84 cells. 
In conclusion, some novel aspects of signal transduction involved in salt 
and water secretion in intestinal epithelial cells are described in this thesis. The 
identification of signalling molecules (G-proteins, phospholipase C) at the apical 
border of rat enterocytes [Chapter 2] was of interest considering the localization 
of all known G-protein-coupled hormone receptors at the basolateral membrane. 
In addition, G-proteins were found to activate a novel class of cr channels 
[Chapter 3]. However, the role of these apical signalling molecules and the G-
protein-gated cr channel in the regulation of net salt and water secretion remains 
to be established [Chapter 2 and 3]. Furthermore, despite the expression of at 
least five PKC isolorms in HT29d.19A cells, only PKC a; was involved in the 
regulation of chloride secretion [Chapter 5]. The targets for PKC a; induced 
stimulation and inhibition of cr secretion were different: cr channels and K+ 
transporters, respectively [Chapter 6]. The identification of the K+ transporters at 
the molecular level, however, awaits further research. 
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SUMMARY 
The major intracellular signalling molecules involved in the regulation of 
intestinal ion transport are: cyclic adenosine monophosphate (cAMP), cyclic 
guanosine monophosphate (cGMP), calcium and diacylglycerol. An increase in 
the intracellular concentrations of any of these mediators results in an increase in 
cr secretion and inhibition of cr absorption, leading to a net accumulation of salt 
and water in the lumen. Abnormalities in the regulation of these processes are 
observed in two major disease states: cystic fibrosis (CF) and secretory diarrhoea 
(SD). CF is the most common fatal genetic disease among the Caucasian 
population with an incidence of about 1 in 2500 and a median life expectation of 
approximately 26 years. The basic defect has been characterized as an 
impairment of cr transport in epithelial cells, leading to functional disturbances in 
various organs, including airways, pancreas, sweat glands and intestine. The 
mutated gene responsible for cystic fibrosis has recently been identified and 
encodes a hormonally-regulated cr channel protein, designated cystic fibrosis 
transmembrane conductance regulator (CFTR). In CF patients, mutations in this 
protein result in its defective processing and/or loss of function. In secretory 
diarrhoea, CFTR becomes hyperactive in response to enterotoxins, such as 
cholera toxin, heat labile and heat stable E.coli toxin. As these enterotoxins act 
through the same signalling molecules (cAMP, cGMP) that are ineffective in 
activating CFTR in CF patients, CF heterozygotes are expected to be less 
sensitive to the excessive and often lethal dehydration associated with SD. 
The vectorial transport of salt and water across epithelial layers is critically 
dependent on the structural and functional polarization of the cell types involved 
and requires an asymmetrical distribution of transport systems among apical 
(luminal) and basolateral membranes. In the intestinal crypt cells, cr channels are 
localized almost exclusively at the apical membrane, whereas other transporters 
required for net cr secretion (i.e. Na+K+CI2-cotransporters, Na+ ;K•-ATPases and 
K+ channels) are localized mainly at the basolateral membrane. The receptors for 
hormones and neurotransmitters are likewise found predominantly at the 
basolateral membrane of intestinal epithelial cells. Our previous finding of a GTP-
activated phospholipase C at the apical membrane of rat enterocytes was 
therefore rather unexpected and prompted us to investigate whether such an 
apical localization was unique for this intracellular signalling pathway. In a first 
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approach, the apical versus basolateral distribution of several G-proteins, known 
to act as coupling factors between hormone receptors and signalling enzymes or 
ion channels, was examined. This study revealed that Gs and Gp were localized 
both apically and basolaterally, whereas Gi2 and Gi3 were detected predominantly 
in the basolateral membrane [Chapter 2]. No evidence was obtained lor a 
redistribution or solubilization of any of the G-protein subunits in response to their 
activation by GTPyS or following cholera toxin or pertussis toxin catalyzed ADP-
ribosylation. The different distribution of Gs and Gi among the apical and the 
basolateral membrane strongly supports the concept that the G-proteins may have 
a specific function at the membrane to which they are targeted. The co-
localization of several G-proteins and intestinal cr channels in the apical 
membrane, together with recent reports documenting G-protein regulation of a 
variety of ion channels, prompted us to study the possible modulation of apical 
cr channels by G-proteins. This study led to the discovery of a novel G-protein 
activated cr channel in the apical membrane of both rat enterocytes and human 
colonocytes. As described in Chapter 3, this channel was clearly distinct in its 
biophysical and regulatory properties from the cAMP-activated cr channel, CFTR. 
The elucidation olthe physiological function ofthis G-protein-activated Cl"-channel 
and the identification of the G-protein involved awaits further research. 
The presence of an apical GTP-triggered phosphoinositide (PI)-pool, 
suggests a local function for PI-derived second messengers (calcium and the 
protein kinase C (PKC) activator diacylglycerol) in this subcellular region. The lack 
of G-protein-coupled hormone receptors at the apical membrane, however, 
prompted us to search for alternative pathways possibly linked to the apical PI-
cycle. Since cAMP-, cGMP- and PI-mediated pathways are all known to provoke 
cr secretion, the possibility was considered that these second messengers could 
amplify their signal by activating the apical PI-pool. Effects ol cAMP, cGMP, 
calcium and PKC on the release of inositol phosphates and calcium were studied 
in the absence and presence of carbachol, a potent activator of the basolateral 
PI-cycle [Chapter 4]. Cyclic AMP had no effect on basal levels of inositol 
phosphates or intracellular free Ca2•, but partially inhibited the carbachol-induced 
calcium mobilization at a step distal from the generation of inositol phosphates. 
In contrast the phorbol ester PMA, a PKC activator, was found to inhibit both 
processes. Although the outcome ol this study revealed the existence of cross-talk 
between the various messenger systems, no stimulatory effects on the (apical) PI-
cycle were found. 
Finally, the role of PKC in general and its isoforms in particular, in the 
134 
regulation of ion transport was investigated. Activators of PKC were found to exert 
both stimulatory and inhibitory effects on transepithelial cr secretion. A possible 
antagonistic role of different isoforms was studied by using PKC-isotype-specific 
antisera. In this study, described in Chapter 5, the expression of multiple isoforms 
of PKC (a:, B1, y, ,, ()could be demonstrated immunologically in the HT29ci.19A 
human colonic cell line. As the prolonged exposure to PMA resulted in the 
selective down-regulation of PKC a, but not of the other isozymes, and was 
accompanied by a loss of the stimulatory effect of PMA on net chloride secretion 
and recovery of the cAMP response, this isoform seems to have a dual role in the 
regulation of intestinal chloride secretion. Further analysis of the transport systems 
involved, revealed that PKC a: had different targets: PKC-stimulated apical cr 
channels and PKC-inhibited basolateral K+ transporters [Chapter 6]. 
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SAMENVAffiNG 
De belangrijkste intracellulaire signaalstoflen, betrokken bij de regulatie 
van ionen transport in darmepitheel, zijn: cyclisch adenosine monofosfaat (cAMP), 
cyclisch guanosine monofosfaat (cGMP), calcium and diacylglycerol. Een 
verhoging van de intracellulaire concentratie van elk van deze signaal moleculen 
leidt tot een verhoogde zout en water uitscheiding in het lumen, doordat de 
secretie van cr gestimuleerd en de absorptie van cr geremd wordt. Een 
pathologische stoornis op het niveau van cr secretie is het kenmerk van twee veel 
voorkomende ziektebeelden: taai slijm ziekte of cystic fibrosis (CF) en secretoire 
diarree (SD). CF is de meest voorkomende lethale genetische ziekte onder het 
blanke ras met een incidentie van 1 op de 2500 en een levensverwachting van ± 
26 jaar. De ziekte wordt gekenmerkt door een verminderd Cr transport in 
epitheelcellen van een groot aantal organen, zoals de luchtwegen, de pancreas 
(alvleesklier), de zweetklieren en de darm. Het gemuteerde gen dat 
verantwoordelijk is voor het ontstaan van CF is recent ontdekt en codeert voor 
een hormonaal reguleerbaar cr kanaal eiwit, dat cystic fibrosis transmembrane 
conductance regulator (CFTR) genoemd wordt. De bij CF patienten aangetroffen 
mutaties in het CFTR hebben tot gevolg dat het eiwit niet in de plasma membraan 
terecht komt enjof functioneel gestoord is. In tegenstelling tot CF zien we bij 
secretoire diarree een over-aktief CFTR. De belangrijkste oorzaak van SD is een 
contact van het darmslijmvlies met toxines van pathogene darmbacterien, zoals 
cholera toxine en het hitte labiele en hitte stabiele E.coli toxine. Deze toxines 
activeren CFTR door de intracellulaire concentratie van cAMP of cGMP drastisch 
te verhogen. Aangezien deze signaal moleculen CFTR niet kunnen activeren in CF 
patienten, kan verwacht worden dat CF heterozygoten (waarbij slechts een van 
de twee genen is gemuteerd) minder gevoelig zijn voor diarree ziekten 
("heterozygoot voordeel"). 
Om het transport van zout en water vectorieel te Iaten veri open (bijv. van 
serosa naar mucosa) is het noodzakelijk dat het betrokken eel type gepolariseerd 
is en dat de transport systemen asymmetrisch zijn verdeeld over de apicale 
(luminal e) en de basolaterale membraan. De chloride kanalen zijn daartoe apicaal 
en de andere transport systemen die nodig zijn voor transepitheliale cr secretie 
(Na+K+CI2-cotransporteurs, Na+ /K+ -ATPases en K+ kanalen) basolateraal 
gelocaliseerd. De receptoren voor hormonen en neurotransmitters zijn ook 
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gepolariseerd gelocaliseerd, namelijk in de basolaterale membraan van darm 
epitheelcellen. Onze vroegere bevinding dat een GTP-activeerbaar fosfolipase C 
in de apicale membraan van rattedarm epitheelcellen aanwezig is was dan ook 
onverwacht. Om te testen of een apicale localisatie uniek is voor deze 
intracellulaire signaal route of dat ook andere signaal moleculen in de hormoon-
receptor arme apicale membraan aanwezig zijn, werd de verdeling van 
verschillende G-eiwitten over de apicale en de basolaterale membraan bestudeerd 
[Hoofdstuk 2]. G-eiwitten koppelen de hormoon receptor aan intracellulaire 
boodschappers of aan ionen kanalen in de eel membraan. Gs and Gp bleken in 
zowel de apicale als de basolaterale membraan te zijn gelocaliseerd, in 
tegenstelling tot Gi2 en Gi3, die voornamenlijk in de basolaterale membraan 
werden aangetroffen. Er waren geen aanwijzingen voor een translocatie of een 
solubilisatie van deze G-eiwitten na activatie door GTPyS of via cholera/ pertussis 
toxine gekataliseerde ADP-ribosylering. Dit verschil in localisatie tussen Gs and Gi 
versterkt het idee dat G-eiwitten een specmeke functie hebben in die membraan 
waarin ze zijn gelegen. De co-localisatie van verschillende G-eiwitten en Cl' 
kanalen in de apicale membraan, tesamen met recent verschenen artikelen waarin 
verschillende ionen kanalen rechtstreeks gereguleerd bleken door G-eiwitten, 
suggereerde een mogelijke modulatie van apicale cr kanalen door G-eiwitten. 
Biochemisch en electrofysiologisch onderzoek van deze hypothese leidde tot de 
ontdekking van een nieuw G-eiwit geactiveerd Cl' kanaal in de apicale membraan 
van zowel rattedarm epitheelcellen als humane colonocyten [Hoofdstuk 3]. Dit 
kanaal was duidelijk te onderscheiden van het cAMP-geactiveerde Cl' kanaal, 
CFTR, op grand van zijn biofysische en regulatoire eigenschappen. Verder 
onderzoek is nodig om de fysiologische functie van dit G-eiwit geactiveerde Cl' 
kanaal en de identiteit van de betrokken G-eiwitten te onthullen. 
De localisatie van een GTP-activeerbaar fosfolipase C in de apicale 
membraan suggereert een locale functie in deze subcellulaire regia voor de 
boodschappers die ontstaan na activatie van dit enzym: calcium en diacylglycerol, 
de activator van protein kinase C (PKC). Aangezien de apicale membraan geen 
G-eiwit gekoppelde hormoon receptoren bevat, werd gezocht naar alternatieve 
routes voor activatie van deze apicale fosfo-inositide (PI)-cyclus. Een mogelijke 
interactie met basolateraal gegenereerde intracellulaire signaal moleculen (cAMP, 
calcium, diacylglycerol) of met de apicale cGMP route ("cross-talk'') werd 
bestudeerd [Hooldstuk 4]. Cyclisch AMP had geen invloed op het basale niveau 
van zowel de inositol fosfaten als de intracellulaire calcium concentratie, maar 
remde gedeeltelijk de carbachol-geinduceerde calcium mobilisatie zonder de 
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productie van inositol fosfaten te beYnvloeden. Daarentegen remde de forbol ester 
PMA, een PKC activator, beide processen. Het resultaat van deze studie laat dus 
de aanwezigheid van "cross-talk" zien tussen cAMP- en Pl-gemedieerde routes, 
maar een stimulerend effect op de (apicale) Pl-cyclus ken niet worden 
aangetoond. 
Tenslotte werd de rol van PKC in het algemeen en van zijn isoformen in 
het bijzonder in de regulatie van ionen transport bestudeerd. Activatoren van PKC 
hadden zowel een stimulerende als een remmende werking op transepitheliale cr 
secretie. Deze antagonistische werking zou gemedieerd kunnen zijn door 
verschillende isoformen van PKC, hetgeen werd bestudeerd door middel van PKC 
isoform-specifieke antilichamen. In het model systeem voor deze studie, 
gepolariseerde monolagen van HT29ci.19A humane colonocyten, werd de 
expressie van meerdere isoformen van PKC (o:, B1, y, TJ, C) immunologisch 
aangetoond. Langdurig behandelen met PMA resulteerde in de selectieve down-
regulatie van PKC o:, maar niet van de andere PKC isoformen, hetgeen gepaard 
ging met het verdwijnen van het stimulerend effect van PMA en met opheffing van 
de remming van de cAMP-gemedieerde netto cr secretie. Deze bevindingen 
suggereren een rol voor PKC a in zowel de stimulering als de remming van 
intestinale chloride secretie [Hoofdstuk 5]. Nadere analyse van de betrokken 
transport systemen leidde tot de conclusie dat het stimulerend effect van PKC a 
verloopt via activering van apicale cr kanalen, terwijl het rem mend effect verklaard 
kan worden door inactivering van basolaterale K+ transporteurs [Hoofdstuk 6]. 
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